Manulife Financial Corp 6-K, filed May 6, 2020
Manulife Financial Corp (MFC)
About this 6-K
Manulife Financial Corp filed this 6-K on May 6, 2020.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of May, 2020
Commission File Number: 1-14942
MANULIFE FINANCIAL CORPORATION
(Translation of registrant's name into English)
200 Bloor Street East
North Tower 10
Toronto, Ontario, Canada M4W 1E5
(416) 926‑3000
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
| Form 20-F | ◻ | Form 40-F | ☑ |
|---|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ◻
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ◻
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
| Yes | ◻ | No | ☑ |
|---|
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________.
The registrant’s Management’s Discussion and Analysis and Unaudited Interim Consolidated Financial Statements for the quarter ended March 31, 2020 included on pages 4 to 33 and 34 to 66, respectively, of the registrant’s 2020 First Quarter Report to Shareholders filed with this Form 6-K as Exhibit 99.1, are incorporated by reference in the registration statements filed with the Securities and Exchange Commission by the registrant on Form S-8 (Registration Nos. 333-12610, 333-13072, 333-114951, 333-129430, 333‑157326, and 333-211366), on Form F‑3 (Registration No. 333-159176) and on Form F-10 (Registration No. 333-235315) and by the registrant and John Hancock Life Insurance Company (U.S.A.) on Form F-3 (Registration Nos. 333-221821-01 and 333-221821, respectively). Except for the foregoing, no other document or portion of a document filed with this Form 6-K is incorporated by reference in the above registration statements.
DOCUMENTS FILED AS PART OF THIS FORM 6-K
The following documents, filed as exhibits to this Form 6-K, are incorporated by reference as part of this Form 6-K:
| Exhibit | Description of Exhibit |
|---|---|
| 99.1 | First Quarter Report to Shareholders |
| 99.2 | Certification Chief Executive Officer |
| 99.3 | Certification Chief Financial Officer |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MANULIFE FINANCIAL CORPORATION | |
|---|---|
| By: /s/ James D. Gallagher | |
| Name: James D. Gallagher | |
| Title: General<br><br><br> Counsel | |
| Date: May 6, 2020 |
EXHIBIT INDEX
| Exhibit | Description of Exhibit |
|---|---|
| 99.1 | First Quarter Report to Shareholders |
| 99.2 | Certification Chief Executive Officer |
| 99.3 | Certification Chief Financial Officer |

Manulife reports 1Q20 net income of $1.3 billion and core earnings of $1.0 billion, a strong capital position with a LICAT ratio of 155%, and net inflows of $3.2 billion in Global Wealth and Asset Management
Today, Manulife announced its 1Q20 results. Key highlights include:
| ◾ | Net income attributed to shareholders of $1.3 billion in 1Q20, down $0.9 billion from 1Q19 |
|---|---|
| ◾ | Core earnings^1^ of $1.0 billion in 1Q20, down 34%^2^ from 1Q19 |
| --- | --- |
| ◾ | Strong LICAT ratio^3^ of 155% |
| --- | --- |
| ◾ | Core ROE^1^ of 8.2% and ROE of 10.4% in 1Q20 |
| --- | --- |
| ◾ | NBV^1^ of $0.5 billion in 1Q20, down 11% from 1Q19 |
| --- | --- |
| ◾ | APE sales^1^ of $1.6 billion in 1Q20, down 9% from 1Q19 |
| --- | --- |
| ◾ | WAM net inflows^1^ of $3.2 billion in 1Q20 compared with net outflows of $1.3<br> billion in 1Q19 |
| --- | --- |
| ◾ | Leverage ratio of 23% on March 31, 2020, down 2.1 percentage points from December 31, 2019 |
| --- | --- |
“As the world battles against COVID-19, the safety and well-being of our employees and customers is a top priority, and we salute the tireless and selfless efforts of those who are helping others during this challenging time, including frontline healthcare workers. We are contributing $25 million to focus on several critical fronts, including relief for our customers, support for our employees, and aid for our communities. We are also supporting the efforts of our employees by matching their donations,” said Manulife President & Chief Executive Officer Roy Gori.
“I am very proud of how our teams have risen to the challenge to be there for our customers when they need us most. To support business continuity, we adapted quickly by accelerating the rollout of digital tools and platforms, enabling us to continue to service existing customers and generate new business from the fulfillment of customers’ insurance and wealth management needs across all our markets globally.
“The COVID-19 pandemic continues to disrupt economies and capital markets worldwide, and our operating conditions during the first quarter were understandably affected. Considering these challenging conditions, we delivered solid results, demonstrating the diversity and resilience of our businesses. In recent years, we’ve taken significant actions to strengthen our capital ratios, reduce our leverage, reduce risk in our legacy businesses, and tightly manage our expense base. As a result, I’m confident that Manulife is well positioned to navigate this crisis and achieve ongoing success in the long-term,” added Mr. Gori.
Phil Witherington, Chief Financial Officer, said, “Our business results were solid in the first quarter. Global Wealth and Asset Management generated net inflows of $3.2 billion with positive contributions from all business lines. Our insurance new business generation remained robust with meaningful growth in new business value in both Hong Kong and Asia Other markets.”
“Our balance sheet has shown resilience in challenging market conditions with our LICAT capital ratio strengthening further to 155% and our leverage ratio declining to 23% as of the end of the first quarter. This combination provides financial flexibility and puts us in a position of strength during challenging macroeconomic times,” added Mr. Witherington.
BUSINESS HIGHLIGHTS:
We made further progress on portfolio optimization in 1Q20, through a variety of initiatives in the U.S. We experienced continued success from our Annuity Guaranteed Minimum Withdrawal Benefit offer program, recognized impacts from the sale of alternative long-duration assets (“ALDA”) enabled by the reinsurance of individual and group payout annuity policies, and expanded reinsurance coverage of certain universal life no lapse guarantee products. In total, these initiatives generated additional capital benefits of $265 million during the quarter.
| ^1^ | Core earnings, core return on common shareholders’ equity (“core ROE”), new business value (“NBV”), annualized premium equivalent (“APE”) sales and net flows are<br> non-GAAP measures. See “Performance and Non-GAAP Measures” below and in our First Quarter 2020 Management’s Discussion and Analysis (“1Q20 MD&A”) for additional information. |
|---|---|
| ^2^ | All percentage growth / declines in financial metrics in this news release are reported on a constant exchange rate basis. Constant exchange rate basis excludes the<br> impact of currency fluctuations and is a non-GAAP measure. See “Performance and Non-GAAP Measures” below and in our 1Q20 MD&A for additional information. |
| --- | --- |
| ^3^ | Life Insurance Capital Adequacy Test (“LICAT”) ratio of The Manufacturers Life Insurance Company (“MLI”). |
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
1
In 1Q20, we continued to leverage and enhance our digital capabilities, while extending support to our customers during the COVID-19 pandemic. Strategic investment in our technology infrastructure in recent years led to a smooth transition for over 95% of employees working from home. In Asia, we accelerated our digital capabilities and supported our customers by extending the use of non face-to-face sales methods across most of our businesses. Additionally, we have provided limited additional benefit coverage and extended premium payment grace periods. In Canada, we provided a temporary extension of emergency out-of-country coverage for our group and individual customers who experienced travel delays and introduced flexible financial solutions to support our banking clients. In the U.S., we have extended the grace period for our life insurance policyholders to make premium payments and increased the payout limits permitted via phone for our annuity and life customers. In addition, in our Global Wealth and Asset Management business in Canada, we launched an online cash withdrawal feature, allowing members to have a safe and reliable way to directly access their retirement plans and in the U.S., we have temporarily waived the fee for 401k hardship withdrawals.
FINANCIAL HIGHLIGHTS:
| ( millions, unless otherwise stated) | 1Q20 | 1Q19 | |||
| Profitability: | |||||
| Net income attributed to shareholders | 1,296 | $ | 2,176 | ||
| Core earnings(1) | 1,028 | $ | 1,548 | ||
| Diluted earnings per common share () | 0.64 | $ | 1.08 | ||
| Diluted core earnings per common share ()(1) | 0.51 | $ | 0.76 | ||
| Return on common shareholders’ equity (“ROE”) | 10.4 | % | 20.1 | % | |
| Core ROE(1) | 8.2 | % | 14.2 | % | |
| Expense efficiency ratio(1) | 60.0 | % | 49.9 | % | |
| Performance: | |||||
| Asia new business value | 356 | $ | 411 | ||
| Canada new business value | 77 | $ | 62 | ||
| U.S. new business value | 36 | $ | 46 | ||
| Total new business value(1) | 469 | $ | 519 | ||
| Asia APE sales | 1,084 | $ | 1,336 | ||
| Canada APE sales | 376 | $ | 261 | ||
| U.S. APE sales | 141 | $ | 143 | ||
| Total APE sales(1) | 1,601 | $ | 1,740 | ||
| Wealth and asset management net flows ( billions)(1) | 3.2 | $ | (1.3 | ) | |
| Wealth and asset management gross flows ( billions)(1) | 38.2 | $ | 27.9 | ||
| Wealth and asset management assets under management and administration ( billions)(1) | 636.2 | $ | 648.1 | ||
| Financial Strength: | |||||
| MLI’s LICAT ratio | 155 | % | 144 | % | |
| Financial leverage ratio | 23.0 | % | 27.0 | % | |
| Book value per common share () | 26.53 | $ | 22.34 | ||
| Book value per common share excluding AOCI () | 20.29 | $ | 19.06 |
All values are in US Dollars.
| ^(1)^ | This item is a non-GAAP measure. See “Performance and Non-GAAP Measures” below and in our 1Q20 MD&A for additional information. |
|---|
PROFITABILITY:
Reported net income attributed to shareholders of $1.3 billion in 1Q20, down $0.9 billion from 1Q19
The decrease compared with 1Q19 was driven by a decline in core earnings of $0.5 billion and charges from investment-related experience and the direct impact of equity markets and variable annuity guarantee liabilities (compared to gains in the prior year), partially offset by gains from the direct impact of interest rates driven by widening corporate spreads (compared to losses in the prior year). Investment-related experience in 1Q20 reflected lower-than-expected returns (including fair value changes) on ALDA driven primarily by the impact of a sharp decline in oil prices, partially offset by the favourable impact of fixed income reinvestment activities.
Manulife Financial Corporation – First Quarter 2020
2
Achieved core earnings of $1.0 billion in 1Q20, a decrease of 34% compared with 1Q19
The decrease in core earnings in 1Q20 compared with 1Q19 was driven by the unfavourable impact of markets on seed money investments in new segregated funds and mutual funds, the absence of core investment gains^1^ in the quarter, lower new business volumes in Japan and unfavourable 1Q20 policyholder experience in North America, including unfavourable travel claims related to COVID-19. These items were partially offset by the impact of in-force business growth in Asia and higher fee income from higher average assets under management and administration levels in our Global Wealth and Asset Management business.
BUSINESS PERFORMANCE:
New business value (“NBV”) of $469 million in 1Q20, a decrease of 11% compared with 1Q19
In Asia, NBV decreased 14% to $356 million as growth in Hong Kong and Asia Other^2^ was more than offset by a decline in Japan. In Canada, NBV of $77 million was up 24% from 1Q19, driven by higher sales across all business lines. In the U.S., NBV of $36 million was down 23% from 1Q19, primarily due to the impact of lower sales volumes and a less favourable business mix.
Annualized premium equivalent (“APE”) sales of $1.6 billion in 1Q20, a decrease of 9% compared with 1Q19
In Asia, APE sales decreased 20% as growth in Hong Kong and Asia Other was more than offset by the impact of tax changes on corporate-owned life insurance product sales in Japan in the prior year. Hong Kong APE sales increased 21% driven by the continued success of our Voluntary Health Insurance Scheme and Qualifying Deferred Annuity products from our active agency force that grew by 18% from 1Q19. Asia Other APE sales increased 5% as strong sales in agency, were partially offset by lower sales in bancassurance. In Canada, APE sales increased 44% driven by higher large-case group insurance sales, growth across our individual insurance business, including a large sale in our affinity markets business, and higher sales of our lower risk segregated funds. In the U.S., APE sales declined 3% compared to the prior year quarter, as lower variable universal life and domestic protection universal life sales following regulatory changes in the fourth quarter of 2019 more than offset higher term life and international sales.
Reported Global Wealth and Asset Management net inflows of $3.2 billion in 1Q20, compared with net outflows of $1.3 billion in 1Q19
Net inflows in Asia were $0.6 billion in 1Q20, in line with 1Q19, as higher net inflows in retirement were offset by higher redemptions, mainly in institutional asset management. Net inflows in Canada were $2.8 billion in 1Q20 compared with net inflows of $2.1 billion in 1Q19, driven by higher gross flows^1^ into institutional asset management equity mandates. This was partially offset by lower net inflows in retirement from lower new plan sales and higher redemptions, and in retail, from higher redemptions amid equity market declines in March partially offset by higher gross flows. Net outflows in the U.S. were $0.2 billion in 1Q20 compared with net outflows of $4.0 billion in 1Q19. The improvement was driven by higher retail gross flows, primarily from strong institutional model allocations and intermediary sales, as well as the sale of a large-case retirement plan of $2.6 billion. This was partially offset by the redemption of several retirement plans and retail redemptions amid equity market declines in March.
^1^ This item is a non-GAAP measure. See “Performance and non-GAAP measures” below and in our 1Q20 MD&A for additional information.
^2^ Asia Other excludes Japan and Hong Kong.
Manulife Financial Corporation – First Quarter 2020
3
MANAGEMENT’S DISCUSSION AND ANALYSIS
This Management’s Discussion and Analysis (“MD&A”) is current as of May 6, 2020, unless otherwise noted. This MD&A should be read in conjunction with our unaudited Interim Consolidated Financial Statements for the three months ended March 31, 2020 and the MD&A and audited Consolidated Financial Statements contained in our 2019 Annual Report.
For further information relating to our risk management practices and risk factors affecting the Company, see “Risk Factors” in our 2019 Annual Information Form, “Risk Management”, “Risk Factors” and “Critical Actuarial and Accounting Policies” in the MD&A in our 2019 Annual Report and the “Risk Management” note to the Consolidated Financial Statements in our most recent annual and interim reports.
In this MD&A, the terms “Company”, “Manulife”, “we” and “our” mean Manulife Financial Corporation (“MFC”) and its subsidiaries. All amounts are reported in Canadian dollars, unless otherwise indicated.
Contents
| A. TOTAL COMPANY PERFORMANCE<br><br> <br>1. Profitability<br><br> <br>2. Business Performance<br><br> <br>3. Financial strength<br><br> <br>4. Revenue<br><br> <br>5. Assets under management and administration<br><br> <br>6. Impact of fair value accounting<br><br> <br>7. Impact of foreign currency exchange rates<br><br> <br>8. Business highlights<br><br> <br>B. PERFORMANCE BY SEGMENT<br><br> <br>1. Asia<br><br> <br>2. Canada<br><br> <br>3. U.S.<br><br> <br>4. Global Wealth and Asset Management<br><br> <br>5. Corporate and Other | C. RISK MANAGEMENT AND RISK FACTORS UPDATE<br><br> <br>1. Variable annuity and segregated fund guarantees<br><br> <br>2. Caution related to sensitivities<br><br> <br>3. Publicly traded equity performance risk<br><br> <br>4. Interest rate and spread risk sensitivities and exposure measures<br><br> <br>5. Alternative long-duration asset performance risk<br><br> <br>6. Credit risk exposure measures<br><br> <br>7. Risk factors - Pandemic risk and potential implications of COVID-19<br><br> <br>8. Risk Factors - Global outlook and economic uncertainties<br><br> <br>D. CRITICAL ACTUARIAL AND ACCOUNTING POLICIES<br><br> <br>1. Critical actuarial and accounting policies<br><br> <br>2. Sensitivity of policy liabilities to asset related assumptions<br><br> <br>3. Accounting and reporting changes<br><br> <br>E. OTHER<br><br> <br>1. Outstanding<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> shares - selected information<br><br> <br>2. Legal<br> and regulatory proceedings<br><br> <br>3. Performance<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> and non-GAAP measures<br><br> <br>4. Caution<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> regarding forward-looking statements<br><br> <br>5. Quarterly<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br> financial information<br><br> <br>6. Other |
|---|
Manulife Financial Corporation – First Quarter 2020
4
A TOTAL COMPANY PERFORMANCE
A1 Profitability
| ( millions, unless otherwise stated) | 1Q20 | 4Q19 | 1Q19 | |||||
| Net income attributed to shareholders | 1,296 | $ | 1,228 | $ | 2,176 | |||
| Core earnings(1) | 1,028 | $ | 1,477 | $ | 1,548 | |||
| Diluted earnings per common share () | 0.64 | $ | 0.61 | $ | 1.08 | |||
| Diluted core earnings per common share ()(1) | 0.51 | $ | 0.73 | $ | 0.76 | |||
| Return on common shareholders’ equity (“ROE”) | 10.4 | % | 10.3 | % | 20.1 | % | ||
| Core ROE(1) | 8.2 | % | 12.5 | % | 14.2 | % | ||
| Expense efficiency ratio(1) | 60.0 | % | 54.2 | % | 49.9 | % |
All values are in US Dollars.
| ^(1)^ | This item is a non-GAAP measure. See “Performance and non-GAAP measures” below. |
|---|
Quarterly profitability
Manulife’s net income attributed to shareholders was $1,296 million in the first quarter of 2020 (“1Q20”) compared with $2,176 million in the first quarter of 2019 (“1Q19”). Net income attributed to shareholders is comprised of core earnings^1^ (consisting of items we believe reflect the underlying earnings capacity of the business), which amounted to $1,028 million in 1Q20 compared with $1,548 million in 1Q19, and items excluded from core earnings, which amounted to a net gain of $268 million in 1Q20 compared with a net gain of $628 million in 1Q19. The effective tax rate on net income attributed to shareholders was 31% compared with 13% in 1Q19, reflecting differences in the jurisdictional mix of pre-tax profits and losses in these periods.
The decrease of $0.9 billion in net income attributed to shareholders compared with 1Q19 was driven by a decline in core earnings of $0.5 billion and charges from investment-related experience and the direct impact of equity markets and variable annuity guarantee liabilities (compared to gains in the prior year), partially offset by gains from the direct impact of interest rates driven by widening corporate spreads (compared to losses in the prior year). Investment-related experience in 1Q20 reflected lower-than-expected returns (including fair value changes) on alternative long-duration assets (“ALDA”) driven primarily by the impact of a sharp decline in oil prices, partially offset by the favourable impact of fixed income reinvestment activities.
Core earnings decreased $0.5 billion or 34% on a constant exchange rate basis compared with 1Q19.^2^ The decrease in core earnings was driven by the unfavourable impact of markets on seed money investments in new segregated funds and mutual funds, the absence of core investment gains^1^ in the quarter, lower new business volumes in Japan and unfavourable 1Q20 policyholder experience in North America, including unfavourable travel claims related to COVID-19. These items were partially offset by the impact of in-force business growth in Asia and higher fee income from higher average assets under management and administration^1^ levels in our Global Wealth and Asset Management (“Global WAM”) business. Core earnings in 1Q20 included net policyholder experience losses of $42 million post-tax ($69 million pre-tax) compared with gains of $20 million post-tax ($19 million pre-tax) in 1Q19.^3^ Reinsurance and ALDA portfolio mix actions to improve the capital efficiency of our legacy businesses resulted in $14 million lower core earnings in 1Q20 compared with 1Q19.
Core earnings by segment and the items excluded from core earnings are outlined in the tables below.
| ^1^ | This item is a non-GAAP measure. See “Performance and non-GAAP measures” below. |
|---|---|
| ^2^ | Percentage growth / declines in core earnings, APE sales, gross flows, net flows, NBV, assets under management and administration, assets under management and core<br> EBITDA are stated on a constant exchange rate basis. Constant exchange rate basis is a non-GAAP measure. See “Performance and non-GAAP measures” below. |
| --- | --- |
| ^3^ | Policyholder experience includes gains of $17 million post-tax from the release of margins on medical policies in Hong Kong that have lapsed for customers who have<br> opted to change their existing policies to the new Voluntary Health Insurance Scheme (“VHIS”) products. These gains did not have a material impact on core earnings as they were mostly offset by new business strain. |
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
5
Core earnings by segment and components of items excluded from core earnings
| Core Earnings by Segment(1) | ||||||||
|---|---|---|---|---|---|---|---|---|
| ( millions, unaudited) | 1Q20 | 4Q19 | 1Q19 | |||||
| Asia | 491 | $ | 494 | $ | 520 | |||
| Canada | 237 | 288 | 283 | |||||
| U.S. | 416 | 489 | 475 | |||||
| Global Wealth and Asset Management | 250 | 265 | 233 | |||||
| Corporate and Other (excluding core investment gains) | (366 | ) | (159 | ) | (63 | ) | ||
| Core investment gains(1),(2) | - | 100 | 100 | |||||
| Total core earnings | 1,028 | $ | 1,477 | $ | 1,548 |
All values are in US Dollars.
^^
| ^(1)^ | This item is a non-GAAP measure. See “Performance and non-GAAP measures” below. | |||||||
|---|---|---|---|---|---|---|---|---|
| ^(2)^ | As outlined in our definition of core earnings in section E3: Up to $400 million of net favourable investment-related experience will be reported<br> in core earnings in a single year, which are referred to as “core investment gains”. This means up to $100 million in the first quarter, up to $200 million on a year-to-date basis in the second quarter, up to $300 million on a<br> year-to-date basis in the third quarter and up to $400 million on a full year basis in the fourth quarter. Any investment-related experience losses reported in a quarter will be offset against the net year-to-date investment-related<br> experience gains with the difference being included in core earnings subject to a maximum of the year-to-date core investment gains and a minimum of zero, which reflects our expectation that investment-related experience will be positive<br> through-the-business cycle. | |||||||
| --- | --- | |||||||
| Items excluded from core earnings | ||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ( millions, unaudited) | 1Q20 | 4Q19 | 1Q19 | |||||
| Investment-related experience outside of core earnings(1) | (608 | ) | $ | 182 | $ | 327 | ||
| Direct impact of equity markets and interest rates and variable annuity<br> guarantee liabilities(2) | 792 | (389 | ) | 249 | ||||
| Direct impact of equity markets and variable<br> annuity guarantee liabilities | (1,309 | ) | 125 | 367 | ||||
| Fixed income reinvestment rates assumed in the<br> valuation of policy liabilities | 1,684 | (583 | ) | (160 | ) | |||
| Sale of AFS bonds and derivative positions in the<br> Corporate and Other segment | 417 | 69 | 42 | |||||
| Reinsurance transactions(3) | 12 | (34 | ) | 52 | ||||
| Tax related items and other(4) | 72 | (8 | ) | - | ||||
| Items excluded from core earnings | 268 | $ | (249 | ) | $ | 628 |
All values are in US Dollars.
| ^(1)^ | Total investment-related experience in 1Q20 was a net charge of $608 million, compared with a net gain of $427 million in 1Q19, and in accordance with<br> our definition of core earnings, we included no investment-related experience gains in core earnings and a $608 million charge in items excluded from core earnings in 1Q20 (gains of $100 million and $327 million, respectively, in 1Q19).<br> Investment-related experience charges in 1Q20 reflected lower-than-expected returns (including fair value changes) on alternative long-duration assets (“ALDA”) primarily driven by fair value losses related to oil and gas, private equity<br> investments and credit downgrades partially offset by the favourable impact of fixed income reinvestment activities on the measurement of our policy liabilities. Investment-related experience gains in 1Q19 reflected higher-than-expected<br> returns (including fair value changes) on ALDA and strong credit experience. |
|---|---|
| ^(2)^ | The direct impact of markets was a net gain of $792 million in 1Q20 driven by gains related to fixed income reinvestment rates as well as gains on the<br> sale of available-for-sale (“AFS”) bonds, partially offset by the unfavourable impact of equity markets. The gains for fixed income reinvestment rates reflected the widening of corporate spreads, primarily in the U.S., which were<br> partially offset by the reduction in risk free rates. Charges from the direct impact of equity markets reflected significant declines of global equity markets in 1Q20. The direct impact of markets was a net gain of $249 million in 1Q19<br> reflecting the favourable impact of the recovery in global equity markets partially offset by the unfavourable impact of interest rates in the quarter, primarily from the narrowing corporate spreads. |
| --- | --- |
| ^(3)^ | Reinsurance transactions in Asia contributed gains of $12 million in 1Q20. In 1Q19 reinsurance transactions in legacy businesses in Canada and the U.S.<br> contributed a gain of $52 million. |
| --- | --- |
| ^(4)^ | In 1Q20, we reported tax benefits from the U.S. CARES Act, as a result of carrying back net operating losses to prior years, which had higher tax rates. |
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
6
A2 Business Performance^(1)^
| ( millions, unaudited) | 1Q20 | 4Q19 | 1Q19 | |||
| Asia APE sales | 1,084 | $ | 975 | $ | 1,336 | |
| Canada APE sales | 376 | $ | 271 | $ | 261 | |
| U.S. APE sales | 141 | $ | 249 | $ | 143 | |
| Total APE sales | 1,601 | $ | 1,495 | $ | 1,740 | |
| Asia new business value | 356 | $ | 390 | $ | 411 | |
| Canada new business value | 77 | $ | 59 | $ | 62 | |
| U.S. new business value | 36 | $ | 77 | $ | 46 | |
| Total new business value | 469 | $ | 526 | $ | 519 | |
| Wealth and asset management net flows ( billions) | 3.2 | $ | 4.9 | $ | (1.3 | ) |
| Wealth and asset management gross flows ( billions) | 38.2 | $ | 32.9 | $ | 27.9 | |
| Wealth and asset management assets under management and administration (<br> billions) | 636.2 | $ | 681.4 | $ | 648.1 |
All values are in US Dollars.
| ^(1)^ | These items are non-GAAP measures. See “Performance and non-GAAP measures” below. |
|---|
Annualized premium equivalent (“APE”) sales^1^^^were $1.6 billion in 1Q20, a decrease of 9% compared with 1Q19. In Asia, APE sales decreased 20% compared with 1Q19 as growth in Hong Kong and Asia Other^2^ was more than offset by the impact of tax changes on corporate-owned life insurance (“COLI”) product sales in Japan in the prior year. Hong Kong APE sales increased 21% compared with 1Q19 driven by the continued success of our Voluntary Health Insurance Scheme (“VHIS”) and Qualifying Deferred Annuity products from our active agency force that grew by 18% from 1Q19. Asia Other APE sales increased 5% compared with 1Q19 as strong sales in agency, were partially offset by lower sales in bancassurance. In Canada, APE sales increased 44% compared with 1Q19 driven by higher large-case group insurance sales, growth across our individual insurance business, including a large sale in our affinity markets business, and higher sales of our lower risk segregated funds. In the U.S., APE sales declined 3% compared with 1Q19, as lower variable universal life and domestic protection universal life sales following regulatory changes in the fourth quarter of 2019 more than offset higher term life and international sales.
New business value (“NBV”)^1^ was
$469 million in 1Q20, a decrease of 11% compared with 1Q19. In Asia, NBV decreased 14% to $356 million compared with 1Q19 as growth in Hong Kong and Asia Other was more than offset by a decline in Japan. In Canada, NBV of $77 million was up 24%
from 1Q19, driven by higher sales across all business lines. In the U.S., NBV of $36 million was down 23% from 1Q19, primarily due to the impact of lower sales volumes and a less favourable business mix.
Wealth and asset management (“WAM”) reported net inflows^1^ of $3.2 billion in 1Q20 compared with net outflows of $1.3 billion in 1Q19. Net inflows in Asia were $0.6 billion in 1Q20, in line with 1Q19, as higher net inflows in retirement were offset by higher redemptions, mainly in institutional asset management. Net inflows in Canada were $2.8 billion in 1Q20 compared with net inflows of $2.1 billion in 1Q19, driven by higher gross flows^1^ into institutional asset management equity mandates. This was partially offset by lower net inflows in retirement, from lower new plan sales and higher redemptions, and in retail, from higher redemptions amid equity market declines in March partially offset by higher gross flows. Net outflows in the U.S. were $0.2 billion in 1Q20 compared with net outflows of $4.0 billion in 1Q19. The improvement was driven by higher retail gross flows, primarily from strong institutional model allocations and intermediary sales, as well as the sale of a large-case retirement plan of $2.6 billion. This was partially offset by the redemption of several retirement plans and retail redemptions amid equity market declines in March.
| ^1^ | This item is a non-GAAP measure. See “Performance and non-GAAP measures” below. |
|---|---|
| ^2^ | Asia Other excludes Japan and Hong Kong. |
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
7
A3 Financial strength
| Quarterly Results | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| (unaudited) | 1Q20 | 4Q19 | 1Q19 | ||||||
| MLI’s LICAT ratio | 155 | % | 140 | % | 144 | % | |||
| Financial leverage ratio | 23.0 | % | 25.1 | % | 27.0 | % | |||
| Total consolidated capital ($ billions)^(1)^ | $ | 63.2 | $ | 57.4 | $ | 57.3 | |||
| Book value per common share ($) | $ | 26.53 | $ | 23.25 | $ | 22.34 | |||
| Book value per common share excluding AOCI ($) | $ | 20.29 | $ | 19.94 | $ | 19.06 |
^(1)^ This item is a non-GAAP measure. See “Performance and non-GAAP measures” below.
The Life Insurance Capital Adequacy Test (“LICAT”) ratio for The Manufacturers Life Insurance Company (“MLI”) as at March 31, 2020 was 155%, compared with 140% as at December 31, 2019. The 15 percentage point increase was primarily driven by the positive impact from the widening of corporate spreads, and lower risk-free rates.
MFC’s LICAT ratio was 146% as at March 31, 2020, compared with 129% as at December 31, 2019. The difference between the MLI and MFC ratios as at March 31, 2020 was largely due to the $5.0 billion of MFC senior debt outstanding that does not qualify as available capital at the MFC level but, based on the form it was down-streamed to MLI, it qualifies as regulatory capital at the MLI level.
MFC’s financial leverage ratio as at March 31, 2020 was 23.0%, a decrease of 2.1 percentage points from 25.1% as at December 31, 2019. The decrease in the quarter was driven by the redemption of $500 million subordinated debt, growth in retained earnings, the impact of lower interest rates which increased values of available-for-sale (“AFS”) debt securities, and the favourable impact from a weaker Canadian dollar, partially offset by share buybacks.
MFC’s total consolidated capital^1^ was $63.2 billion as at March 31, 2020 compared with $57.4 billion as at December 31, 2019, an increase of $5.8 billion. The increase was primarily driven by the impact of a weaker Canadian dollar, the impact of lower interest rates which increased values of AFS debt securities and higher retained earnings, partially offset by the above-noted redemption of subordinated debt and share buybacks.
Book value per common share as at March 31, 2020 was $26.53, an increase of 14% compared with $23.25 as at December 31, 2019. Book value per common share excluding accumulated other comprehensive income (“AOCI”) was $20.29 as at March 31, 2020, an increase of 2% compared with $19.94 as at December 31, 2019. Common shareholders’ equity increased for similar reasons as outlined above. The number of common shares outstanding was 1,939 million as at March 31, 2020 and was 1,949 million as at December 31, 2019.
A4 Revenue
| ( millions, unaudited) | 1Q20 | 4Q19 | 1Q19 | |||||
| Gross premiums | 10,725 | $ | 10,535 | $ | 10,187 | |||
| Premiums ceded to reinsurers | (1,370 | ) | (1,297 | ) | (1,873 | ) | ||
| Net premium income | 9,355 | 9,238 | 8,314 | |||||
| Investment income | 3,284 | 4,004 | 3,747 | |||||
| Other revenue | 2,980 | 2,433 | 2,562 | |||||
| Revenue before realized and unrealized investment gains and losses | 15,619 | 15,675 | 14,623 | |||||
| Realized and unrealized gains and losses on assets supporting<br> insurance and investment contract liabilities and on the macro hedge program | 4,558 | (4,503 | ) | 8,926 | ||||
| Total revenue | 20,177 | $ | 11,172 | $ | 23,549 |
All values are in US Dollars.
Total revenue in 1Q20 was $20.2 billion compared with $23.5 billion in 1Q19. The amount of revenue reported in any fiscal period can be significantly affected by fair value accounting, which can materially impact the reported realized and unrealized investment gains or losses on assets supporting insurance and investment contract liabilities and on the macro hedge program, a component of revenue (see “Impact of fair value accounting” below). Accordingly, we discuss specific drivers of revenue in each segment before realized and unrealized investment gains and losses in section B “Performance by Segment” below.
1Q20 revenue before realized and unrealized investment gains and losses of $15.6 billion increased $1.0 billion compared with 1Q19 primarily due to the non-recurrence of a one-time ceded premium from the reinsurance of our legacy U.S. individual
| ^1^ | This item is a non-GAAP measure. See “Performance and non-GAAP measures” below. |
|---|
Manulife Financial Corporation – First Quarter 2020
8
payout annuities business in 1Q19, business growth in Asia and the impact of changes in foreign currency exchange rates, partially offset by lower investment income.
Net realized and unrealized investment gains and losses on assets supporting insurance and investment contract liabilities and on the macro hedge program was a net gain of $4.6 billion in 1Q20 compared with a gain of $8.9 billion in 1Q19. The 1Q20 gain was primarily due to the impact of interest rate declines in the U.S., partially offset by fair value losses on bonds, which were mostly in the energy sector. The impact of sharp declines in equity markets in 1Q20 on our equity holdings was more than offset by gains from derivatives hedging of our equity exposure. The 1Q19 gain was primarily due to an overall decrease in interest rates and rising equity markets.
See “Impact of fair value accounting” below.
| A5 | Assets under management and administration (“AUMA”)^1^ |
|---|
AUMA as at March 31, 2020 was $1.2 trillion, a decrease of 8% compared with December 31, 2019. The primary driver of the decrease was the unfavourable impact of markets.
| A6 | Impact of fair value accounting |
|---|
Fair value accounting policies affect the measurement of both our assets and our liabilities. The difference between the reported amounts of our assets and liabilities determined as of the balance sheet date and the immediately preceding balance sheet date in accordance with the applicable fair value accounting principles is reported as investment-related experience and the direct impact of equity markets and interest rates and variable annuity guarantees, each of which impacts net income attributed to shareholders (see “Profitability” section above for discussion of 1Q20 experience).
Net realized and unrealized investment gains on assets supporting insurance and investment contract liabilities and on the macro hedge program were $4.6 billion for 1Q20 (1Q19 – gains of $8.9 billion). See “Revenue” section above for discussion of results.
As outlined in “Critical Actuarial and Accounting Policies” in the MD&A in our 2019 Annual Report, net insurance contract liabilities, under IFRS 4, are determined using Canadian Asset Liability Method (“CALM”), as required by the Canadian Institute of Actuaries (“CIA”). The measurement of policy liabilities includes the estimated value of future policyholder benefits and settlement obligations to be paid over the term remaining on in-force policies, including the costs of servicing the policies, reduced by the future expected policy revenues and future expected investment income on assets supporting the policies. Investment returns are projected using current asset portfolios and projected reinvestment strategies. Experience gains and losses are reported when current period activity differs from what was assumed in the policy liabilities at the beginning of the period. We classify gains and losses by assumption type. For example, current period investing activities that increase (decrease) the future expected investment income on assets supporting the policies will result in an investment-related experience gain (loss). See description of investment-related experience in “Performance and non-GAAP measures” below.
As noted in “Critical Actuarial and Accounting Policies – Future Accounting and Reporting Changes” in the MD&A in our 2019 Annual Report, IFRS 17 is expected to replace IFRS 4 and therefore CALM. In March 2020, the IASB has decided to defer the effective date of the IFRS 17 implementation to January 1, 2023. The new standard will materially change insurance contract measurement and the timing of recognition of earnings. The measurement of the discount rate used to estimate the present value of insurance contract liabilities and the reporting of new business gains are among the more significant changes. We reported $150 million (post-tax) of new business gains in net income attributed to shareholders in 1Q20 (1Q19 - $225 million). Under IFRS 17, new business gains are recorded on the balance sheet (in the contractual service margin component of the insurance contract liability) and are amortized into income as services are provided.
| A7 | Impact of foreign currency exchange rates |
|---|
Changes in foreign currency exchange rates increased core earnings by $12 million in 1Q20 compared with 1Q19 primarily due to a weaker Canadian dollar compared with the U.S. dollar. The impact of foreign currency exchange rates on items excluded from core earnings does not provide relevant information given the nature of those items.
| A8 | Business highlights |
|---|
We made further progress on portfolio optimization in 1Q20, through a variety of initiatives in the U.S. We experienced continued success from our Annuity Guaranteed Minimum Withdrawal Benefit offer program, recognized impacts from the sale of ALDA enabled by the reinsurance of individual and group payout annuity policies, and expanded reinsurance coverage of certain universal life no lapse guarantee products. In total, these initiatives generated additional capital benefits of $265 million during the quarter.
| ^1^ | This item is a non-GAAP measure. See “Performance and non-GAAP measures” below. |
|---|
Manulife Financial Corporation – First Quarter 2020
9
In 1Q20, we continued to leverage and enhance our digital capabilities, while extending support to our customers during the COVID-19 pandemic. Strategic investment in our technology infrastructure in recent years led to a smooth transition for over 95% of employees working from home. In Asia, we accelerated our digital capabilities and supported our customers by extending the use of non face-to-face sales methods across most of our businesses. Additionally, we have provided limited additional benefit coverage and extended premium payment grace periods. In Canada, we provided a temporary extension of emergency out-of-country coverage for our group and individual customers who experienced travel delays and introduced flexible financial solutions to support our banking clients. In the U.S., we have extended the grace period for our life insurance policyholders to make premium payments and increased the payout limits permitted via phone for our annuity and life customers. In addition, in our Global Wealth and Asset Management business in Canada, we launched an online cash withdrawal feature, allowing members to have a safe and reliable way to directly access their retirement plans and in the U.S., we have temporarily waived the fee for 401k hardship withdrawals.
B PERFORMANCE BY SEGMENT
| B1 | Asia | |
|---|---|---|
| ( millions, unless otherwise stated) | ||
| --- | --- | --- |
| Canadian dollars | ||
| Net income attributed to shareholders(1) | ||
| Core earnings(1) | ||
| Annualized premium equivalent sales | ||
| New business value | ||
| Revenue | ||
| Revenue before realized and unrealized investment gains and losses(2) | ||
| Assets under management ( billions) | ||
| U.S. dollars | ||
| Net income attributed to shareholders(1) | US 481 | US 522 |
| Core earnings(1) | ||
| Annualized premium equivalent sales | ||
| New business value | ||
| Revenue | ||
| Revenue before realized and unrealized investment gains and losses(2) | ||
| Assets under management ( billions) |
All values are in US Dollars.
| ^(1)^ | See “Performance and non-GAAP measures” for a reconciliation between net income (loss) attributed to shareholders<br> and core earnings. |
|---|---|
| ^(2)^ | See section A6 “Impact of fair value accounting”. |
| --- | --- |
Asia’s net income attributed to shareholders was $95 million in 1Q20 compared with $695 million in 1Q19. Net income attributed to shareholders is comprised of core earnings, which was $491 million in 1Q20 compared with $520 million in 1Q19, and items excluded from core earnings, which amounted to a net charge of $396 million in 1Q20 compared with a net gain of $175 million in 1Q19. The changes in net income attributed to shareholders and core earnings expressed in Canadian dollars are due to the factors described below and, in addition, core earnings reflected a net $5 million favourable impact due to changes in foreign currency exchange rates versus the Canadian dollar.
Expressed in U.S. dollars, the presentation currency of the segment, net income attributed to shareholders was US$71 million in 1Q20 compared with US$522 million in 1Q19 and core earnings were US$365 million in 1Q20 compared with US$391 million in 1Q19. Items excluded from core earnings were a net charge of US$294 million in 1Q20 compared with a net gain of US$131 million in 1Q19 (see a reconciliation of net income (loss) attributed to shareholders to core earnings in “Performance and non-GAAP measures” below).
Core earnings in 1Q20 decreased 7% compared with 1Q19 driven by lower new business volumes in Japan, partially offset by in-force business growth across Asia, and improved policyholder experience in Hong Kong (excluding VHIS). Sales in 1Q20 of VHIS products launched in 2019 did not have a material current period impact on core earnings as experience gains from the release of margins for customers who opted to change their existing medical coverage to the new VHIS product were mostly offset by new business strain.
APE sales in 1Q20 were US$806 million, a decrease of 20% compared with 1Q19 as growth in Hong Kong and Asia Other was more than offset by the impact of tax changes on COLI product sales in Japan in the prior year. NBV in 1Q20 was US$265 million, a 14% decrease compared with 1Q19. Growth in Hong Kong and Asia Other was more than offset by a decline in
Manulife Financial Corporation – First Quarter 2020
10
Japan. New business value margin (“NBV margin”)^1^^^was 37.2% in 1Q20 compared with 33.6% in 1Q19.
| • | Japan APE sales in 1Q20 were US$164 million, a decrease of 60% compared with 1Q19 driven by a combination of<br> accelerated COLI sales in 1Q19 in anticipation of a change in tax regulations and the impact of those tax changes on COLI sales in 1Q20. Japan NBV in 1Q20 of US$43 million decreased 63% compared with 1Q19 and Japan NBV margin was 26.1% in<br> 1Q20, a decrease of 2.1 percentage points compared with 1Q19. |
|---|---|
| • | Hong Kong APE sales in 1Q20 were US$199 million, a 21% increase compared with 1Q19. The increase in APE sales<br> was driven by the continued success of our VHIS and Qualifying Deferred Annuity products sold by our growing agency force. Hong Kong NBV in 1Q20 of US$122 million increased 25% compared with 1Q19. Hong Kong NBV margin was 61.4% in 1Q20,<br> an increase of 1.9 percentage points compared with 1Q19. |
| --- | --- |
| • | Asia Other APE sales in 1Q20 were US$443 million, a 5% increase compared with 1Q19. Strong sales in agency<br> were partially offset by lower sales in bancassurance. Asia Other NBV in 1Q20 of US$100 million increased 6% compared with 1Q19. Asia Other NBV margin was 28.7% in 1Q20, an increase of 1.1 percentage points compared with 1Q19. |
| --- | --- |
Revenue was US$3.3 billion in 1Q20 compared with US$6.6 billion in 1Q19. Revenue before realized and unrealized investment gains and losses was US$5.1 billion in 1Q20, an increase of US$0.5 billion compared with 1Q19, driven by recurring premium growth from in-force business, partially offset by lower new business volumes in Japan.
Assets under management^1^ were US$90.6 billion as at March 31, 2020, a decrease of US$2.8 billion or 2% compared with December 31, 2019, due to the unfavourable impact of markets during 1Q20.
Business highlights - We extended our strategic bancassurance arrangement with PT Bank Danamon Indonesia Tbk in the quarter. The new agreement extends the term covered in the original agreement to 2036. We also accelerated our digital capabilities and extended our non face-to-face sales methods across most of our businesses to further support our customers during the COVID-19 pandemic. Additionally, we have provided limited additional benefit coverages and extended premium payment grace periods.
B2 Canada
| ( millions, unless otherwise stated) | 1Q20 | 4Q19 | 1Q19 | |||
| Net income (loss) attributed to shareholders(1) | (866 | ) | $ | 226 | $ | 751 |
| Core earnings(1) | 237 | 288 | 283 | |||
| Annualized premium equivalent sales | 376 | 271 | 261 | |||
| Manulife Bank average net lending assets ( billions) | 22.3 | 22.1 | 21.7 | |||
| Revenue | 3,385 | 2,243 | 7,090 | |||
| Revenue before realized and unrealized investment income gains and<br> losses(2) | 3,075 | 3,835 | 3,766 | |||
| Assets under management ( billions) | 146.6 | 151.3 | 146.6 |
All values are in US Dollars.
| ^(1)^ | See “Performance and non-GAAP measures” below for a reconciliation between net income (loss) attributed to shareholders and core<br> earnings. |
|---|---|
| ^(2)^ | See section A6 “Impact of fair value accounting”. |
| --- | --- |
Canada’s 1Q20 net loss attributed to shareholders was $866 million compared with net income attributed to shareholders of $751 million in 1Q19. Net income attributed to shareholders is comprised of core earnings, which were $237 million in 1Q20 compared with $283 million in 1Q19, and items excluded from core earnings, which amounted to a net charge of $1,103 million in 1Q20 compared with a net gain of $468 million in 1Q19 (see a reconciliation of net income (loss) attributed to shareholders to core earnings in “Performance and non-GAAP measures” below).
Core earnings decreased $46 million or 16% compared with 1Q19, primarily reflecting unfavourable travel claims experience related to COVID-19. The variance in policyholder experience for the remaining businesses had a net neutral impact on core earnings. Favourable policyholder experience in annuities and retail insurance was offset by less favourable policyholder experience in Group Benefits.
APE sales of $376 million in 1Q20 increased by $115 million or 44% compared with 1Q19, driven by large-case group insurance sales, growth across our individual insurance business and higher sales of our lower risk segregated funds.
| • | Individual insurance APE sales in 1Q20 of $128 million increased $50 million or 64% compared with 1Q19 driven by a large<br> affinity markets sale and higher par product sales. |
|---|---|
| • | Group insurance APE sales in 1Q20 of $171 million increased $44 million or 35% compared with 1Q19, due to higher large-case<br> sales. |
| --- | --- |
| ^1^ | This item is a non-GAAP measure. See “Performance and non-GAAP measures” below. |
|---|
Manulife Financial Corporation – First Quarter 2020
11
| • | Annuities APE sales in 1Q20 of $77 million increased $21 million or 38% compared with 1Q19 due to higher sales of our lower risk segregated funds. We are focused on growth in lower risk segregated fund products, which in 1Q20 grew by 49% compared with 1Q19 and accounted for 82% of annuity APE sales. |
|---|
Manulife Bank average net lending assets in the quarter were $22.3 billion, up $0.2 billion or 1% from the fourth quarter of 2019 average.
Revenue in 1Q20 was $3.4 billion compared with $7.1 billion in 1Q19. Revenue before realized and unrealized investment gains and losses was $3.1 billion in 1Q20, a decrease of $0.7 billion compared with 1Q19 due to lower investment income as a result of the unfavourable impact of sharp declines in oil and gas prices in 1Q20.
Assets under management were $146.6 billion as at March 31, 2020, a decrease of $4.7 billion or 3% from December 31, 2019, due to the unfavourable impact of markets during 1Q20.
Business highlights - In 1Q20, we took actions to support our customers during the pandemic. We enhanced our product offerings and provided relief for our customers, including a temporary extension of emergency out-of-country
coverage for our group and individual customers who experienced travel delays. We also introduced flexible financial solutions to support our banking clients.
B3 U.S.
| ( millions, unless otherwise stated) | |||||
|---|---|---|---|---|---|
| Canadian dollars | 1Q20 | 4Q19 | 1Q19 | ||
| Net income attributed to shareholders(1) | 1,852 | $ | 143 | $ | 441 |
| Core earnings(1) | 416 | 489 | 475 | ||
| Annualized premium equivalent sales | 141 | 249 | 143 | ||
| Revenue(2) | 10,663 | 1,155 | 6,116 | ||
| Revenue before realized and unrealized investment income gains and losses(2),(3) | 4,050 | 4,340 | 3,205 | ||
| Assets under management ( billions) | 245.8 | 230.4 | 224.3 | ||
| U.S. dollars | |||||
| Net income attributed to shareholders(1) | 1,377 | US$ | 109 | US$ | 332 |
| Core earnings(1) | 310 | 371 | 357 | ||
| Annualized premium equivalent sales | 105 | 189 | 108 | ||
| Revenue(2) | 7,929 | 875 | 4,600 | ||
| Revenue before realized and unrealized investment income gains and losses(2),(3) | 3,012 | 3,288 | 2,411 | ||
| Assets under management ( billions) | 173.2 | 177.4 | 167.8 |
All values are in US Dollars.
| ^(1)^ | See “Performance and non-GAAP measures” below for a reconciliation between net income (loss) attributed to shareholders and core<br> earnings. |
|---|---|
| ^(2)^ | 1Q19 has been restated to conform to the presentation adopted in the second quarter of 2019 (“2Q19”). |
| --- | --- |
| ^(3)^ | See section A6 “Impact of fair value accounting”. |
| --- | --- |
U.S. 1Q20 net income attributed to shareholders was $1,852 million compared with $441 million in 1Q19. Net income attributed to shareholders is comprised of core earnings, which amounted to $416 million in 1Q20 compared with $475 million in 1Q19, and items excluded from core earnings, which amounted to a net gain of $1,436 million in 1Q20 compared with a net charge of $34 million in 1Q19. The changes in net income attributed to shareholders and core earnings expressed in Canadian dollars are due to the factors described below and, in addition, the change in core earnings reflected a net $5 million favourable currency impact from the strengthening of the U.S. dollar compared with the Canadian dollar.
Expressed in U.S. dollars, the functional currency of the segment, 1Q20 net income attributed to shareholders was US$1,377 million compared with US$332 million in 1Q19, core earnings were US$310 million in 1Q20 compared with US$357 million in 1Q19, and items excluded from core earnings were a net gain of US$1,067 million in 1Q20 compared with a net charge of US$25 million in 1Q19 (see a reconciliation of net income (loss) attributed to shareholders to core earnings in “Performance and non-GAAP measures” below).
Core earnings decreased US$47 million or 13% compared with 1Q19 driven by unfavourable life insurance policyholder experience. Long-term care policyholder experience was net neutral in both quarters.
APE sales in 1Q20 of US$105 million declined 3% compared with 1Q19, as lower variable universal life and domestic protection universal life sales more than offset higher term life and international sales. Regulatory changes contributed to lower domestic brokerage sales of universal life during the quarter. Sales of products with the John Hancock Vitality PLUS feature in 1Q20 increased 22% compared with 1Q19.
Manulife Financial Corporation – First Quarter 2020
12
Revenue in 1Q20 was US$7.9 billion compared with US$4.6 billion in 1Q19. Revenue before net realized and unrealized investment gains and losses was US$3.0 billion in 1Q20 compared with US$2.4 billion in 1Q19. The US$0.6 billion increase was primarily due to the impact of a one-time ceded premium of US$0.5 billion in 1Q19 from the reinsurance of our legacy individual and group payout annuities business on policies originally sold in New York.
Assets under management as at March 31, 2020 were US$173.2 billion, a decrease of 2% from December 31, 2019. The decrease was driven by the unfavourable impact of equity markets on segregated fund assets and the continued run-off of the annuity business, partially offset by favourable mark-to-market movement from lower interest rates.
Business highlights - In 1Q20, we made further progress on our portfolio optimization strategic priority, through a variety of initiatives. We experienced continued success from our Annuity Guaranteed Minimum Withdrawal Benefit offer program; recognized impacts from the sale of ALDA enabled by the reinsurance of individual and group payout annuity policies, and expanded reinsurance coverage of certain universal life no lapse guarantee products. In total, these initiatives generated additional capital benefits of US$185 million during the quarter. Additionally, to support our customers during the COVID-19 pandemic, we have extended the grace period for our life insurance policyholders to make premium payments and increased the payout limits permitted via phone for our annuity and life customers.
B4 Global Wealth and Asset Management
| ( millions, unless otherwise stated) | 1Q20 | 4Q19 | 1Q19 | |||
| Net income attributed to shareholders(1) | 250 | $ | 265 | $ | 233 | |
| Core earnings(1) | 250 | 265 | 233 | |||
| Core EBITDA(2) | 390 | 391 | 366 | |||
| Sales | ||||||
| Wealth and asset management gross flows | 38,172 | 32,928 | 27,873 | |||
| Wealth and asset management net flows | 3,158 | 4,888 | (1,323 | ) | ||
| Revenue(3) | 1,426 | 1,433 | 1,358 | |||
| Assets under management and administration ( billions) | 636.2 | 681.4 | 648.1 | |||
| Average assets under management and administration ( billions)(4) | 680.3 | 668.30 | 627.2 |
All values are in US Dollars.
| ^(1)^ | See “Performance and non-GAAP measures” below for a reconciliation between net income (loss) attributed to shareholders and core<br> earnings. |
|---|---|
| ^(2)^ | Core EBITDA is a non-GAAP measure and is core earnings before interest, taxes, depreciation and amortization. See “Performance and non-GAAP measures”<br> below. |
| --- | --- |
| ^(3)^ | 1Q19 has been restated to conform to the presentation adopted in 2Q19. |
| --- | --- |
| ^(4)^ | Average assets under management and administration (“average AUMA”) is a non-GAAP measure reflecting the average of Global WAM’s AUMA during the<br> reporting period. See “Performance and non-GAAP measures” below. |
| --- | --- |
Global Wealth and Asset Management’s net income attributed to shareholders was $250 million in 1Q20 compared with $233 million in 1Q19. Net income attributed to shareholders is comprised of core earnings, which were $250 million in 1Q20 compared with $233 million in 1Q19 and items excluded from core earnings, which were nil in 1Q20 and 1Q19 (see a reconciliation of net income (loss) attributed to shareholders to core earnings in “Performance and non-GAAP measures” below).
Core earnings in 1Q20 increased 6% compared with 1Q19 driven by higher average assets under management and administration levels, partially offset by lower investment income. Core EBITDA^1^ was $390 million in 1Q20, an increase of 5% compared with 1Q19, driven by the same factors as mentioned above.
Gross flows and net flows - Gross flows were $38.2 billion in 1Q20, an increase of 36% compared with 1Q19, and net inflows were $3.2 billion in 1Q20, compared with net outflows of $1.3 billion in 1Q19. By geography, the results were:
WAM Asia:
| • | Gross flows in Asia in 1Q20 were $5.6 billion, an increase of $1.0 billion or 21% compared with 1Q19, driven by the sale of a<br> plan and higher individual contributions in retirement, higher retail gross flows in Indonesia, Hong Kong and Japan, and higher gross flows in institutional asset management. This was partially offset by lower gross flows in mainland<br> China from retail money markets funds. |
|---|---|
| • | Net inflows in Asia in 1Q20 were $0.6 billion, in line with 1Q19, driven by higher gross flows as mentioned above offset by<br> higher redemptions mainly in institutional asset management. |
| --- | --- |
WAM Canada:
| • | Gross flows in Canada in 1Q20 were $8.1 billion, an increase of $1.8 billion or 28% compared with 1Q19, driven by |
|---|
^1^This item is a non-GAAP measure. See “Performance and non-GAAP measures” below.
Manulife Financial Corporation – First Quarter 2020
13
| higher gross flows into equity mandates totaling $1.5 billion in institutional asset management, and higher retail gross<br> flows through February across our product line-up. This was partially offset by lower new plan sales in retirement. | |
|---|---|
| • | Net inflows in Canada were $2.8 billion in 1Q20 compared with net inflows of $2.1 billion in 1Q19, driven by higher gross<br> flows as mentioned above, partially offset by higher retail redemptions amid equity market declines in March and to a lesser extent, higher redemptions in retirement. |
| --- | --- |
WAM U.S.:
| • | Gross flows in the U.S. in 1Q20 were $24.5 billion, an increase of $7.6 billion or 43% compared with 1Q19, driven by growth in<br> retail, mainly from strong institutional model allocations and intermediary sales, and in retirement, from the sale of a large-case plan of $2.6 billion and recurring deposits growth. |
|---|---|
| • | Net outflows in the U.S. were $0.2 billion in 1Q20 compared with net outflows of $4.0 billion in 1Q19, driven by higher gross<br> flows as mentioned above, partially offset by the redemption of several retirement plans and higher redemptions in fixed income mandates in institutional asset management. Retail redemptions while largely in line with 1Q19, increased in<br> March amid equity market declines. |
| --- | --- |
Revenue in 1Q20 was $1.4 billion, an increase of 4% on a constant exchange rate basis compared with 1Q19, driven by higher average assets under management and administration levels, partially offset by lower investment income on investments.
Assets under management and administration of $636.2 billion as at March 31, 2020 decreased 12% compared with December 31, 2019. The reduction in AUMA was driven by the unfavourable impact of markets, partially offset by net inflows of $3.2 billion in 1Q20. Global WAM also manages $195.4 billion in assets for the Company’s non-WAM reporting segments. Including those managed assets, AUMA managed by Global WAM was $831.6 billion as at March 31, 2020 compared with $879.2 billion as at December 31, 2019.
Business highlights - In 1Q20, we generated gross flows of $38.2 billion with double-digit growth across all geographies and business lines. In Asia, we maintained our positive net flows trend amid challenging market conditions during the quarter. In the U.S., we went live with a large-case retirement plan worth $2.6 billion with over 100,000 participants. In addition, to support our customers during the pandemic, we launched an online cash withdrawal feature in Canada, allowing members to have a safe and reliable way to access their retirement plans, and in the U.S., we have temporarily waived the fee for 401k hardship withdrawals.
B5 Corporate and Other
| ( millions, unless otherwise stated) | 1Q20 | 4Q19 | 1Q19 | |||||
| Net income (loss) attributed to shareholders(1) | (35 | ) | $ | (42 | ) | $ | 56 | |
| Core loss excluding core investment gains(1) | (366 | ) | $ | (159 | ) | $ | (63 | ) |
| Core investment gains | - | 100 | 100 | |||||
| Total core gain (loss) | (366 | ) | $ | (59 | ) | $ | 37 | |
| Revenue | 226 | $ | 220 | $ | 234 |
All values are in US Dollars.
^\(1\)^See “Performance and non-GAAP
measures” for a reconciliation between net income \(loss\) attributed to shareholders and core earnings.
Corporate and Other is composed of investment performance on assets backing capital, net of amounts allocated to operating segments; financing costs; costs incurred by the corporate office related to shareholder activities (not allocated to the operating segments); our Property and Casualty (“P&C”) Reinsurance business; as well as run-off reinsurance operations including variable annuities and accident and health.
For segment reporting purposes, settlement costs for macro equity hedges and other non-operating items are included in Corporate and Other earnings. This segment is also where we reclassify favourable investment-related experience to core earnings from items excluded from core earnings, subject to certain limits (see “Performance and non-GAAP measures” below). In each of the operating segments, we report all investment-related experience in items excluded from core earnings.
Corporate and Other reported a net loss attributed to shareholders of $35 million in 1Q20 compared with net income attributed to shareholders of $56 million in 1Q19. The core loss was $366 million in 1Q20 compared with a core gain of $37 million in 1Q19 and the items excluded from core loss amounted to a net gain of $331 million in 1Q20 compared with a net gain of $19 million in 1Q19 (see a reconciliation of net income (loss) attributed to shareholders to core earnings in “Performance and non-GAAP measures” below).
Manulife Financial Corporation – First Quarter 2020
14
The $403 million increase in core loss was primarily related to the unfavourable impact of markets on seed money investments in new segregated funds and mutual funds in 1Q20 compared with gains in the prior year, nil core investment gains in 1Q20 compared with $100 million in 1Q19 and higher withholding taxes on future U.S. remittances, partially offset by lower interest on external debt.
The items excluded from core loss amounted to a net gain of $331 million in 1Q20 and were primarily due to gains from the sale of AFS bonds and the one-time favourable tax benefit of the U.S. CARES Act, as a result of carrying back net operating losses to prior years, which had higher tax rates.
Revenue in 1Q20 was a gain of $226 million compared with a gain of $234 million in 1Q19. Higher realized gains in AFS bonds were more than offset by losses on seed money investments and the unfavourable impact of changes in foreign currency due to a stronger U.S. dollar compared to the Canadian dollar.
C RISK MANAGEMENT AND RISK FACTORS UPDATE
This section provides an update to our risk management practices and risk factors outlined in the MD&A in our 2019 Annual Report (“2019 MD&A”). The shaded text and tables in this section of the MD&A represent our disclosure on market and liquidity risk in accordance with IFRS 7 “Financial Instruments – Disclosures”. Accordingly, the following shaded text and tables represent an integral part of our unaudited Interim Consolidated Financial Statements.
C1 Variable annuity and segregated fund guarantees
As described in the MD&A in our 2019 Annual Report, guarantees on variable annuity products and segregated funds may include one or more of death, maturity, income and withdrawal guarantees. Variable annuity and segregated fund guarantees are contingent on and only payable upon the occurrence of the relevant event, if fund values at that time are below guaranteed values. Depending on future equity market levels, liabilities on current in-force business would be due primarily in the period from 2020 to 2040.
We seek to mitigate a portion of the risks embedded in our retained (i.e. net of reinsurance) variable annuity and segregated fund guarantee business through the combination of our dynamic and macro hedging strategies (see section C3 “Publicly traded equity performance risk” below).
The table below shows selected information regarding the Company’s variable annuity and segregated fund investment-related guarantees gross and net of reinsurance.
Variable annuity and segregated fund guarantees, net of reinsurance
| March 31, 2020 | December 31, 2019 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As at<br><br> <br>($ millions) | Guarantee<br><br> <br>value | Fund value | Amount at<br><br> <br>risk^(4),(5)^ | Guarantee<br><br> <br>value | Fund value | Amount at<br><br> <br>risk^(4),(5)^ | ||||||
| Guaranteed minimum income benefit | $ | 4,957 | $ | 3,220 | $ | 1,740 | $ | 4,629 | $ | 3,696 | $ | 998 |
| Guaranteed minimum withdrawal benefit | 55,457 | 43,035 | 12,468 | 53,355 | 48,031 | 6,030 | ||||||
| Guaranteed minimum accumulation benefit | 18,396 | 18,443 | 210 | 17,994 | 18,362 | 10 | ||||||
| Gross living benefits^(1)^ | 78,810 | 64,698 | 14,418 | 75,978 | 70,089 | 7,038 | ||||||
| Gross death benefits^(2),(3)^ | 10,156 | 13,815 | 1,708 | 9,555 | 17,186 | 802 | ||||||
| Total gross of reinsurance | 88,966 | 78,513 | 16,126 | 85,533 | 87,275 | 7,840 | ||||||
| Living benefits reinsured | 4,255 | 2,782 | 1,474 | 3,977 | 3,199 | 832 | ||||||
| Death benefits reinsured | 767 | 486 | 332 | 718 | 500 | 318 | ||||||
| Total reinsured | 5,022 | 3,268 | 1,806 | 4,695 | 3,699 | 1,150 | ||||||
| Total, net of reinsurance | $ | 83,944 | $ | 75,245 | $ | 14,320 | $ | 80,838 | $ | 83,576 | $ | 6,690 |
| ^(1)^ | Where a policy includes both living and death benefits, the guarantee in excess of the living benefit is included in the death benefit category as<br> outlined in footnote 3. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Contracts with guaranteed long-term care benefits are included in this category. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | Death benefits include standalone guarantees and guarantees in excess of living benefit guarantees where both death and living benefits are provided<br> on a policy. | |||||||||||
| --- | --- | |||||||||||
| ^(4)^ | Amount at risk (in-the-money amount) is the excess of guarantee values over fund values on all policies where the guarantee value exceeds the fund<br> value. This amount is not currently payable. For guaranteed minimum death benefit, the amount at risk is defined as the current guaranteed minimum death benefit in excess of the current account balance. For guaranteed minimum income<br> benefit, the amount at risk is defined as the excess of the current annuitization income base over the current account value. For all guarantees, the amount at risk is floored at zero at the single contract level. | |||||||||||
| --- | --- | |||||||||||
| ^(5)^ | The amount at risk net of reinsurance at March 31, 2020 was $14,320 million (December 31, 2019 – $6,690 million) of which: US$7,626 million (December<br> 31, 2019 – US$3,995 million) was on our U.S. business, $2,775 million (December 31, 2019 – $1,178 million) was on our Canadian business, US$275 million (December 31, 2019 – US$104 million) was on our Japan business and US$237 million<br> (December 31, 2019 – US$145 million) was related to Asia (other than Japan) and our run-off reinsurance business. | |||||||||||
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
15
C2 Caution related to sensitivities
In this document, we provide sensitivities and risk exposure measures for certain risks. These include sensitivities due to specific changes in market prices and interest rate levels projected using internal models as at a specific date, and are measured relative to a starting level reflecting the Company’s assets and liabilities at that date and the actuarial factors, investment activity and investment returns assumed in the determination of policy liabilities. The risk exposures measure the impact of changing one factor at a time and assume that all other factors remain unchanged. Actual results can differ significantly from these estimates for a variety of reasons including the interaction among these factors when more than one changes; changes in actuarial and investment return and future investment activity assumptions; actual experience differing from the assumptions, changes in business mix, effective tax rates and other market factors; and the general limitations of our internal models. For these reasons, the sensitivities should only be viewed as directional estimates of the underlying sensitivities for the respective factors based on the assumptions outlined below. Given the nature of these calculations, we cannot provide assurance that the actual impact on net income attributed to shareholders or on MLI’s LICAT total ratio will be as indicated. Market movements affect LICAT capital sensitivities both through income and other components of the regulatory capital framework. For example, LICAT is affected by changes to other comprehensive income.
C3 Publicly traded equity performance risk
As outlined in our 2019 Annual Report, we have net exposure to equity risk through asset and liability mismatches; our variable annuity guarantee dynamic hedging strategy is not designed to completely offset the sensitivity of policy liabilities to all risks associated with the guarantees embedded in these products. The macro hedging strategy is designed to mitigate public equity risk arising from variable annuity guarantees not dynamically hedged and from other unhedged exposures in our insurance liabilities (see pages 44 and 45 of our 2019 Annual Report).
Changes in equity prices may impact other items including, but not limited to, asset-based fees earned on assets under management and administration or policyholder account value, and estimated profits and amortization of deferred policy acquisition and other costs. These items are not hedged.
The table below shows the potential impact on net income attributed to shareholders resulting from an immediate 10%, 20% and 30% change in market values of publicly traded equities followed by a return to the expected level of growth assumed in the valuation of policy liabilities. If market values were to remain flat for an entire year, the potential impact would be roughly equivalent to an immediate decline in market values equal to the expected level of annual growth assumed in the valuation of policy liabilities. Further, if after market values dropped 10%, 20% or 30% they continued to decline, remained flat, or grew more slowly than assumed in the valuation, the potential impact on net income attributed to shareholders could be considerably more than shown. Refer to section D2 “Sensitivity of policy liabilities to asset related assumptions” for more information on the level of growth assumed and on the net income sensitivity to changes in these long-term assumptions. The potential impact is shown after taking into account the impact of the change in markets on the hedge assets. While we cannot reliably estimate the amount of the change in dynamically hedged variable annuity guarantee liabilities that will not be offset by the profit or loss on the dynamic hedge assets, we make certain assumptions for the purposes of estimating the impact on net income attributed to shareholders.
This estimate assumes that the performance of the dynamic hedging program would not completely offset the gain/loss from the dynamically hedged variable annuity guarantee liabilities. It assumes that the hedge assets are based on the actual position at the period end, and that equity hedges in the dynamic program are rebalanced at 5% intervals. In addition, we assume that the macro hedge assets are rebalanced in line with market changes.
It is also important to note that these estimates are illustrative, and that the dynamic and macro hedging programs may underperform these estimates, particularly during periods of high realized volatility and/or periods where both interest rates and equity market movements are unfavourable.
The Standards of Practice for the valuation of insurance contract liabilities and guidance published by the CIA constrain the investment return assumptions for public equities and certain ALDA assets based on historical return benchmarks for public equities. The potential impact on net income attributed to shareholders does not consider possible changes to investment return assumptions resulting from the impact of declines in public equity market values on these historical return benchmarks.
Manulife Financial Corporation – First Quarter 2020
16
Potential immediate impact on net income attributed to shareholders arising from changes to public equity returns^(1),(2),(3)^
| As at March 31, 2020 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ( millions) | -30 | % | -20 | % | -10 | % | +10 | % | +20 | % | +30 | % | |||||
| Underlying sensitivity to net income attributed to shareholders(4) | |||||||||||||||||
| Variable annuity guarantees | (3,430 | ) | $ | (2,160 | ) | $ | (1,010 | ) | $ | 860 | $ | 1,570 | $ | 2,130 | |||
| General fund equity investments(5) | (1,220 | ) | (820 | ) | (410 | ) | 320 | 630 | 950 | ||||||||
| Total underlying sensitivity before hedging | (4,650 | ) | (2,980 | ) | (1,420 | ) | 1,180 | 2,200 | 3,080 | ||||||||
| Impact of macro and dynamic hedge assets(6) | 2,720 | 1,730 | 810 | (780 | ) | (1,430 | ) | (1,950 | ) | ||||||||
| Net potential impact on net income<br> attributed to shareholders after impact of<br> hedging | (1,930 | ) | $ | (1,250 | ) | $ | (610 | ) | $ | 400 | $ | 770 | $ | 1,130 | |||
| As at December 31, 2019 | |||||||||||||||||
| ( millions) | -30 | % | -20 | % | -10 | % | +10 | % | +20 | % | +30 | % | |||||
| Underlying sensitivity to net income<br> attributed to shareholders(4) | |||||||||||||||||
| Variable annuity guarantees | (3,270 | ) | $ | (1,930 | ) | $ | (860 | ) | $ | 620 | $ | 1,060 | $ | 1,360 | |||
| General fund equity investments(5) | (1,140 | ) | (720 | ) | (330 | ) | 340 | 680 | 1,020 | ||||||||
| Total underlying sensitivity before hedging | (4,410 | ) | (2,650 | ) | (1,190 | ) | 960 | 1,740 | 2,380 | ||||||||
| Impact of macro and dynamic hedge assets(6) | 2,690 | 1,580 | 670 | (580 | ) | (1,020 | ) | (1,340 | ) | ||||||||
| Net potential impact on net income<br> attributed to shareholders after impact of<br> hedging | (1,720 | ) | $ | (1,070 | ) | $ | (520 | ) | $ | 380 | $ | 720 | $ | 1,040 |
All values are in US Dollars.
| ^(1)^ | See “Caution related to sensitivities” above. |
|---|---|
| ^(2)^ | The tables above show the potential impact on net income attributed to shareholders resulting from an immediate 10%, 20% and<br> 30% change in market values of publicly traded equities followed by a return to the expected level of growth assumed in the valuation of policy liabilities, excluding impacts from asset-based fees earned on assets under management and<br> policyholder account value. |
| --- | --- |
| ^(3)^ | Please refer to section D2 “Sensitivity of policy liabilities to asset related assumptions” for more information on the level<br> of growth assumed and on the net income sensitivity to changes in these long-term assumptions. |
| --- | --- |
| ^(4)^ | Defined as earnings sensitivity to a change in public equity markets including settlements on reinsurance contracts, but before<br> the offset of hedge assets or other risk mitigants. |
| --- | --- |
| ^(5)^ | This impact for general fund equity investments includes general fund investments supporting our policy liabilities, investment<br> in seed money investments (in new segregated and mutual funds made by Corporate and Other segment) and the impact on policy liabilities related to the projected future fee income on variable universal life and other unit linked<br> products. The impact does not include: (i) any potential impact on public equity weightings; (ii) any gains or losses on AFS public equities held in the Corporate and Other segment; or (iii) any gains or losses on public equity<br> investments held in Manulife Bank. The participating policy funds are largely self-supporting and generate no material impact on net income attributed to shareholders as a result of changes in equity markets. |
| --- | --- |
| ^(6)^ | Includes the impact of rebalancing equity hedges in the macro and dynamic hedging program. The impact of dynamic hedge<br> rebalancing represents the impact of rebalancing equity hedges for dynamically hedged variable annuity guarantee best estimate liabilities at 5% intervals, but does not include any impact in respect of other sources of hedge<br> ineffectiveness (e.g. fund tracking, realized volatility and equity, interest rate correlations different from expected among other factors). |
| --- | --- |
Changes in equity markets impact our available and required components of the LICAT total ratio. The following table shows the potential impact to MLI’s LICAT total ratio resulting from changes in public equity market values.
Potential immediate impact on MLI’s LICAT total ratio arising from public equity returns different than the expected return for policy liability valuation^(1),(2),(3)^
| Impact on MLI's LICAT total ratio | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Percentage points | -30 | % | -20 | % | -10 | % | +10 | % | +20 | % | +30 | % | |
| March 31, 2020 | (4 | ) | (2 | ) | (1 | ) | - | 1 | 1 | ||||
| December 31, 2019 | (5 | ) | (3 | ) | (1 | ) | 1 | 4 | 5 | ||||
| ^(1)^ | See “Caution related to sensitivities” above. In addition, estimates exclude changes to the net actuarial<br> gains/losses with respect to the Company’s pension obligations as a result of changes in equity markets, as the impact on the quoted sensitivities is not considered to be material. | ||||||||||||
| --- | --- | ||||||||||||
| ^(2)^ | The potential impact is shown assuming that the change in value of the hedge assets does not completely offset the change in the<br> dynamically hedged variable annuity guarantee liabilities. The estimated amount that would not be completely offset relates to our practices of not hedging the provisions for adverse deviation and of rebalancing equity hedges for<br> dynamically hedged variable annuity liabilities at 5% intervals. | ||||||||||||
| --- | --- | ||||||||||||
| ^(3)^ | The Office of the Superintendent of Financial Institutions (“OSFI”) rules for segregated fund guarantees reflect full capital impacts of shocks over 20<br> quarters within a prescribed range. As such, the deterioration in equity markets could lead to further increases in capital requirements after the initial shock. | ||||||||||||
| --- | --- |
C4 Interest rate and spread risk sensitivities and exposure measures
As at March 31, 2020, we estimated the sensitivity of our net income attributed to shareholders to a 50 basis point parallel decline in interest rates to be a benefit of $300 million, and to a 50 basis point increase in interest rates to be a charge of $300 million.
The table below shows the potential impact on net income attributed to shareholders from a 50 basis point parallel move in interest rates. This includes a change of 50 basis points in current government, swap and corporate rates for all maturities across all markets with no change in credit spreads between government, swap and corporate rates, and with a floor of zero
Manulife Financial Corporation – First Quarter 2020
17
on government rates where government rates are not currently negative, relative to the rates assumed in the valuation of policy liabilities, including embedded derivatives. For variable annuity guarantee liabilities that are dynamically hedged, it is assumed that interest rate hedges are rebalanced at 20 basis point intervals.
As the sensitivity to a 50 basis point change in interest rates includes any associated change in the applicable reinvestment scenarios, the impact of changes to interest rates for less than, or more than 50 basis points is unlikely to be linear. Furthermore, our sensitivities are not consistent across all regions in which we operate, and the impact of yield curve changes will vary depending upon the geography where the change occurs. Reinvestment assumptions used in the valuation of policy liabilities tend to amplify the negative effects of a decrease in interest rates and dampen the positive effects of interest rate increases. This is because the reinvestment assumptions used in the valuation of our insurance liabilities are based on interest rate scenarios and calibration criteria set by the Canadian Actuarial Standards Board, while our interest rate hedges are valued using current market interest rates. Therefore, in any particular quarter, changes to the reinvestment assumptions are not fully aligned to changes in current market interest rates especially when there is a significant change in the shape of the interest rate curve. As a result, the impact from non-parallel movements may be materially different from the estimated impact of parallel movements. For example, if long-term interest rates increase more than short-term interest rates (sometimes referred to as a steepening of the yield curve) in North America, the decrease in the value of our swaps may be greater than the decrease in the value of our insurance liabilities. This could result in a charge to net income attributed to shareholders in the short-term even though the rising and steepening of the yield curve, if sustained, may have a positive long-term economic impact.
The interest rate and spread risk sensitivities are determined in isolation of each other and therefore do not reflect the combined impact of changes in government rates and credit spreads between government, swap and corporate rates occurring simultaneously. As a result, the impact of the summation of each individual sensitivity may be materially different from the impact of sensitivities to simultaneous changes in interest rate and spread risk.
The potential impact on net income attributed to shareholders does not take into account any future potential changes to our ultimate reinvestment rate assumptions or calibration criteria for stochastic risk-free rates. At December 31, 2019, we estimated the sensitivity of our net income attributed to shareholders to a 10 basis point reduction in the URR in all geographies, and a corresponding change to stochastic risk-free modeling, to be a charge of $350 million (post-tax); and note that the impact of changes to the URR are not linear. The long-term URR for risk-free rates in Canada is prescribed at 3.05% and we use the same assumption for the U.S. Our assumption for Japan is 1.6%. The ASB does not anticipate an update to this promulgation prior to the effective date of IFRS 17, expected to be 2023 at the earliest.
The potential impact on net income attributable to shareholders does not take into account other potential impacts of lower interest rate levels, for example, increased strain on the sale of new business or lower interest earned on our surplus assets. The impact also does not reflect any unrealized gains or losses on AFS fixed income assets held in our Corporate and Other segment. Changes in the market value of these assets may provide a natural economic offset to the interest rate risk arising from our product liabilities. In order for there to also be an accounting offset, the Company would need to realize a portion of the AFS fixed income asset unrealized gains or losses. It is not certain we would realize any of the unrealized gains or losses available.
The impact does not reflect any potential effect of changing interest rates to the value of our ALDA assets. Rising interest rates could negatively impact the value of our ALDA (see “Critical Actuarial and Accounting Policies – Fair Value of Invested Assets”, on page 67 of our 2019 Annual Report). More information on ALDA assets can be found under the section C5 “Alternative long-duration asset performance risk”.
Under LICAT, changes in unrealized gains or losses in our AFS bond portfolio resulting from interest rate shocks tend to dominate capital sensitivities. As a result, the reduction in interest rates improves LICAT total ratios and vice-versa.
The following table shows the potential impact on net income attributed to shareholders including the change in the market value of AFS fixed income assets held in our Corporate and Other segment, which could be realized through the sale of these assets.
Manulife Financial Corporation – First Quarter 2020
18
Potential impact on net income attributed to shareholders and MLI’s LICAT total ratio of an immediate parallel change in interest rates relative to rates assumed in the valuation of policy liabilities^(1),(2),(3),(4)^
| December 31, 2019 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| As at | -50 | bp | +50 | bp | -50 | bp | +50 | bp | |||
| Net income attributed to shareholders ( millions) | |||||||||||
| Excluding change in market value of AFS fixed income assets held in the Corporate and Other segment | 300 | $ | (300 | ) | $ | (100 | ) | $ | (100 | ) | |
| From fair value changes in AFS fixed income assets held in the Corporate and Other segment, if realized | 2,200 | (2,000 | ) | 1,700 | (1,600 | ) | |||||
| MLI's LICAT total ratio (Percentage points) | |||||||||||
| LICAT total ratio change in percentage points(5) | 6 | (6 | ) | 4 | (4 | ) |
All values are in US Dollars.
| ^(1)^ | See “Caution related to sensitivities” above. In addition, estimates exclude changes to the net actuarial gains/losses with<br> respect to the Company’s pension obligations as a result of changes in interest rates, as the impact on the quoted sensitivities is not considered to be material. |
|---|---|
| ^(2)^ | Includes guaranteed insurance and annuity products, including<br> variable annuity contracts as well as adjustable benefit products where benefits are generally adjusted as interest rates and investment returns change, a portion of which have minimum credited rate guarantees. For adjustable benefit<br> products subject to minimum rate guarantees, the sensitivities are based on the assumption that credited rates will be floored at the minimum. |
| --- | --- |
| ^(3)^ | The amount of gain or loss that can be realized on AFS fixed income assets held in the<br> Corporate and Other segment will depend on the aggregate amount of unrealized gain or loss. |
| --- | --- |
| ^(4)^ | Sensitivities are based on projected asset and liability cash flows and the impact of<br> realizing fair value changes in AFS fixed income is based on the holdings at the end of the period. |
| --- | --- |
| ^(5)^ | LICAT impacts include realized and unrealized fair value changes in AFS fixed income assets. LICAT impacts do not reflect the impact of the scenario switch discussed below. |
| --- | --- |
The following tables show the potential impact on net income attributed to shareholders resulting from a change in corporate spreads and swap spreads over government bond rates for all maturities across all markets with a floor of zero on the total interest rate, relative to the spreads assumed in the valuation of policy liabilities.
Potential impact on net income attributed to shareholders and MLI’s LICAT total ratio arising from changes to corporate spreads and swap spreads^(1),(2),(3)^
| Corporate spreads^(4),(5)^ | March 31, 2020 | December 31, 2019 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As at | -50 | bp | +50 | bp | -50 | bp | +50 | bp | ||||
| Net income attributed to shareholders ($ millions) | $ | (900 | ) | $ | 800 | $ | (800 | ) | $ | 800 | ||
| MLI’s LICAT total ratio (change in percentage points)^(6)^ | (5 | ) | 2 | (7 | ) | 5 | ||||||
| Swap spreads | March 31, 2020 | December 31, 2019 | ||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| As at | -20 | bp | +20 | bp | -20 | bp | +20 | bp | ||||
| Net income attributed to shareholders ($ millions) | $ | - | $ | - | $ | 100 | $ | (100 | ) | |||
| MLI’s LICAT total ratio (change in percentage points)^(6)^ | nil | nil | nil | nil | ||||||||
| ^(1)^ | See “Caution related to sensitivities” above. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | The impact on net income attributed to shareholders assumes no gains or losses are realized on our AFS fixed income assets held in the Corporate and<br> Other segment and excludes the impact of changes in segregated fund bond values due to changes in credit spreads. The participating policy funds are largely self-supporting and generate no material impact on net income attributed to<br> shareholders as a result of changes in corporate and swap spreads. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | Sensitivities are based on projected asset and liability cash flows. | |||||||||||
| --- | --- | |||||||||||
| ^(4)^ | Corporate spreads are assumed to grade to the long-term average over five years. | |||||||||||
| --- | --- | |||||||||||
| ^(5)^ | As the sensitivity to a 50 basis point decline in corporate spreads includes the impact of a change in deterministic reinvestment scenarios where<br> applicable, the impact of changes to corporate spreads for less than, or more than, the amounts indicated are unlikely to be linear. | |||||||||||
| --- | --- | |||||||||||
| ^(6)^ | LICAT impacts include realized and unrealized fair value change in AFS fixed income assets. Under LICAT, spread movements are determined from a<br> selection of investment grade bond indices with BBB and better bonds for each jurisdiction. For LICAT, we use the following indices: FTSE TMX Canada All Corporate Bond Index, Barclays USD Liquid Investment Grade Corporate Index, and<br> Nomura-BPI (Japan). LICAT impacts presented for corporate spreads do not reflect the impact of the scenario switch discussed below. | |||||||||||
| --- | --- |
LICAT Scenario Switch
Typically, a reduction in interest rates improves LICAT capital ratios and vice-versa. However, when interest rates decline past a certain threshold, reflecting the combined movement in risk-free rates and corporate spreads, a different prescribed interest rate stress scenario needs to be taken into account in the LICAT ratio calculation according to the OSFI guideline.
The OSFI guideline specifies four stress scenarios for interest rates and prescribes the methodology to determine the most adverse scenario to apply for each geographic region based on current market inputs and the Company’s balance sheet.
We estimate the potential impact of a switch in the scenarios would be approximately a one-time five percentage point decrease in MLI’s total LICAT ratio. Under recently issued guidelines from OSFI in 1Q20, should the scenario switch be
Manulife Financial Corporation – First Quarter 2020
19
triggered, the impact would be reflected over 6 quarters using a rolling average of interest rate risk capital for participating products.
The potential negative impact of a switch in scenarios is not reflected in the stated risk-free rate and corporate spread sensitivities, as it is a one-time impact. After this one-time event, the sensitivity of the LICAT ratio to further decreases in risk-free interest rates would continue to improve the LICAT capital position.
The level of interest rates and corporate spreads that would trigger a switch in the scenarios is dependent on market conditions and movements in the Company’s asset and liability position. The scenario switch could reverse in response to subsequent increases in rates and/or spreads.
C5 Alternative long-duration asset performance risk
The following table shows the potential impact on net income attributed to shareholders resulting from an immediate 10% change in market values of ALDA followed by a return to the expected level of growth assumed in the valuation of policy liabilities. If market values were to remain flat for an entire year, the potential impact would be roughly equivalent to an immediate decline in market values equal to the expected level of annual growth assumed in the valuation of policy liabilities. Further, if after market values dropped 10% they continued to decline, remained flat, or grew more slowly than assumed in the valuation of policy liabilities, the potential impact on net income attributed to shareholders could be considerably more than shown. Refer to section D2 “Sensitivity of policy liabilities to asset related assumptions”, for more information on the level of growth assumed and on the net income sensitivity to changes in these long-term assumptions.
ALDA includes commercial real estate, timber and farmland real estate, oil and gas direct holdings, and private equities, some of which relate to oil and gas.
Potential impact on net income attributed to shareholders and MLI LICAT arising from changes in ALDA returns^(1),(2),(3),(4),(5),(6)^
| As at | December 31, 2019 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ( millions) | -10 | % | +10 | % | -10 | % | +10 | % | |||
| Net income attributed to shareholders | |||||||||||
| Real estate, agriculture and timber assets | (1,300 | ) | $ | 1,200 | $ | (1,300 | ) | $ | 1,200 | ||
| Private equities and other ALDA | (1,800 | ) | 1,700 | (1,800 | ) | 1,700 | |||||
| Total | (3,100 | ) | $ | 2,900 | $ | (3,100 | ) | $ | 2,900 | ||
| MLI’s LICAT total ratio (change in percentage points) | (5 | ) | 3 | (5 | ) | 4 |
All values are in US Dollars.
| ^(1)^ | See “Caution Related to Sensitivities” above. |
|---|---|
| ^(2)^ | This impact is calculated as at a point-in-time impact and does not include: (i) any potential<br> impact on ALDA weightings; or (ii) any gains or losses on ALDA held in the Corporate and Other segment. |
| --- | --- |
| ^(3)^ | The participating policy funds are largely self-supporting and generate no material impact on net<br> income attributed to shareholders as a result of changes in ALDA returns. For some classes of ALDA, where there is not an appropriate long-term benchmark available, the return assumptions used in valuation are not permitted by the<br> Standards of Practice and CIA guidance to result in a lower reserve than an assumption based on a historical return benchmark for public equities in the same jurisdiction. |
| --- | --- |
| ^(4)^ | Net income impact does not consider any impact of the market correction on assumed future return<br> assumptions. |
| --- | --- |
| ^(5)^ | Please refer to section D2 “Sensitivity of policy liabilities to asset related assumptions" for<br> more information on the level of growth assumed and on the net income sensitivity to changes in these long-term assumptions. |
| --- | --- |
| ^(6)^ | The impact of changes to the portfolio asset mix supporting our North American legacy businesses are reflected in the sensitivities when the changes<br> take place. |
| --- | --- |
C6 Credit risk exposure measures
As at March 31, 2020 and December 31, 2019, the impact of a 50% increase in credit defaults over the next year in excess of the rates provided for in policy liabilities, would reduce net income attributed to shareholders by $77 million and $69 million in each year, respectively. Credit downgrades for fixed income investments would adversely impact our regulatory capital, as required capital levels for such investments are based on the credit quality of each instrument. In addition, credit downgrades could also be higher than assumed in policy liabilities, resulting in policy liability increases and a reduction in net income attributed to shareholders.
Manulife Financial Corporation – First Quarter 2020
20
The table below shows net impaired assets and allowances for loan losses.
Net Impaired Assets and Loan Losses
| As at<br><br> <br>($ millions, unless otherwise stated) | March 31, 2020 | December 31, 2019 | ||||
|---|---|---|---|---|---|---|
| Net impaired fixed income assets | $ | 250 | $ | 234 | ||
| Net impaired fixed income assets as a % of total invested assets | 0.062 | % | 0.062 | % | ||
| Allowance for loan losses | $ | 27 | $ | 20 |
C7 Risk factors - Pandemic risk and potential implications of COVID-19
In our 2019 MD&A we outlined risk factors that may affect future results, including the potential impact of catastrophic events such as the global spread of diseases or illnesses. In 1Q20, the viral outbreak known as COVID-19 rapidly developed into a global pandemic. In response, worldwide emergency measures were taken, and continue to be taken, to combat the spread of the virus, including the imposition of travel restrictions, business closure orders, and regional quarantines and physical distancing requirements. These directives may continue and could be expanded. In addition, governments are implementing monetary and fiscal policy changes aimed to help stabilize economies and capital markets. We cannot predict legal and regulatory responses to concerns about the COVID-19 pandemic and related public health issues and how these responses may impact our business. The COVID-19 pandemic, actions taken globally in response to it, and the ensuing economic downturn has caused significant disruption to global supply chains, business activities and economies. The depth, breadth and duration of these disruptions remain highly uncertain at this time. Furthermore, governments are developing frameworks for the staged resumption of business activities. As a result, it is difficult to predict how significant the impact of the COVID-19 pandemic, including any responses to it, will be on the global economy and our business. These disruptions, if they continue, could have a significant adverse impact on our global businesses and operations and on our financial results.
We have outlined these risks in more detail in two parts. Those risk factors related specifically to the COVID-19 pandemic are described in this section and those related to the broader economic uncertainty are described below (see C8 - Global outlook and economic uncertainties).
Strategic Risk Factors
| ◾ | The ongoing COVID-19 pandemic could continue to adversely impact our financial results in future periods as a result of reduced<br> new business, reduced asset-based fee revenue, and net unfavourable policyholder experience including claims experience and premium persistency. The uncertainty around the expected duration of the pandemic and the measures put in place by<br> governments to respond to it could further depress business activity and financial markets, which could lead to lower net income attributed to shareholders. While in recent years we’ve taken significant actions to diversify and bolster<br> the resilience of our Company, further management actions may be required, including, but not limited to, changes to business and product mix, pricing structures on in-force and new business, investment mix, hedging programs, and the use<br> of reinsurance. |
|---|---|
| ◾ | Collaborative activities required to advance our strategic initiatives could also be impeded as emergency measures to combat<br> the virus significantly restrict direct human interactions and movement. Although we expect that our digital capabilities and tools should enable us to reasonably conduct business while emergency measures are in place, there can be no<br> assurance these or other strategies taken to address adverse impacts related to the COVID-19 pandemic will be successful. |
| --- | --- |
| ◾ | We also anticipate continued disruptions to our health and medical underwriting processes as a result of government measures<br> taken to limit or temporarily cease paramedical services in some markets, which could lead to lower sales volumes until such services can be resumed. To help mitigate the impacts of these disruptions, we have taken steps to change our<br> underwriting processes to allow us to accept certain low risk applications while postponing higher risk cases until emergency measures are eased. |
| --- | --- |
Product Risk Factors
| ◾ | Adverse experience relative to the assumptions used in the design and pricing of our insurance products and services could significantly impact our<br> operations and financial condition. This may result in an increase in policy liabilities and a decrease in net income attributable to shareholders. Further, large-scale events such as COVID-19 reduce the overall level of economic activity<br> as well as activity through our distribution channels, which could continue to adversely impact our ability to write new business. It is also possible that geographic concentration of insured individuals could increase the severity of<br> claims experience. The efficacy of external parties, including governmental |
|---|
Manulife Financial Corporation – First Quarter 2020
21
| and non-governmental organizations, in combating the pandemic is outside of our control but could also have a material and adverse impact on our<br> results of operations. | |
|---|---|
| ◾ | Increased economic uncertainty and increased unemployment resulting from the economic impacts of the spread of COVID-19 may also result in<br> policyholders seeking sources of liquidity and withdrawing at rates greater than we previously expected. If policyholder lapse and surrender rates significantly exceed our expectations, it could have a material adverse effect on our<br> business, financial condition, results of operations and cash flows. |
| --- | --- |
Operational Risk Factors
| ◾ | The pandemic has resulted in the imposition of government measures to restrict the movement of people, including travel bans<br> and social distancing requirements. These measures have led to disruptions to business operations across our global offices. While our business continuity plans have been executed across the organization with the vast majority of<br> employees shifting to remote work arrangements and our networks and systems have generally remained stable in supporting this large-scale effort, there can be no assurance that our ability to continue to operate our business will not be<br> adversely impacted if our networks and systems, including those aspects of our operations which rely on services provided by third parties, fail to operate as expected. The successful execution of business continuity strategies by third<br> parties is outside our control. If one or more of the third parties to whom we outsource certain critical business activities fails to perform as a result of the impacts from the spread of COVID-19, it may have a material adverse effect<br> on our business and operations. |
|---|---|
| ◾ | Our global processing centres’ operational capacity has been significantly impacted due to strict government measures to lock<br> down businesses and limit the movement of people within their jurisdictions, which has resulted in slower processing times and lower than expected customer experience, and has required us to reallocate capacity to less impacted<br> geographies, expand the use of remote work capabilities, and deprioritize non-essential business activities. |
| --- | --- |
| ◾ | The implementation of widespread remote work arrangements also increases other operational risks, including, but not limited<br> to, fraud, information security, and third-party risks, and we are relying on our risk management strategies to monitor these and other operational risks during this period of heightened uncertainty. |
| --- | --- |
C8 Risk Factors - Global outlook and economic uncertainties
The COVID-19 pandemic and actions taken in response to it have resulted in a significant economic downturn and significant disruptions in supply chains and business activity globally. Updates to specific risk factors are noted below:
Market Risk Factors
| ◾ | The pandemic and resulting economic downturn have created significant volatility and declines in financial and commodity<br> markets. Central banks have announced emergency interest rate cuts, while governments are implementing unprecedented fiscal stimulus packages to support economic stability. The pandemic could result in a global recessionary environment<br> with continued market volatility and low or negative interest rates, which may continue to impact our net income attributed to shareholders. Our investment portfolio has been, and may continue to be, adversely affected as a result of<br> market developments from the COVID-19 pandemic and related uncertainty. |
|---|---|
| ◾ | We have hedging programs, supported by a comprehensive collateral management program in place to help mitigate the risk of<br> interest rate and public equity market volatility. Our interest rate and public equity variable annuity hedging programs have performed with a high level of effectiveness during this period of volatility to date. |
| --- | --- |
| ◾ | Extreme market volatility may leave us unable to react to market events in a manner consistent with our historical investment<br> practices in dealing with more orderly markets. Market dislocations, decreases in observable market activity or unavailability of information arising from the spread of COVID-19, may restrict our access to key inputs used to derive<br> certain estimates and assumptions made in connection with financial reporting or otherwise, including estimates and changes in long term macro-economic assumptions relating to accounting for future credit losses. Restricted access to such<br> inputs may make our financial statement balances and estimates and assumptions used to run our business subject to greater variability and subjectivity. |
| --- | --- |
| ◾ | The significant increase in global oil production and supply experienced in 1Q20 compounded downward pressure on oil prices<br> that were already declining as a result of measures taken to mitigate COVID-19. We expect these events may continue to have an adverse impact on the value of our oil and gas investments and ALDA portfolio. |
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
22
Liquidity risk and capital management
| ◾ | Extreme market volatility and stressed conditions resulting from COVID-19 and the measures implemented to control its spread<br> could limit our access to capital markets and could result in additional cash and collateral demands primarily from changes to policyholder termination or renewal rates, withdrawals of customer deposit balances, borrowers renewing or<br> extending their loans when they mature, derivative settlements or collateral demands, and reinsurance settlements or collateral demands. We maintain strong financial strength ratings from our credit rating agencies. However, sustained<br> global economic uncertainty could result in adverse credit ratings changes which in turn could result in more costly or limited access to funding sources. In addition, while we currently have a variety of sources of liquidity including<br> cash balances, short-term investments, government and highly rated corporate bonds, and access to contingent liquidity facilities, there can be no assurance that these sources will provide us with sufficient liquidity on commercially<br> reasonable terms in the future. |
|---|---|
| ◾ | On March 13, 2020, OSFI announced measures to support the resilience of financial institutions. Consistent with these measures,<br> OSFI set the expectation for all federally regulated financial institutions that dividend increases and share buybacks should be halted for the time being. Accordingly, the Company has not repurchased its shares since March 13, 2020. |
| --- | --- |
Credit Risk Factors
| ◾ | An economic slowdown or recession could impact a wide range of industries to which we are exposed. The impact could increase borrower or<br> counterparty defaults or downgrades and cause increased provisions or impairments related to our general fund invested assets and derivative financial instruments, and an increase in provisions for future credit impairments to be included<br> in our policy liabilities. This could result in losses potentially above our long-term expected levels. |
|---|---|
| ◾ | We are monitoring our credit risk as we anticipate downgrades across some industries in our portfolio in subsequent quarters. The general fund<br> portfolio is constructed through credit selection criteria and is diversified with the majority of the portfolio rated investment grade which helps to mitigate risks associated with the current economic downturn. Our approach includes<br> seeking investments which perform more favourably in the longer term, throughout economic and business cycles, but there can be no assurance these or other strategies taken to address adverse impacts related to the COVID-19 pandemic will<br> be successful. |
| --- | --- |
D CRITICAL ACTUARIAL AND ACCOUNTING POLICIES
D1 Critical actuarial and accounting policies
Our significant accounting policies are described in note 1 to our Consolidated Financial Statements for the year ended December 31, 2019. The critical actuarial and accounting policies and estimation processes relate to the determination of insurance and investment contract liabilities, assessment of control over other entities for consolidation, estimation of fair value of invested assets, evaluation of invested asset impairment, accounting for derivative financial instruments, determination of pension and other post-employment benefit obligations and expenses, accounting for income taxes and uncertain tax positions and valuation and impairment of goodwill and intangible assets as described on pages 60 to 68 of our 2019 Annual Report.
D2 Sensitivity of policy liabilities to asset related assumptions
When the assumptions underlying our determination of policy liabilities are updated to reflect recent and emerging experience or change in outlook, the result is a change in the value of policy liabilities which in turn affects net income attributed to shareholders. The sensitivity of net income attributed to shareholders to updates to certain asset related assumptions underlying policy liabilities is shown below and assumes that there is a simultaneous change in the assumptions across all business units.
For changes in asset related assumptions, the sensitivity is shown net of the corresponding impact on income of the change in the value of the assets supporting policy liabilities. In practice, experience for each assumption will frequently vary by geographic market and business, and assumption updates are made on a business/geographic specific basis. Actual results can differ materially from these estimates for a variety of reasons including the interaction among these factors when more than one changes, changes in actuarial and investment return and future investment activity assumptions, actual experience differing from the assumptions, changes in business mix, effective tax rates and other market factors, and the general limitations of our internal models.
Manulife Financial Corporation – First Quarter 2020
23
Potential impact on net income attributed to shareholders arising from changes to asset related assumptions supporting actuarial liabilities
| Increase (decrease) in after-tax net income attributed to<br><br> <br>shareholders | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As at | March 31, 2020 | December 31, 2019 | ||||||||||
| ($ millions) | Increase | Decrease | Increase | Decrease | ||||||||
| Asset related assumptions updated periodically in valuation basis changes | ||||||||||||
| 100 basis point change in future annual returns for public equities^(1)^ | $ | 600 | $ | (600 | ) | $ | 500 | $ | (500 | ) | ||
| 100 basis point change in future annual returns for ALDA^(2)^ | 4,000 | (4,600 | ) | 3,800 | (4,400 | ) | ||||||
| 100 basis point change in equity volatility assumption for stochastic segregated fund modelling^(3)^ | (200 | ) | 200 | (300 | ) | 300 | ||||||
| ^(1)^ | The sensitivity to public equity returns above includes the impact on both segregated fund guarantee reserves and on other policy<br> liabilities. Expected long-term annual market growth assumptions for public equities are based on long-term historical observed experience and compliance with actuarial standards. As at March 31, 2020, the growth rates inclusive of<br> dividends in the major markets used in the stochastic valuation models for valuing segregated fund guarantees are 9.2% per annum in Canada, 9.6% per annum in the U.S. and 6.2% per annum in Japan. Growth assumptions for European equity<br> funds are market-specific and vary between 8.3% and 9.9%. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | ALDA include commercial real estate, timber, farmland, direct oil and gas properties, and private equities, some of which relate to oil and gas.<br> Expected long-term return assumptions for ALDA and public equity are set in accordance with the Standards of Practice for the valuation of insurance contract liabilities and guidance published by the CIA. Annual best estimate return<br> assumptions for ALDA and public equity include market growth rates and annual income, such as rent, production proceeds and dividends, and will vary based on our holding period. Over a 20-year horizon, our best estimate return assumptions<br> range between 5.25% and 11.65%, with an average of 9.3% based on the current asset mix backing our guaranteed insurance and annuity business as of March 31, 2020. Our return assumptions including the margins for adverse deviations in our<br> valuation, which take into account the uncertainty of achieving the returns, range between 2.5% and 7.5%, with an average of 6.1% based on the asset mix backing our guaranteed insurance and annuity business as of March 31, 2020. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | Volatility assumptions for public equities are based on long-term historical observed experience and compliance with actuarial<br> standards. The resulting volatility assumptions are 16.5% per annum in Canada and 17.15% per annum in the U.S. for large-cap public equities, and 19.25% per annum in Japan. For European equity funds, the volatility varies between 16.5%<br> and 18.4%. | |||||||||||
| --- | --- |
D3 Accounting and reporting changes
For accounting and reporting changes during the quarter, refer to note 2 of our unaudited Interim Consolidated Financial Statements for the three months ended March 31, 2020.
In addition, we have provided enhanced disclosures on measurement uncertainty in notes 1, 3 and 11 of our unaudited Interim Consolidated Financial Statements for the three months ended March 31, 2020.
E OTHER
E1 Outstanding shares – selected information
Common shares
As at April 30, 2020 MFC had 1,939,463,693 common shares outstanding.
E2 Legal and regulatory proceedings
We are regularly involved in legal actions, both as a defendant and as a plaintiff. Information on legal and regulatory proceedings can be found in note 12 of our unaudited Interim Consolidated Financial Statements for the three months ended March 31, 2020.
E3 Performance and non-GAAP measures
We use a number of non-GAAP financial measures to measure overall performance and to assess each of our businesses. A financial measure is considered a non-GAAP measure for Canadian securities law purposes if it is presented other than in accordance with generally accepted accounting principles used for the Company’s audited financial statements. Non-GAAP measures include: core earnings (loss); core ROE; diluted core earnings per common share; core earnings before income taxes, depreciation and amortization (“core EBITDA”); core EBITDA margin; core investment gains; constant exchange rate basis (measures that are reported on a constant exchange rate basis include percentage growth/decline in core earnings, sales, APE sales, gross flows, core EBITDA, new business value (“NBV”), new business value margin (“NBV margin”), assets under management, assets under management and administration (“AUMA”) and average assets under management and administration (“average AUMA”)); assets under administration; expense efficiency ratio; assets under management and administration; assets under management; average AUMA, consolidated capital; embedded value; new business value; new business value margin; sales; APE sales; gross flows; and net flows. Non-GAAP financial measures are not defined terms under GAAP and, therefore, are unlikely to be comparable to similar terms used by other issuers. Therefore, they should not be considered in isolation or as a substitute for any other financial information prepared in accordance with GAAP.
Manulife Financial Corporation – First Quarter 2020
24
Core earnings (loss) is a non-GAAP measure which we believe aids investors in better understanding the long-term earnings capacity and valuation of the business. Core earnings allows investors to focus on the Company’s operating performance by excluding the direct impact of changes in equity markets and interest rates, changes in actuarial methods and assumptions as well as a number of other items, outlined below, that we believe are material, but do not reflect the underlying earnings capacity of the business. For example, due to the long-term nature of our business, the mark-to-market movements of equity markets, interest rates, foreign currency exchange rates and commodity prices from period-to-period can, and frequently do, have a substantial impact on the reported amounts of our assets, liabilities and net income attributed to shareholders. These reported amounts are not actually realized at the time and may never be realized if the markets move in the opposite direction in a subsequent period. This makes it very difficult for investors to evaluate how our businesses are performing from period-to-period and to compare our performance with other issuers.
We believe that core earnings better reflect the underlying earnings capacity and valuation of our business. We use core earnings as the basis for management planning and reporting and, along with net income attributed to shareholders, as a key metric used in our short and mid-term incentive plans at the total Company and operating segment level.
While core earnings is relevant to how we manage our business and offers a consistent methodology, it is not insulated from macro-economic factors which can have a significant impact. See “Quarterly financial information” below for reconciliation of core earnings to net income (loss) attributed to shareholders.
Any future changes to the core earnings definition referred to below, will be disclosed.
Items included in core earnings:
| 1. | Expected earnings on in-force policies, including expected release of provisions for adverse deviation, fee income, margins on<br> group business and spread business such as Manulife Bank and asset fund management. |
|---|---|
| 2. | Macro hedging costs based on expected market returns. |
| --- | --- |
| 3. | New business strain and gains. |
| --- | --- |
| 4. | Policyholder experience gains or losses. |
| --- | --- |
| 5. | Acquisition and operating expenses compared with expense assumptions used in the measurement of policy liabilities. |
| --- | --- |
| 6. | Up to $400 million of net favourable investment-related experience reported in a single year, which are referred to as “core<br> investment gains”. This means up to $100 million in the first quarter, up to $200 million on a year-to-date basis in the second quarter, up to $300 million on a year-to-date basis in the third quarter and up to $400 million on a full year<br> basis in the fourth quarter. Any investment-related experience losses reported in a quarter will be offset against the net year-to-date investment-related experience gains with the difference being included in core earnings subject to a<br> maximum of the year-to-date core investment gains and a minimum of zero, which reflects our expectation that investment-related experience will be positive through-the-business cycle. To the extent any investment-related experience losses<br> cannot be fully offset in a quarter they will be carried forward to be offset against investment-related experience gains in subsequent quarters in the same year, for purposes of determining core investment gains. Investment-related<br> experience relates to fixed income investing, ALDA returns, credit experience and asset mix changes other than those related to a strategic change. An example of a strategic asset mix change is outlined below. |
| --- | --- |
| • | This favourable and unfavourable investment-related experience is a combination of reported investment experience as well as<br> the impact of investing activities on the measurement of our policy liabilities. We do not attribute specific components of investment-related experience to amounts included or excluded from core earnings. |
| --- | --- |
| • | The $400 million threshold represents the estimated average annualized amount of net favourable investment-related experience<br> that the Company reasonably expects to achieve through-the-business cycle based on historical experience. It is not a forecast of expected net favourable investment-related experience for any given fiscal year. |
| --- | --- |
| • | Our average net annualized investment-related experience calculated from the introduction of core earnings in 2012 to the end<br> of 2019 was $527 million (2012 to the end of 2018 was $493 million). |
| --- | --- |
| • | The decision announced on December 22, 2017 to reduce the allocation to ALDA in the portfolio asset mix supporting our legacy<br> businesses was the first strategic asset mix change since we introduced the core earnings metric in 2012. We refined our description of investment-related experience in 2017 to note that asset mix changes other than those related to a<br> strategic change are taken into consideration in the investment-related experience component of core investment gains. |
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
25
| • | While historical investment return time horizons may vary in length based on underlying asset classes generally exceeding 20<br> years, for purposes of establishing the threshold, we look at a business cycle that is five or more years and includes a recession. We monitor the appropriateness of the threshold as part of our annual five-year planning process and would<br> adjust it, either to a higher or lower amount, in the future if we believed that our threshold was no longer appropriate. |
|---|---|
| • | Specific criteria used for evaluating a potential adjustment to the threshold may include, but are not limited to, the extent<br> to which actual investment-related experience differs materially from actuarial assumptions used in measuring insurance contract liabilities, material market events, material dispositions or acquisitions of assets, and regulatory or<br> accounting changes. |
| --- | --- |
| 7. | Earnings on surplus other than mark-to-market items. Gains on available-for-sale (“AFS”) equities and seed money investments in<br> new segregated and mutual funds are included in core earnings. |
| --- | --- |
| 8. | Routine or non-material legal settlements. |
| --- | --- |
| 9. | All other items not specifically excluded. |
| --- | --- |
| 10. | Tax on the above items. |
| --- | --- |
| 11. | All tax related items except the impact of enacted or substantively enacted income tax rate changes. |
| --- | --- |
Items excluded from core earnings:
| 1. | The direct impact of equity markets and interest rates and variable annuity guarantee liabilities includes the items listed<br> below. |
|---|---|
| • | The earnings impact of the difference between the net increase (decrease) in variable annuity liabilities that are dynamically<br> hedged and the performance of the related hedge assets. Our variable annuity dynamic hedging strategy is not designed to completely offset the sensitivity of insurance and investment contract liabilities to all risks or measurements<br> associated with the guarantees embedded in these products for a number of reasons, including; provisions for adverse deviation, fund performance, the portion of the interest rate risk that is not dynamically hedged, realized equity and<br> interest rate volatilities and changes to policyholder behaviour. |
| --- | --- |
| • | Gains (charges) on variable annuity guarantee liabilities not dynamically hedged. |
| --- | --- |
| • | Gains (charges) on general fund equity investments supporting policy liabilities and on fee income. |
| --- | --- |
| • | Gains (charges) on macro equity hedges relative to expected costs. The expected cost of macro hedges is calculated using the<br> equity assumptions used in the valuation of insurance and investment contract liabilities. |
| --- | --- |
| • | Gains (charges) on higher (lower) fixed income reinvestment rates assumed in the valuation of insurance and investment contract<br> liabilities. |
| --- | --- |
| • | Gains (charges) on sale of AFS bonds and open derivatives not in hedging relationships in the Corporate and Other segment. |
| --- | --- |
| 2. | Net favourable investment-related experience in excess of $400 million per annum or net unfavourable investment-related<br> experience on a year-to-date basis. |
| --- | --- |
| 3. | Mark-to-market gains or losses on assets held in the Corporate and Other segment other than gains on AFS equities and seed<br> money investments in new segregated or mutual funds. |
| --- | --- |
| 4. | Changes in actuarial methods and assumptions. As noted in the “Critical actuarial and accounting policies” section of our 2019<br> MD&A, policy liabilities for IFRS are valued in Canada under standards established by the Actuarial Standards Board. The standards require a comprehensive review of actuarial methods and assumptions to be performed annually. The<br> review is designed to reduce the Company’s exposure to uncertainty by ensuring assumptions for both asset related and liability related risks remain appropriate and is accomplished by monitoring experience and selecting assumptions which<br> represent a current best estimate view of expected future experience, and margins that are appropriate for the risks assumed. Changes related to ultimate reinvestment rates (“URR”) are included in the direct impact of equity markets and<br> interest rates and variable annuity guarantee liabilities. By excluding the results of the annual reviews, core earnings assist investors in evaluating our operational performance and comparing our operational performance from period to<br> period with other global insurance companies because the associated gain or loss is not reflective of current year performance and not reported in net income in most actuarial standards outside of Canada. |
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
26
| 5. | The impact on the measurement of policy liabilities of changes in product features or new reinsurance transactions, if<br> material. |
|---|---|
| 6. | Goodwill impairment charges. |
| --- | --- |
| 7. | Gains or losses on disposition of a business. |
| --- | --- |
| 8. | Material one-time only adjustments, including highly unusual/extraordinary and material legal settlements or other items that<br> are material and exceptional in nature. |
| --- | --- |
| 9. | Tax on the above items. |
| --- | --- |
| 10. | Impact of enacted or substantially enacted income tax rate changes. |
| --- | --- |
The following table summarizes for the past eight quarters core earnings and net income (loss) attributed to shareholders.
Total Company
| ( millions, unaudited) | 1Q20 | 4Q19 | 3Q19 | 2Q19 | 1Q19 | 4Q18 | 3Q18 | 2Q18 | |||||||||||||||
| Core earnings (loss) | |||||||||||||||||||||||
| Asia | 491 | $ | 494 | $ | 520 | $ | 471 | $ | 520 | $ | 463 | $ | 461 | $ | 411 | ||||||||
| Canada | 237 | 288 | 318 | 312 | 283 | 305 | 344 | 395 | |||||||||||||||
| U.S. | 416 | 489 | 471 | 441 | 475 | 454 | 467 | 446 | |||||||||||||||
| Global Wealth and Asset<br> Management | 250 | 265 | 281 | 242 | 233 | 231 | 288 | 239 | |||||||||||||||
| Corporate and Other (excluding<br> core investment gains) | (366 | ) | (159 | ) | (163 | ) | (114 | ) | (63 | ) | (216 | ) | (121 | ) | (164 | ) | |||||||
| Core investment gains | - | 100 | 100 | 100 | 100 | 100 | 100 | 104 | |||||||||||||||
| Total core earnings | 1,028 | 1,477 | 1,527 | 1,452 | 1,548 | 1,337 | 1,539 | 1,431 | |||||||||||||||
| Items to reconcile core earnings<br> (loss) to net income (loss) attributed<br> to shareholders: | |||||||||||||||||||||||
| Investment-related experience<br> outside of core earnings | (608 | ) | 182 | (289 | ) | 146 | 327 | (130 | ) | 312 | 18 | ||||||||||||
| Direct impact of equity markets<br> and interest rates and variable<br> annuity guarantee liabilities | 792 | (389 | ) | (494 | ) | (144 | ) | 249 | (675 | ) | (277 | ) | 45 | ||||||||||
| Change in actuarial methods and<br> assumptions | - | - | (21 | ) | - | - | - | (51 | ) | - | |||||||||||||
| Reinsurance transactions | 12 | (34 | ) | - | 63 | 52 | 142 | (65 | ) | 12 | |||||||||||||
| Restructuring charge | - | - | - | - | - | (63 | ) | - | (200 | ) | |||||||||||||
| Tax-related items and other | 72 | (8 | ) | - | (42 | ) | - | (18 | ) | 115 | (44 | ) | |||||||||||
| Net income (loss) attributed<br> to shareholders | 1,296 | $ | 1,228 | $ | 723 | $ | 1,475 | $ | 2,176 | $ | 593 | $ | 1,573 | $ | 1,262 |
All values are in US Dollars.
Asia
| ( millions, unaudited) | 1Q20 | 4Q19 | 3Q19 | 2Q19 | 1Q19 | 4Q18 | 3Q18 | 2Q18 | |||||||||||||
| Asia core earnings(1) | 491 | $ | 494 | $ | 520 | $ | 471 | $ | 520 | $ | 463 | $ | 461 | $ | 411 | ||||||
| Items to reconcile core earnings<br> to net income (loss) attributed to<br> shareholders: | |||||||||||||||||||||
| Investment-related experience<br> outside of core earnings | 50 | 46 | (13 | ) | 47 | 116 | 99 | 91 | 46 | ||||||||||||
| Direct impact of equity markets<br> and interest rates and variable<br> annuity guarantee liabilities | (458 | ) | 96 | (372 | ) | (42 | ) | 59 | (244 | ) | (18 | ) | (86 | ) | |||||||
| Change in actuarial methods<br> and assumptions | - | - | (7 | ) | - | - | - | 27 | - | ||||||||||||
| Reinsurance transactions | 12 | - | - | - | - | - | 5 | - | |||||||||||||
| Tax-related items and other | - | - | - | - | - | - | - | (3 | ) | ||||||||||||
| Net income (loss) attributed<br> to shareholders(1) | 95 | $ | 636 | $ | 128 | $ | 476 | $ | 695 | $ | 318 | $ | 566 | $ | 368 |
All values are in US Dollars.
| ^(1)^ | 2018 core earnings and net income (loss) attributed to shareholders have been updated to reflect the 2019<br> methodology for allocating capital and interest on surplus to our insurance segments from the Corporate and Other segment. |
|---|
Manulife Financial Corporation – First Quarter 2020
27
Canada
| ( millions, unaudited) | 1Q20 | 4Q19 | 3Q19 | 2Q19 | 1Q19 | 4Q18 | 3Q18 | 2Q18 | ||||||||||||||
| Canada core earnings(1) | 237 | $ | 288 | $ | 318 | $ | 312 | $ | 283 | $ | 305 | $ | 344 | $ | 395 | |||||||
| Items to reconcile core earnings<br> to net income (loss) attributed to<br> shareholders: | ||||||||||||||||||||||
| Investment-related experience<br> outside of core earnings | (378 | ) | 69 | (47 | ) | 2 | 453 | (143 | ) | 155 | 83 | |||||||||||
| Direct impact of equity markets<br> and interest rates and variable<br> annuity guarantee liabilities | (725 | ) | (97 | ) | (335 | ) | 7 | 11 | (234 | ) | (26 | ) | 13 | |||||||||
| Change in actuarial methods<br> and assumptions | - | - | (108 | ) | - | - | - | (370 | ) | - | ||||||||||||
| Reinsurance transactions | - | (34 | ) | - | - | 4 | - | 4 | 12 | |||||||||||||
| Tax-related items and other | - | - | - | (4 | ) | - | (2 | ) | (5 | ) | (1 | ) | ||||||||||
| Net income (loss) attributed<br> to shareholders(1) | (866 | ) | $ | 226 | $ | (172 | ) | $ | 317 | $ | 751 | $ | (74 | ) | $ | 102 | $ | 502 |
All values are in US Dollars.
| ^(1)^ | 2018 core earnings and net income (loss) attributed to shareholders have been updated to reflect the 2019<br> methodology for allocating capital and interest on surplus to our insurance segments from the Corporate and Other segment. |
|---|
U.S.
| ( millions, unaudited) | 1Q20 | 4Q19 | 3Q19 | 2Q19 | 1Q19 | 4Q18 | 3Q18 | 2Q18 | |||||||||||||||
| U.S. core earnings(1) | 416 | $ | 489 | $ | 471 | $ | 441 | $ | 475 | $ | 454 | $ | 467 | $ | 446 | ||||||||
| Items to reconcile core earnings<br> to net income (loss) attributed to<br> shareholders: | |||||||||||||||||||||||
| Investment-related experience<br> outside of core earnings | (266 | ) | 177 | (134 | ) | 166 | (143 | ) | 15 | 162 | (59 | ) | |||||||||||
| Direct impact of equity markets<br> and interest rates and variable<br> annuity guarantee liabilities | 1,702 | (515 | ) | (66 | ) | (173 | ) | 61 | (95 | ) | (204 | ) | 267 | ||||||||||
| Change in actuarial methods and<br> assumptions | - | - | 71 | - | - | - | 286 | - | |||||||||||||||
| Reinsurance transactions | - | - | - | 63 | 48 | 142 | (74 | ) | - | ||||||||||||||
| Tax-related items and other | - | (8 | ) | - | 5 | - | (3 | ) | (7 | ) | (34 | ) | |||||||||||
| Net income (loss) attributed<br> to shareholders(1) | 1,852 | $ | 143 | $ | 342 | $ | 502 | $ | 441 | $ | 513 | $ | 630 | $ | 620 |
All values are in US Dollars.
| ^(1)^ | 2018 core earnings and net income (loss) attributed to shareholders have been updated to reflect the 2019<br> methodology for allocating capital and interest on surplus to our insurance segments from the Corporate and Other segment. |
|---|
Global Wealth and Asset Management
| ( millions, unaudited) | 1Q20 | 4Q19 | 3Q19 | 2Q19 | 1Q19 | 4Q18 | 3Q18 | 2Q18 | ||||||||||
| Global WAM core earnings | 250 | $ | 265 | $ | 281 | $ | 242 | $ | 233 | $ | 231 | $ | 288 | $ | 239 | |||
| Items to reconcile core earnings<br> to net income (loss) attributed to<br> shareholders: | ||||||||||||||||||
| Tax-related items and other | - | - | - | 1 | - | (13 | ) | (8 | ) | (6 | ) | |||||||
| Net income (loss) attributed<br> to shareholders | 250 | $ | 265 | $ | 281 | $ | 243 | $ | 233 | $ | 218 | $ | 280 | $ | 233 |
All values are in US Dollars.
Corporate and Other
| ( millions, unaudited) | 1Q20 | 4Q19 | 3Q19 | 2Q19 | 1Q19 | 4Q18 | 3Q18 | 2Q18 | |||||||||||||||
| Corporate and Other core<br> income (loss) (excluding core<br> investment gains)(1) | (366 | ) | $ | (159 | ) | $ | (163 | ) | $ | (114 | ) | $ | (63 | ) | $ | (216 | ) | $ | (121 | ) | $ | (164 | ) |
| Core investment gains (loss) | - | 100 | 100 | 100 | 100 | 100 | 100 | 104 | |||||||||||||||
| Total core earnings (loss) | (366 | ) | (59 | ) | (63 | ) | (14 | ) | 37 | (116 | ) | (21 | ) | (60 | ) | ||||||||
| Other items to reconcile core<br> earnings (loss) to net income (loss)<br> attributed to shareholders: | |||||||||||||||||||||||
| Investment-related experience<br> outside of core earnings | (14 | ) | (110 | ) | (95 | ) | (69 | ) | (99 | ) | (101 | ) | (96 | ) | (52 | ) | |||||||
| Direct impact of equity markets<br> and interest rates | 273 | 127 | 279 | 64 | 118 | (102 | ) | (29 | ) | (149 | ) | ||||||||||||
| Changes in actuarial methods<br> and assumptions | - | - | 23 | - | - | - | 6 | - | |||||||||||||||
| Tax-related items and other | 72 | - | - | (44 | ) | - | - | 135 | - | ||||||||||||||
| Restructuring charge | - | - | - | - | - | (63 | ) | - | (200 | ) | |||||||||||||
| Net income (loss) attributed<br> to shareholders(1) | (35 | ) | $ | (42 | ) | $ | 144 | $ | (63 | ) | $ | 56 | $ | (382 | ) | $ | (5 | ) | $ | (461 | ) |
All values are in US Dollars.
| ^(1)^ | The Corporate and Other segment includes earnings on assets backing capital net of amounts allocated to operating segments. 2018 core<br> income (loss) (excluding core investment gains) and net income (loss) attributed to shareholders have been updated to reflect the 2019 methodology for allocating capital and interest on surplus to our insurance segments from the Corporate<br> and Other segment. |
|---|
Manulife Financial Corporation – First Quarter 2020
28
Core return on common shareholders’ equity (“core
ROE”\) is a non-GAAP profitability measure that presents core earnings available to common shareholders as a percentage of the capital deployed to earn the core earnings. The Company calculates core ROE using average common shareholders’
equity.
Diluted core earnings per common share is core earnings available to common shareholders expressed per diluted weighted average common share outstanding.
The Company also uses financial performance measures that are prepared on a constant exchange rate basis, which are non-GAAP measures that exclude the impact of currency fluctuations (from local currency to Canadian dollars at a total Company level and from local currency to U.S. dollars in Asia). Quarterly amounts stated on a constant exchange rate basis in this MD&A are calculated, as appropriate, using the income statement and balance sheet exchange rates effective for 1Q20. Measures that are reported on a constant exchange rate basis include growth in core earnings, sales, APE sales, gross flows, core EBITDA, new business value, new business value margin, assets under management, assets under management and administration, and average assets under management and administration.
Assets under management and administration (“AUMA”) is a non-GAAP measure of the size of the Company. It is comprised of the non-GAAP measures assets under management (“AUM”), which includes both assets of general account and external client assets for which we provide investment management services, and assets under administration (“AUA”), which includes assets for which we provide administrative services only. Assets under management and administration is a common industry metric for WAM businesses.
| Assets under management and administration | ||||||
|---|---|---|---|---|---|---|
| As at | ||||||
| ($ millions) | March 31,<br><br> <br>2020 | December 31,<br><br> <br>2019 | March 31,<br><br> <br>2019 | |||
| Total invested assets | $ | 405,329 | $ | 378,527 | $ | 359,458 |
| Segregated funds net assets | 312,253 | 343,108 | 334,425 | |||
| Assets under management per financial statements | 717,582 | 721,635 | 693,883 | |||
| Mutual funds | 195,249 | 217,015 | 200,158 | |||
| Institutional advisory accounts (excluding segregated funds) | 97,427 | 95,410 | 97,782 | |||
| Other funds | 8,613 | 9,401 | 8,488 | |||
| Total assets under management | 1,018,871 | 1,043,461 | 1,000,311 | |||
| Other assets under administration | 138,943 | 145,397 | 134,201 | |||
| Currency impact | - | 75,888 | 48,316 | |||
| AUMA at constant exchange rates | $ | 1,157,814 | $ | 1,264,746 | $ | 1,182,828 |
Average assets under management and administration (“average AUMA”) is a non-GAAP measure of the average of Global WAM’s AUMA during the reporting period. It is a measure used in analyzing and explaining fee income and earnings of our Global Wealth and Asset Management segment. It is calculated as the average of the opening balance of AUMA and the ending balance of AUMA using daily balances where available and month-end or quarter-end averages when daily averages are unavailable.
Consolidated capital is a non-GAAP measure. It serves as a foundation of our capital management activities at the MFC level. For regulatory reporting purposes, the numbers are further adjusted for various additions or deductions to capital as mandated by the guidelines used by OSFI. Consolidated capital is calculated as the sum of (i) total equity excluding accumulated other comprehensive income (“AOCI”) on cash flow hedges; and (ii) liabilities for capital instruments.
| Consolidated capital | ||||||
|---|---|---|---|---|---|---|
| As at | ||||||
| ($ millions) | March 31,<br><br> <br>2020 | December 31,<br><br> 2019 | March 31,<br><br> <br>2019 | |||
| Total equity | $ | 56,061 | $ | 50,106 | $ | 48,994 |
| Add AOCI loss on cash flow hedges | 360 | 143 | 146 | |||
| Add qualifying capital instruments | 6,796 | 7,120 | 8,185 | |||
| Consolidated capital | $ | 63,217 | $ | 57,369 | $ | 57,325 |
Core EBITDA is a non-GAAP measure which Manulife uses to better understand the long-term earnings capacity and valuation of our Global WAM business on a basis more comparable to how the profitability of global asset managers is generally measured. Core EBITDA presents core earnings before the impact of interest, taxes, depreciation, and amortization.
Manulife Financial Corporation – First Quarter 2020
29
Core EBITDA excludes certain acquisition expenses related to insurance contracts in our retirement businesses which are deferred and amortized over the expected life time of the customer relationship under the CALM. Core EBITDA was selected as a key performance indicator for our Global WAM business, as EBITDA is widely used among asset management peers, and core earnings is a primary profitability metric for the Company overall.
Core EBITDA margin is a non-GAAP measure which Manulife uses to better understand the long-term profitability of our Global WAM business on a more comparable basis to how profitability of global asset managers are measured. Core EBITDA margin presents core earnings before the impact of interest, taxes, depreciation, and amortization divided by total revenue from these businesses. Core EBITDA margin was selected as a key performance indicator for our Global WAM business, as EBITDA margin is widely used among asset management peers, and core earnings is a primary profitability metric for the Company overall.
Global Wealth and Asset Management
| ( millions, unaudited) | 1Q20 | 4Q19 | 3Q19 | 2Q19 | 1Q19 | 4Q18 | 3Q18 | 2Q18 | |||||||||||||||
| Core EBITDA | 390 | $ | 391 | $ | 404 | $ | 375 | $ | 366 | $ | 362 | $ | 405 | $ | 370 | ||||||||
| Amortization of deferred acquisition<br> costs and other depreciation | (80 | ) | (78 | ) | (78 | ) | (79 | ) | (76 | ) | (77 | ) | (76 | ) | (75 | ) | |||||||
| Amortization of deferred sales<br> commissions | (22 | ) | (19 | ) | (19 | ) | (20 | ) | (23 | ) | (22 | ) | (23 | ) | (24 | ) | |||||||
| Core earnings before income taxes | 288 | 294 | 307 | 276 | 267 | 263 | 306 | 271 | |||||||||||||||
| Core income tax (expense) recovery | (38 | ) | (29 | ) | (26 | ) | (34 | ) | (34 | ) | (32 | ) | (18 | ) | (32 | ) | |||||||
| Core earnings | 250 | $ | 265 | $ | 281 | $ | 242 | $ | 233 | $ | 231 | $ | 288 | $ | 239 |
All values are in US Dollars.
Expense efficiency ratio is a non-GAAP measure which Manulife uses to measure progress towards our target to be more efficient. Efficiency ratio is defined as pre-tax general expenses included in core earnings divided by the sum of pre-tax core earnings and pre-tax general expenses included in core earnings.
Embedded value (“EV”) is a measure of the present value of shareholders’ interests in the expected future distributable earnings on in-force business reflected in the Consolidated Statements of Financial Position of Manulife, excluding any value associated with future new business. EV is calculated as the sum of the adjusted net worth and the value of in-force business. The adjusted net worth is the IFRS shareholders’ equity adjusted for goodwill and intangibles, fair value of surplus assets, the carrying value of debt and preferred shares, and local statutory balance sheet, regulatory reserve, and capital for Manulife’s Asian business. The value of in-force business in Canada and the U.S. is the present value of expected future IFRS earnings on in-force business less the present value of the cost of holding capital to support the in-force business under the LICAT framework. The value of in-force business in Asia reflects local statutory earnings and capital requirements. The value of in-force excludes our Global WAM, Manulife Bank and Property and Casualty Reinsurance businesses.
New business value (“NBV”) is the change in embedded value as a result of sales in the reporting period. NBV is calculated as the present value of shareholders’ interests in expected future distributable earnings, after the cost of capital, on actual new business sold in the period using assumptions that are consistent with the assumptions used in the calculation of embedded value. NBV excludes businesses with immaterial insurance risks, such as the Company’s Global WAM, Manulife Bank and the short-term Property and Casualty Reinsurance businesses. NBV is a useful metric to evaluate the value created by the Company’s new business franchise.
New business value margin (“NBV margin”) is calculated as NBV divided by APE excluding non-controlling interests. APE is calculated as 100% of annualized first year premiums for recurring premium products, and as 10% of single premiums for single premium products. Both NBV and APE used in the NBV margin calculation are after non-controlling interests and exclude our Global WAM, Manulife Bank and Property and Casualty Reinsurance businesses. The NBV margin is a useful metric to help understand the profitability of our new business.
Sales are measured according to product type:
For individual insurance, sales include 100% of new annualized premiums and 10% of both excess and single premiums. For individual insurance, new annualized premiums reflect the annualized premium expected in the first year of a policy that requires premium payments for more than one year. Single premium is the lump sum premium from the sale of a single premium product, e.g. travel insurance. Sales are reported gross before the impact of reinsurance.
For group insurance, sales include new annualized premiums and administrative services only premium equivalents on new cases, as well as the addition of new coverages and amendments to contracts, excluding rate increases.
Manulife Financial Corporation – First Quarter 2020
30
APE sales are comprised of 100% of regular premiums/deposits and 10% of single premiums/deposits for both insurance and insurance-based wealth accumulation products.
Insurance-based wealth accumulation product sales include all new deposits into variable and fixed annuity contracts. As we discontinued sales of new Variable Annuity contracts in the U.S. in 1Q13, subsequent deposits into existing U.S. Variable Annuity contracts are not reported as sales. Asia variable annuity deposits are included in APE sales.
Bank new lending volumes include bank loans and mortgages authorized in the period.
Gross flows is a new business measure presented for our Global WAM business and includes all deposits into mutual funds, college savings 529 plans, group pension/retirement savings products, private wealth and institutional asset management products. Gross flows is a common industry metric for WAM businesses as it provides a measure of how successful the businesses are at attracting assets.
Net flows is presented for our Global WAM business and includes gross flows less redemptions for mutual funds, college savings 529 plans, group pension/retirement savings products, private wealth and institutional asset management products. Net flows is a common industry metric for WAM businesses as it provides a measure of how successful the businesses are atattracting and retaining assets. When gross flows exceed redemptions, net flows will be positive and will be referred to as net inflows. Conversely, when redemptions exceed gross flows, net flows will be negative and will be referred to as net outflows.
E4 Caution regarding forward-looking statements
From time to time, MFC makes written and/or oral forward-looking statements, including in this document. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such statements are made pursuant to the “safe harbour” provisions of Canadian provincial securities laws and the U.S. Private Securities Litigation Reform Act of 1995.
The forward-looking statements in this document include, but are not limited to, statements with respect to our business continuity plans and measures implemented in response to the COVID-19 pandemic and its expected impact on our businesses, operations, earnings and results and also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and estimates, and can generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, “suspect”, “outlook”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “forecast”, “objective”, “seek”, “aim”, “continue”, “goal”, “restore”, “embark” and “endeavour” (or the negative thereof) and words and expressions of similar import, and include statements concerning possible or assumed future results. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts’ expectations in any way.
Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); the severity, duration and spread of the COVID-19 outbreak, as well as actions that may be taken by governmental authorities to contain COVID-19 or to treat its impact; changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements; our ability to execute strategic plans and changes to strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies, actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified as available-for-sale; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other
Manulife Financial Corporation – First Quarter 2020
31
risks associated with our non-North American operations; acquisitions and our ability to complete acquisitions including the availability of equity and debt financing for this purpose; the disruption of or changes to key elements of the Company’s or public infrastructure systems; environmental concerns; our ability to protect our intellectual property and exposure to claims of infringement; and our inability to withdraw cash from subsidiaries.
Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in this document under “Risk Management and Risk Factors Update” and “Critical Actuarial and Accounting Policies”, under “Risk Management”, “Risk Factors” and “Critical Actuarial and Accounting Policies” in the Management’s Discussion and Analysis in our most recent annual report and, in the “Risk Management” note to the consolidated financial statements in our most recent annual and interim reports and elsewhere in our filings with Canadian and U.S. securities regulators.
The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are presented for the purpose of assisting investors and others in understanding our financial position and results of operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other purposes. We do not undertake to update any forward-looking statements, except as required by law.
E5 Quarterly financial information
The following table provides summary information related to our eight most recently completed quarters.
| As at and for the three months ended | Dec 31, | Sept 30, | Jun 30, | Mar 31, | Dec 31, | Sept 30, | Jun 30, | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ( millions, except per share amounts or<br> otherwise stated, unaudited) | 2019 | 2019 | 2019 | 2019 | 2018 | 2018 | 2018 | ||||||||||||||||
| Revenue | |||||||||||||||||||||||
| Premium income | |||||||||||||||||||||||
| Life and health insurance | 8,454 | $ | 8,373 | $ | 8,309 | $ | 7,696 | $ | 8,077 | $ | 7,724 | $ | 7,700 | $ | 7,628 | ||||||||
| Annuities and pensions(1) | 901 | 865 | 1,026 | 995 | 237 | (5,892 | ) | (2,599 | ) | 1,126 | |||||||||||||
| Net premium income | 9,355 | 9,238 | 9,335 | 8,691 | 8,314 | 1,832 | 5,101 | 8,754 | |||||||||||||||
| Investment income | 3,284 | 4,004 | 3,932 | 3,710 | 3,747 | 3,278 | 3,481 | 3,566 | |||||||||||||||
| Realized and unrealized gains and losses<br> on assets supporting insurance and<br> investment contract liabilities(2) | 4,558 | (4,503 | ) | 6,592 | 7,185 | 8,926 | 1,113 | (3,210 | ) | (1,615 | ) | ||||||||||||
| Other revenue | 2,980 | 2,433 | 2,770 | 2,634 | 2,562 | 2,291 | 2,671 | 2,964 | |||||||||||||||
| Total revenue | 20,177 | $ | 11,172 | $ | 22,629 | $ | 22,220 | $ | 23,549 | $ | 8,514 | $ | 8,043 | $ | 13,669 | ||||||||
| Income (loss) before income taxes | 1,704 | $ | 1,225 | $ | 715 | $ | 1,756 | $ | 2,524 | $ | 359 | $ | 1,911 | $ | 1,535 | ||||||||
| Income tax (expense) recovery | (597 | ) | (89 | ) | (100 | ) | (240 | ) | (289 | ) | (43 | ) | (6 | ) | (246 | ) | |||||||
| Net income (loss) | 1,107 | $ | 1,136 | $ | 615 | $ | 1,516 | $ | 2,235 | $ | 316 | $ | 1,905 | $ | 1,289 | ||||||||
| Net income (loss) attributed to<br> shareholders | 1,296 | $ | 1,228 | $ | 723 | $ | 1,475 | $ | 2,176 | $ | 593 | $ | 1,573 | $ | 1,262 | ||||||||
| Reconciliation of core earnings to<br> net income attributed to shareholders | |||||||||||||||||||||||
| Total core earnings(3) | 1,028 | $ | 1,477 | $ | 1,527 | $ | 1,452 | $ | 1,548 | $ | 1,337 | $ | 1,539 | $ | 1,431 | ||||||||
| Other items to reconcile net income<br> attributed to shareholders to core<br> earnings(4): | |||||||||||||||||||||||
| Investment-related experience outside<br> of core earnings | (608 | ) | 182 | (289 | ) | 146 | 327 | (130 | ) | 312 | 18 | ||||||||||||
| Direct impact of equity markets, interest<br> rates and variable annuity guarantee<br> liabilities | 792 | (389 | ) | (494 | ) | (144 | ) | 249 | (675 | ) | (277 | ) | 45 | ||||||||||
| Change in actuarial methods and<br> assumptions | - | - | (21 | ) | - | - | - | (51 | ) | - | |||||||||||||
| Reinsurance transactions | 12 | (34 | ) | - | 63 | 52 | 142 | (65 | ) | 12 | |||||||||||||
| Restructuring charge | - | - | - | - | - | (63 | ) | - | (200 | ) | |||||||||||||
| Tax-related items and other | 72 | (8 | ) | - | (42 | ) | - | (18 | ) | 115 | (44 | ) | |||||||||||
| Net income (loss) attributed to<br> shareholders | 1,296 | $ | 1,228 | $ | 723 | $ | 1,475 | $ | 2,176 | $ | 593 | $ | 1,573 | $ | 1,262 | ||||||||
| Basic earnings (loss) per common<br> share | 0.64 | $ | 0.61 | $ | 0.35 | $ | 0.73 | $ | 1.09 | $ | 0.28 | $ | 0.77 | $ | 0.61 | ||||||||
| Diluted earnings (loss) per common<br> share | 0.64 | $ | 0.61 | $ | 0.35 | $ | 0.73 | $ | 1.08 | $ | 0.28 | $ | 0.77 | $ | 0.61 | ||||||||
| Segregated funds deposits | 11,215 | $ | 9,417 | $ | 9,160 | $ | 9,398 | $ | 10,586 | $ | 9,212 | $ | 9,424 | $ | 9,872 | ||||||||
| Total assets (in billions) | 831 | $ | 809 | $ | 812 | $ | 790 | $ | 780 | $ | 750 | $ | 748 | $ | 752 | ||||||||
| Weighted average common shares (in<br> millions) | 1,943 | 1,948 | 1,961 | 1,965 | 1,965 | 1,980 | 1,984 | 1,984 | |||||||||||||||
| Diluted weighted average common<br> shares (in millions) | 1,947 | 1,953 | 1,965 | 1,969 | 1,969 | 1,983 | 1,989 | 1,989 | |||||||||||||||
| Dividends per common share | 0.280 | $ | 0.250 | $ | 0.250 | $ | 0.250 | $ | 0.250 | $ | 0.250 | $ | 0.220 | $ | 0.220 | ||||||||
| CDN to US1 - Statement of Financial<br> Position | 1.4187 | 1.2988 | 1.3243 | 1.3087 | 1.3363 | 1.3642 | 1.2945 | 1.3168 | |||||||||||||||
| CDN to US1 - Statement of Income | 1.3449 | 1.3200 | 1.3204 | 1.3377 | 1.3295 | 1.3204 | 1.3069 | 1.2912 |
All values are in US Dollars.
| ^(1)^ | Includes ceded premiums related to the reinsurance of a block of our legacy U.S. individual payout annuities of US$0.5 billion in 1Q19, US$5.3 billion<br> in 4Q18 and US$2.8 billion in 3Q18. |
|---|---|
| ^(2)^ | For fixed income assets supporting insurance and investment contract liabilities and for equities supporting pass-through products and derivatives<br> related to variable hedging programs, the impact of realized and unrealized gains and losses on the assets is largely offset in the change in insurance and investment contract liabilities. |
| --- | --- |
| ^(3)^ | Core earnings is a non-GAAP measure. See “Performance and non-GAAP measures” above. |
| --- | --- |
| ^(4)^ | For explanations of other items, see “Items excluded from core earnings” table in section A1 “Profitability” and for an operating<br> segment split of these items see the 8 quarter trend tables in “Performance and non-GAAP measures” which reconcile net income (loss) attributed to shareholders to core earnings. |
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
32
E6 Other
No changes were made in our internal control over financial reporting during the three months ended March 31, 2020, that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.
As in prior quarters, MFC’s Audit Committee reviewed this MD&A and the unaudited interim financial report and MFC’s Board of Directors approved this MD&A prior to its release.
Manulife Financial Corporation – First Quarter 2020
33
| Consolidated Statements of Financial Position | ||||||
|---|---|---|---|---|---|---|
| As at | ||||||
| (Canadian $ in millions, unaudited) | March 31, 2020 | December 31, 2019 | ||||
| Assets | ||||||
| Cash and short-term securities | $ | 27,087 | $ | 20,300 | ||
| Debt securities | 213,506 | 198,122 | ||||
| Public equities | 19,706 | 22,851 | ||||
| Mortgages | 51,781 | 49,376 | ||||
| Private placements | 40,847 | 37,979 | ||||
| Policy loans | 7,255 | 6,471 | ||||
| Loans to bank clients | 1,789 | 1,740 | ||||
| Real estate | 13,767 | 12,928 | ||||
| Other invested assets | 29,591 | 28,760 | ||||
| Total invested assets (note 3) | 405,329 | 378,527 | ||||
| Other assets | ||||||
| Accrued investment income | 2,627 | 2,416 | ||||
| Outstanding premiums | 1,661 | 1,385 | ||||
| Derivatives (note 4) | 39,670 | 19,449 | ||||
| Reinsurance assets | 45,054 | 41,446 | ||||
| Deferred tax assets | 4,494 | 4,574 | ||||
| Goodwill and intangible assets | 10,413 | 9,975 | ||||
| Miscellaneous | 9,929 | 8,250 | ||||
| Total other assets | 113,848 | 87,495 | ||||
| Segregated funds net assets (note 14) | 312,253 | 343,108 | ||||
| Total assets | $ | 831,430 | $ | 809,130 | ||
| Liabilities and Equity | ||||||
| Liabilities | ||||||
| Insurance contract liabilities (note 5) | $ | 383,466 | $ | 351,161 | ||
| Investment contract liabilities (note 5) | 3,385 | 3,104 | ||||
| Deposits from bank clients | 21,250 | 21,488 | ||||
| Derivatives (note 4) | 21,190 | 10,284 | ||||
| Deferred tax liabilities | 2,865 | 1,972 | ||||
| Other liabilities | 19,201 | 16,244 | ||||
| 451,357 | 404,253 | |||||
| Long-term debt (note 7) | 4,963 | 4,543 | ||||
| Capital instruments (note 8) | 6,796 | 7,120 | ||||
| Segregated funds net liabilities (note 14) | 312,253 | 343,108 | ||||
| Total liabilities | 775,369 | 759,024 | ||||
| Equity | ||||||
| Preferred shares (note 9) | 3,822 | 3,822 | ||||
| Common shares (note 9) | 23,025 | 23,127 | ||||
| Contributed surplus | 254 | 254 | ||||
| Shareholders' retained earnings | 16,069 | 15,488 | ||||
| Shareholders' accumulated other comprehensive income (loss): | ||||||
| Pension and other post-employment plans | (355 | ) | (350 | ) | ||
| Available-for-sale securities | 4,080 | 1,511 | ||||
| Cash flow hedges | (360 | ) | (143 | ) | ||
| Real estate revaluation surplus | 31 | 31 | ||||
| Translation of foreign operations | 8,711 | 5,398 | ||||
| Total shareholders' equity | 55,277 | 49,138 | ||||
| Participating policyholders' equity | (388 | ) | (243 | ) | ||
| Non-controlling interests | 1,172 | 1,211 | ||||
| Total equity | 56,061 | 50,106 | ||||
| Total liabilities and equity | $ | 831,430 | $ | 809,130 | ||
| The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements. | ||||||
| Roy Gori | John Cassaday | |||||
| President and Chief Executive Officer | Chairman of the Board of Directors |
Manulife Financial Corporation – First Quarter 2020
34
| Consolidated Statements of Income | ||||||
|---|---|---|---|---|---|---|
| For the three months ended March 31, | ||||||
| (Canadian $ in millions except per share amounts, unaudited) | 2020 | 2019 | ||||
| Revenue | ||||||
| Premium income | ||||||
| Gross premiums | $ | 10,725 | $ | 10,187 | ||
| Premiums ceded to reinsurers | (1,370 | ) | (1,873 | ) | ||
| Net premiums | 9,355 | 8,314 | ||||
| Investment income (note 3) | ||||||
| Investment income | 3,284 | 3,747 | ||||
| Realized and unrealized gains (losses) on assets supporting insurance and investment contract liabilities<br> and on the macro hedge program | 4,558 | 8,926 | ||||
| Net investment income (loss) | 7,842 | 12,673 | ||||
| Other revenue (note 10) | 2,980 | 2,562 | ||||
| Total revenue | 20,177 | 23,549 | ||||
| Contract benefits and expenses | ||||||
| To contract holders and beneficiaries | ||||||
| Gross claims and benefits (note 5) | 7,655 | 7,169 | ||||
| Increase (decrease) in insurance contract liabilities | 8,100 | 11,407 | ||||
| Increase (decrease) in investment contract liabilities | 46 | 43 | ||||
| Benefits and expenses ceded to reinsurers | (1,829 | ) | (1,474 | ) | ||
| (Increase) decrease in reinsurance assets (note 5) | 117 | (298 | ) | |||
| Net benefits and claims | 14,089 | 16,847 | ||||
| General expenses | 1,845 | 1,801 | ||||
| Investment expenses | 510 | 403 | ||||
| Commissions | 1,555 | 1,548 | ||||
| Interest expense | 369 | 328 | ||||
| Net premium taxes | 105 | 98 | ||||
| Total contract benefits and expenses | 18,473 | 21,025 | ||||
| Income before income taxes | 1,704 | 2,524 | ||||
| Income tax expense | (597 | ) | (289 | ) | ||
| Net income | $ | 1,107 | $ | 2,235 | ||
| Net income (loss) attributed to: | ||||||
| Non-controlling interests | $ | (43 | ) | $ | 73 | |
| Participating policyholders | (146 | ) | (14 | ) | ||
| Shareholders | 1,296 | 2,176 | ||||
| $ | 1,107 | $ | 2,235 | |||
| Net income attributed to shareholders | $ | 1,296 | $ | 2,176 | ||
| Preferred share dividends | (43 | ) | (43 | ) | ||
| Common shareholders' net income | $ | 1,253 | $ | 2,133 | ||
| Earnings per share | ||||||
| Basic earnings per common share (note 9) | $ | 0.64 | $ | 1.09 | ||
| Diluted earnings per common share (note 9) | 0.64 | 1.08 | ||||
| Dividends per common share | 0.28 | 0.25 | ||||
| The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements. |
Manulife Financial Corporation – First Quarter 2020
35
| Consolidated Statements of Comprehensive Income | ||||||
|---|---|---|---|---|---|---|
| For the three months ended March 31, | ||||||
| (Canadian $ in millions, unaudited) | 2020 | 2019 | ||||
| Net income | $ | 1,107 | $ | 2,235 | ||
| Other comprehensive income (loss) ("OCI"), net of tax | ||||||
| Items that may be subsequently reclassified to net income: | ||||||
| Foreign exchange gains (losses) on: | ||||||
| Translation of foreign operations | 3,769 | (788 | ) | |||
| Net investment hedges | (457 | ) | 97 | |||
| Available-for-sale financial securities: | ||||||
| Unrealized gains (losses) arising during the period | 2,919 | 992 | ||||
| Reclassification of net realized (gains) losses and impairments to net income | (342 | ) | (39 | ) | ||
| Cash flow hedges: | ||||||
| Unrealized gains (losses) arising during the period | (191 | ) | (19 | ) | ||
| Reclassification of realized losses to net income | (26 | ) | - | |||
| Share of other comprehensive income (losses) of associates | (6 | ) | 1 | |||
| Total items that may be subsequently reclassified to net income | 5,666 | 244 | ||||
| Items that will not be reclassified to net income: | ||||||
| Change in pension and other post-employment plans | (5 | ) | 3 | |||
| Real estate revaluation reserve | - | 11 | ||||
| Total items that will not be reclassified to net income | (5 | ) | 14 | |||
| Other comprehensive income (loss), net of tax | 5,661 | 258 | ||||
| Total comprehensive income (loss), net of tax | $ | 6,768 | $ | 2,493 | ||
| Total comprehensive income (loss) attributed to: | ||||||
| Non-controlling interests | $ | (43 | ) | $ | 75 | |
| Participating policyholders | (145 | ) | (14 | ) | ||
| Shareholders | 6,956 | 2,432 | ||||
| Income Taxes included in Other Comprehensive Income | ||||||
| --- | --- | --- | --- | --- | --- | --- |
| For the three months ended March 31, | ||||||
| (Canadian $ in millions, unaudited) | 2020 | 2019 | ||||
| Income tax expense (recovery) on: | ||||||
| Unrealized foreign exchange gains/losses on translation of foreign operations | $ | 2 | $ | - | ||
| Unrealized foreign exchange gains/losses on net investment hedges | (55 | ) | 14 | |||
| Unrealized gains/losses on available-for-sale financial securities | 607 | 252 | ||||
| Reclassification of realized gains/losses and recoveries/impairments to net income on available-for-sale<br> financial securities | (122 | ) | (11 | ) | ||
| Unrealized gains/losses on cash flow hedges | (68 | ) | (3 | ) | ||
| Reclassification of realized gains/losses to net income on cash flow hedges | (9 | ) | - | |||
| Share of other comprehensive income (loss) of associates | (1 | ) | - | |||
| Change in pension and other post-employment plans | (1 | ) | 1 | |||
| Total income tax expense (recovery) | $ | 353 | $ | 253 | ||
| The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements. |
Manulife Financial Corporation – First Quarter 2020
36
| Consolidated Statements of Changes in Equity | ||||||
|---|---|---|---|---|---|---|
| For the three months ended March 31, | ||||||
| (Canadian $ in millions, unaudited) | 2020 | 2019 | ||||
| Preferred shares | ||||||
| Balance, beginning of period | $ | 3,822 | $ | 3,822 | ||
| Issued during the period | - | - | ||||
| Issuance costs, net of tax | - | - | ||||
| Balance, end of period | 3,822 | 3,822 | ||||
| Common shares | ||||||
| Balance, beginning of period | 23,127 | 22,961 | ||||
| Repurchased (note 9) | (121 | ) | (116 | ) | ||
| Issued on exercise of stock options and deferred share units | 19 | 14 | ||||
| Issued under dividend reinvestment and share purchase plans | - | 193 | ||||
| Balance, end of period | 23,025 | 23,052 | ||||
| Contributed surplus | ||||||
| Balance, beginning of period | 254 | 265 | ||||
| Exercise of stock options and deferred share units | (3 | ) | (3 | ) | ||
| Stock option expense | 3 | 3 | ||||
| Balance, end of period | 254 | 265 | ||||
| Shareholders' retained earnings | ||||||
| Balance, beginning of period | 15,488 | 12,704 | ||||
| Opening adjustment on adoption of IFRS 16 | - | (19 | ) | |||
| Net income attributed to shareholders | 1,296 | 2,176 | ||||
| Common shares repurchased (note 9) | (132 | ) | (90 | ) | ||
| Preferred share dividends | (43 | ) | (43 | ) | ||
| Common share dividends | (540 | ) | (489 | ) | ||
| Balance, end of period | 16,069 | 14,239 | ||||
| Shareholders' accumulated other comprehensive income (loss) ("AOCI") | ||||||
| Balance, beginning of period | 6,447 | 6,212 | ||||
| Change in unrealized foreign exchange gains (losses) of net foreign operations | 3,313 | (691 | ) | |||
| Change in actuarial gains (losses) on pension and other post-employment plans | (5 | ) | 3 | |||
| Change in unrealized gains (losses) on available-for-sale financial securities | 2,575 | 951 | ||||
| Change in unrealized gains (losses) on derivative instruments designated as cash flow hedges | (217 | ) | (19 | ) | ||
| Change in real estate revaluation reserve | - | 11 | ||||
| Share of other comprehensive income (losses) of associates | (6 | ) | 1 | |||
| Balance, end of period | 12,107 | 6,468 | ||||
| Total shareholders' equity, end of period | 55,277 | 47,846 | ||||
| Participating policyholders' equity | ||||||
| Balance, beginning of period | (243 | ) | 94 | |||
| Opening adjustment on adoption of IFRS 16 | - | (3 | ) | |||
| Net income (loss) attributed to participating policyholders | (146 | ) | (14 | ) | ||
| Other comprehensive income (loss) attributed to policyholders | 1 | - | ||||
| Balance, end of period | (388 | ) | 77 | |||
| Non-controlling interests | ||||||
| Balance, beginning of period | 1,211 | 1,093 | ||||
| Net income attributed to non-controlling interests | (43 | ) | 73 | |||
| Other comprehensive income (loss) attributed to non-controlling interests | - | 2 | ||||
| Contributions (distributions/disposal), net | 4 | (97 | ) | |||
| Balance, end of period | 1,172 | 1,071 | ||||
| Total equity, end of period | $ | 56,061 | $ | 48,994 | ||
| The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements. |
Manulife Financial Corporation – First Quarter 2020
37
| Consolidated Statements of Cash Flows | ||||||
|---|---|---|---|---|---|---|
| For the three months ended March 31, | ||||||
| (Canadian $ in millions, unaudited) | 2020 | 2019 | ||||
| Operating activities | ||||||
| Net income | $ | 1,107 | $ | 2,235 | ||
| Adjustments: | ||||||
| Increase (decrease) in insurance contract liabilities | 8,100 | 11,407 | ||||
| Increase (decrease) in investment contract liabilities | 46 | 43 | ||||
| (Increase) decrease in reinsurance assets excluding coinsurance transactions (note 5) | 117 | 414 | ||||
| Amortization of (premium) discount on invested assets | 28 | 30 | ||||
| Other amortization | 174 | 155 | ||||
| Net realized and unrealized (gains) losses and impairment on assets | (4,304 | ) | (9,311 | ) | ||
| Deferred income tax expense (recovery) | 451 | 132 | ||||
| Stock option expense | 3 | 3 | ||||
| Cash provided by operating activities before undernoted items | 5,722 | 5,108 | ||||
| Changes in policy related and operating receivables and payables | (953 | ) | (1,197 | ) | ||
| Cash provided by (used in) operating activities | 4,769 | 3,911 | ||||
| Investing activities | ||||||
| Purchases and mortgage advances | (26,984 | ) | (19,525 | ) | ||
| Disposals and repayments | 28,625 | 15,925 | ||||
| Change in investment broker net receivables and payables | 311 | 130 | ||||
| Net cash flows from acquisition and disposal of subsidiaries and businesses | - | 253 | ||||
| Cash provided by (used in) investing activities | 1,952 | (3,217 | ) | |||
| Financing activities | ||||||
| Change in repurchase agreements and securities sold but not yet purchased | (163 | ) | 203 | |||
| Redemption of capital instruments (note 8) | (500 | ) | (500 | ) | ||
| Secured borrowing | 840 | - | ||||
| Changes in deposits from Bank clients, net | (288 | ) | 308 | |||
| Lease payments | (34 | ) | (27 | ) | ||
| Shareholders' dividends paid in cash | (583 | ) | (339 | ) | ||
| Contributions from (distributions to) non-controlling interests, net | 4 | - | ||||
| Common shares repurchased (note 9) | (253 | ) | (206 | ) | ||
| Common shares issued, net (note 9) | 19 | 14 | ||||
| Cash provided by (used in) financing activities | (958 | ) | (547 | ) | ||
| Cash and short-term securities | ||||||
| Increase (decrease) during the period | 5,763 | 147 | ||||
| Effect of foreign exchange rate changes on cash and short-term securities | 1,092 | (206 | ) | |||
| Balance, beginning of period | 19,548 | 15,382 | ||||
| Balance, end of period | 26,403 | 15,323 | ||||
| Cash and short-term securities | ||||||
| Beginning of period | ||||||
| Gross cash and short-term securities | 20,300 | 16,215 | ||||
| Net payments in transit, included in other liabilities | (752 | ) | (833 | ) | ||
| Net cash and short-term securities, beginning of period | 19,548 | 15,382 | ||||
| End of period | ||||||
| Gross cash and short-term securities | 27,087 | 16,097 | ||||
| Net payments in transit, included in other liabilities | (684 | ) | (774 | ) | ||
| Net cash and short-term securities, end of period | $ | 26,403 | $ | 15,323 | ||
| Supplemental disclosures on cash flow information | ||||||
| Interest received | $ | 2,685 | $ | 2,761 | ||
| Interest paid | 294 | 259 | ||||
| Income taxes paid (refund) | 216 | 302 | ||||
| The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements. |
Manulife Financial Corporation – First Quarter 2020
38
CONDENSED NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
(Canadian $ in millions except per share amounts or unless otherwise stated, unaudited)
Note 1 Nature of Operations and Significant Accounting Policies
| (a) | Reporting entity |
|---|
Manulife Financial Corporation (“MFC”) is a publicly traded company and the holding company of The Manufacturers Life Insurance Company (“MLI”), a Canadian life insurance company. MFC and its subsidiaries (collectively, “Manulife” or the “Company”) is a leading financial services group with principal operations in Asia, Canada and the United States. Manulife’s international network of employees, agents and distribution partners offers financial protection and wealth management products and services to personal and business clients as well as asset management services to institutional customers. The Company operates as Manulife in Canada and Asia and as John Hancock in the United States.
These Interim Consolidated Financial Statements and condensed notes have been prepared in accordance with International Accounting Standard (“IAS”) 34 “Interim Financial Reporting” as issued by the International Accounting Standards Board (“IASB”), using accounting policies which are consistent with those used in the Company’s 2019 Annual Consolidated Financial Statements, except as disclosed in note 2.
These Interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements for the year ended December 31, 2019, included on pages 96 to 178 of the Company’s 2019 Annual Report, as well as the disclosures on risk in the shaded text and tables in the” Risk Management and Risk Factors” section the First Quarter 2020 Management Discussion and Analysis. These risk disclosures are considered an integral part of these Interim Consolidated Financial Statements.
These Interim Consolidated Financial Statements as at and for the three months ended March 31, 2020 were authorized for issue by MFC’s Board of Directors on May 6, 2020.
| (b) | Basis of preparation |
|---|
Refer to note 1 of the 2019 Consolidated Financial Statements for a summary of the most significant estimation processes used in the preparation of the Consolidated Financial Statements under IFRS and description of the Company’s measurement techniques in determining carrying values and respective fair values of its assets and liabilities.
The Company’s results and operations have been and may continue to be adversely impacted by the COVID -19 pandemic and the recent economic downturn. The adverse effects include but are not limited to significant declines in equity markets and interest rates, increase in credit risk, strain on commodity markets, foreign currency exchange rate volatility, increases in insurance claims, persistency and redemptions, and disruption of business operations. The breadth and depth of these events and how long they will continue have introduced additional uncertainty around estimates used in determining the carrying value of certain assets and liabilities included in these Interim Consolidated Financial Statements.
The uncertainty regarding key inputs used in establishing the carrying amounts of certain invested assets and net obligations for defined benefit obligations are outlined in notes 3 and 11, respectively. The Company has applied appropriate measurement techniques using reasonable judgment and estimates from a market participant perspective to reflect current economic conditions. The impact of these techniques have been reflected in these Interim Consolidated Financial Statements. Changes in the inputs used could materially impact the respective carrying values.
| Note 2 | Accounting and Reporting Changes |
|---|---|
| (a) | Changes in accounting and reporting policy |
| --- | --- |
| (I) | Amendments to IFRS 3 “Business Combinations” |
| --- | --- |
Amendments to IFRS 3 “Business Combinations” were issued in October 2018 and are effective for business combinations occurring on or after January 1, 2020, with earlier application permitted. The amendments revise the definition of a business and permit a simplified assessment of whether an acquired set of activities and assets qualifies as a business. Application of the amendments are expected to result in fewer acquisitions qualifying as business combinations. Adoption of these amendments did not have a significant impact on the Company’s Consolidated Financial Statements.
| (II) | Amendments to IAS 1 “Presentation of Financial Statements” and IAS 8 “Accounting Policies,<br> Changes in Accounting Estimates and Errors” |
|---|
Amendments to IAS 1 “Presentation of Financial Statements” and IAS 8 “Accounting Policies, Changes in Accounting
Manulife Financial Corporation – First Quarter 2020
39
Estimates and Errors” were issued in October 2018. The amendments are effective for annual periods beginning on or after January 1, 2020 and are to be applied prospectively. The amendments update the definition of material. Adoption of theseamendments did not have a significant impact on the Company’s Consolidated Financial Statements.
| (III) | Interest Rate Benchmark Reform Amendments to IFRS 9, IAS 39 and IFRS 7 |
|---|
Amendments to IFRS 9, IAS 39 and IFRS 7 were issued in September 2019 related to interest rate benchmark reform and are effective retrospectively for annual periods beginning on or after January 1, 2020. The amendments provide temporary relief for hedge accounting to continue during the period of uncertainty before replacement of an existing interest rate benchmark with an alternative risk-free rate. The amendments apply to all hedge accounting relationships that are affected by the interest rate benchmark reform. The IASB is expected to issue further guidance addressing various accounting issues that will arise when the existing interest rate benchmark has been replaced. Adoption of these amendments did not have a significant impact on the Company’s Consolidated Financial Statements.
| (b) | Future accounting and reporting changes |
|---|---|
| (I) | IFRS 17 “Insurance Contracts” and IFRS 9 “Financial Instruments” |
| --- | --- |
Proposed amendments to IFRS 17, published in June 2019, included an extension of the deferral date of IFRS 17 by one year, to January 1, 2022. In March 2020, the IASB’s redeliberations of the amendments included a decision to extend the deferral date of both IFRS 17 and IFRS 9 by two years, to January 1, 2023. The Company will continue to monitor IASB’s future developments related to IFRS 17. The Company is currently assessing the implications of IFRS 17 on its Consolidated Financial Statements.
Manulife Financial Corporation – First Quarter 2020
40
| Note 3 | Invested Assets and Investment Income | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (a) | Carrying values and fair values of invested assets | |||||||||
| --- | --- | |||||||||
| As at March 31, 2020 | FVTPL^(1)^ | AFS^(2)^ | Other^(3)^ | Total carrying<br><br> <br>value | Total fair<br><br> <br>value | |||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash and short-term securities^(4)^ | $ | 2,733 | $ | 16,202 | $ | 8,152 | $ | 27,087 | $ | 27,087 |
| Debt securities^(5)^ | ||||||||||
| Canadian government and agency | 18,821 | 3,457 | - | 22,278 | 22,278 | |||||
| U.S. government and agency | 10,128 | 23,090 | - | 33,218 | 33,218 | |||||
| Other government and agency | 19,486 | 4,843 | - | 24,329 | 24,329 | |||||
| Corporate | 124,314 | 5,653 | - | 129,967 | 129,967 | |||||
| Mortgage/asset-backed securities | 3,528 | 186 | - | 3,714 | 3,714 | |||||
| Public equities | 17,510 | 2,196 | - | 19,706 | 19,706 | |||||
| Mortgages | - | - | 51,781 | 51,781 | 53,842 | |||||
| Private placements | - | - | 40,847 | 40,847 | 43,769 | |||||
| Policy loans | - | - | 7,255 | 7,255 | 7,255 | |||||
| Loans to Bank clients | - | - | 1,789 | 1,789 | 1,792 | |||||
| Real estate | ||||||||||
| Own use property | - | - | 2,090 | 2,090 | 3,540 | |||||
| Investment property | - | - | 11,677 | 11,677 | 11,677 | |||||
| Other invested assets | ||||||||||
| Alternative long-duration assets^(6),(7)^ | 15,741 | 110 | 9,422 | 25,273 | 26,138 | |||||
| Various other | 166 | - | 4,152 | 4,318 | 4,319 | |||||
| Total invested assets | $ | 212,427 | $ | 55,737 | $ | 137,165 | $ | 405,329 | $ | 412,631 |
| As at December 31, 2019 | FVTPL^(1)^ | AFS^(2)^ | Other^(3)^ | Total carrying<br><br> <br>value | Total fair<br><br> <br>value | |||||
| Cash and short-term securities^(4)^ | $ | 1,859 | $ | 13,084 | $ | 5,357 | $ | 20,300 | $ | 20,300 |
| Debt securities^(5)^ | ||||||||||
| Canadian government and agency | 18,582 | 4,779 | - | 23,361 | 23,361 | |||||
| U.S. government and agency | 11,031 | 17,221 | - | 28,252 | 28,252 | |||||
| Other government and agency | 17,383 | 4,360 | - | 21,743 | 21,743 | |||||
| Corporate | 116,044 | 5,285 | - | 121,329 | 121,329 | |||||
| Mortgage/asset-backed securities | 3,267 | 170 | - | 3,437 | 3,437 | |||||
| Public equities | 20,060 | 2,791 | - | 22,851 | 22,851 | |||||
| Mortgages | - | - | 49,376 | 49,376 | 51,450 | |||||
| Private placements | - | - | 37,979 | 37,979 | 41,743 | |||||
| Policy loans | - | - | 6,471 | 6,471 | 6,471 | |||||
| Loans to Bank clients | - | - | 1,740 | 1,740 | 1,742 | |||||
| Real estate | ||||||||||
| Own use property | - | - | 1,926 | 1,926 | 3,275 | |||||
| Investment property | - | - | 11,002 | 11,002 | 11,002 | |||||
| Other invested assets | ||||||||||
| Alternative long-duration assets^(6),(7)^ | 15,252 | 99 | 9,492 | 24,843 | 25,622 | |||||
| Various other | 149 | - | 3,768 | 3,917 | 3,918 | |||||
| Total invested assets | $ | 203,627 | $ | 47,789 | $ | 127,111 | $ | 378,527 | $ | 386,496 |
| ^(1)^ | FVTPL classification was elected for securities backing insurance contract liabilities to substantially reduce any accounting mismatch<br> arising from changes in the fair value of these assets and changes in the value of the related insurance contract liabilities. If this election had not been made and instead the available-for-sale (“AFS”) classification was selected,<br> there would be an accounting mismatch because changes in insurance contract liabilities are recognized in net income rather than in OCI. | |||||||||
| --- | --- | |||||||||
| ^(2)^ | Securities that are designated as AFS are not actively traded by the Company but sales do occur as circumstances warrant. Such sales result in a<br> reclassification of any accumulated unrealized gain (loss) in AOCI to net income as a realized gain (loss). | |||||||||
| --- | --- | |||||||||
| ^(3)^ | Primarily includes assets classified as loans and carried at amortized cost, own use properties, investment properties, equity method accounted<br> investments, oil and gas investments, and leveraged leases. | |||||||||
| --- | --- | |||||||||
| ^(4)^ | Includes short-term securities with maturities of less than one year at acquisition amounting to $4,197 (December 31, 2019 – $3,806) cash equivalents<br> with maturities of less than 90 days at acquisition amounting to $14,738 (December 31, 2019 – $11,137) and cash of $8,152 (December 31, 2019 – $5,357). | |||||||||
| --- | --- | |||||||||
| ^(5)^ | Debt securities include securities which were acquired with maturities of less than one year and less than 90 days of $707 and $20, respectively<br> (December 31, 2019 – $537 and $69, respectively). | |||||||||
| --- | --- | |||||||||
| ^(6)^ | Alternative long-duration assets (“ALDA”) Include investments in private equity of $7,112, infrastructure of $8,884, oil and gas of $2,511, timber and<br> agriculture of $4,877 and various other invested assets of $1,889 (December 31, 2019 – $6,396, $8,854, $3,245, $4,669 and $1,679, respectively). | |||||||||
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
41
| ^(7)^ | In 2019, the Company sold $1,112 of North American Private Equity investments to Manulife Private Equity Partners, L.P, a<br> closed-end pooled fund of funds. The Company provides management services to the fund. | ||||
|---|---|---|---|---|---|
| (b) | Investment income | ||||
| --- | --- | ||||
| For the three months ended March 31, | 2020 | 2019 | |||
| --- | --- | --- | --- | --- | --- |
| Interest income | $ | 2,933 | $ | 2,828 | |
| Dividend, rental and other income | 488 | 668 | |||
| Impairments, provisions and recoveries, net | (547 | ) | 60 | ||
| Other | 410 | 191 | |||
| 3,284 | 3,747 | ||||
| Realized and unrealized gains (losses) on assets supporting insurance and investment contract liabilities and<br> on the<br><br> <br>macro equity hedging program | |||||
| Debt securities | (3,144 | ) | 5,666 | ||
| Public equities | (3,246 | ) | 1,704 | ||
| Mortgages | (46 | ) | 13 | ||
| Private placements | (156 | ) | 22 | ||
| Real estate | 86 | 77 | |||
| Other invested assets | (341 | ) | 321 | ||
| Derivatives, including macro equity hedging program | 11,405 | 1,123 | |||
| 4,558 | 8,926 | ||||
| Total investment income | $ | 7,842 | $ | 12,673 | |
| (c) | Fair value measurement | ||||
| --- | --- |
The following table presents fair values and the fair value hierarchy of invested assets and segregated funds net assets measured at fair value in the Consolidated Statements of Financial Position.
| As at March 31, 2020 | Total fair<br><br> <br>value | Level 1 | Level 2 | Level 3 | ||||
|---|---|---|---|---|---|---|---|---|
| Cash and short-term securities | ||||||||
| FVTPL | $ | 2,733 | $ | - | $ | 2,733 | $ | - |
| AFS | 16,202 | - | 16,202 | - | ||||
| Other | 8,152 | 8,152 | - | - | ||||
| Debt securities | ||||||||
| FVTPL | ||||||||
| Canadian government and agency | 18,821 | - | 18,821 | - | ||||
| U.S. government and agency | 10,128 | - | 10,128 | - | ||||
| Other government and agency | 19,486 | - | 19,486 | - | ||||
| Corporate | 124,314 | - | 123,564 | 750 | ||||
| Residential mortgage-backed securities | 13 | - | 13 | - | ||||
| Commercial mortgage-backed securities | 1,398 | - | 1,398 | - | ||||
| Other asset-backed securities | 2,117 | - | 2,117 | - | ||||
| AFS | ||||||||
| Canadian government and agency | 3,457 | - | 3,457 | - | ||||
| U.S. government and agency | 23,090 | - | 23,090 | - | ||||
| Other government and agency | 4,843 | - | 4,843 | - | ||||
| Corporate | 5,653 | - | 5,651 | 2 | ||||
| Residential mortgage-backed securities | 2 | - | 2 | - | ||||
| Commercial mortgage-backed securities | 113 | - | 113 | - | ||||
| Other asset-backed securities | 71 | - | 71 | - | ||||
| Public equities | ||||||||
| FVTPL | 17,510 | 17,510 | - | - | ||||
| AFS | 2,196 | 2,194 | 2 | - | ||||
| Real estate - investment property^(1)^ | 11,677 | - | - | 11,677 | ||||
| Other invested assets^(2)^ | 18,823 | - | - | 18,823 | ||||
| Segregated funds net assets^(3)^ | 312,253 | 264,825 | 42,764 | 4,664 | ||||
| Total | $ | 603,052 | $ | 292,681 | $ | 274,455 | $ | 35,916 |
Manulife Financial Corporation – First Quarter 2020
42
| As at December 31, 2019 | Total fair<br><br> <br>value | Level 1 | Level 2 | Level 3 | ||||
|---|---|---|---|---|---|---|---|---|
| Cash and short-term securities | ||||||||
| FVTPL | $ | 1,859 | $ | - | $ | 1,859 | $ | - |
| AFS | 13,084 | - | 13,084 | - | ||||
| Other | 5,357 | 5,357 | - | - | ||||
| Debt securities | ||||||||
| FVTPL | ||||||||
| Canadian government and agency | 18,582 | - | 18,582 | - | ||||
| U.S. government and agency | 11,031 | - | 11,031 | - | ||||
| Other government and agency | 17,383 | - | 17,383 | - | ||||
| Corporate | 116,044 | - | 115,411 | 633 | ||||
| Residential mortgage-backed securities | 13 | - | 13 | - | ||||
| Commercial mortgage-backed securities | 1,271 | - | 1,271 | - | ||||
| Other asset-backed securities | 1,983 | - | 1,983 | - | ||||
| AFS | ||||||||
| Canadian government and agency | 4,779 | - | 4,779 | - | ||||
| U.S. government and agency | 17,221 | - | 17,221 | - | ||||
| Other government and agency | 4,360 | - | 4,360 | - | ||||
| Corporate | 5,285 | - | 5,270 | 15 | ||||
| Residential mortgage-backed securities | 1 | - | 1 | - | ||||
| Commercial mortgage-backed securities | 102 | - | 102 | - | ||||
| Other asset-backed securities | 67 | - | 67 | - | ||||
| Public equities | ||||||||
| FVTPL | 20,060 | 20,060 | - | - | ||||
| AFS | 2,791 | 2,788 | 3 | - | ||||
| Real estate - investment property^(1)^ | 11,002 | - | - | 11,002 | ||||
| Other invested assets^(2)^ | 18,194 | 91 | - | 18,103 | ||||
| Segregated funds net assets^(3)^ | 343,108 | 293,903 | 44,693 | 4,512 | ||||
| Total | $ | 613,577 | $ | 322,199 | $ | 257,113 | $ | 34,265 |
| ^(1)^ | For real estate investment properties, the significant unobservable inputs are capitalization rates (ranging from 2.75% to 8.50%<br> during the period and ranging from 2.75% to 8.75% during the year 2019) and terminal capitalization rates (ranging from 3.70% to 9.25% during the period and ranging from 3.80% to 9.25% during the year 2019). Holding other factors<br> constant, a lower capitalization or terminal capitalization rate will tend to increase the fair value of an investment property. Changes in fair value based on variations in unobservable inputs generally cannot be extrapolated because the<br> relationship between the directional changes of each input is not usually linear. | |||||||
| --- | --- | |||||||
| ^(2)^ | Other invested assets measured at fair value are held primarily in the power and infrastructure and timber sectors. The significant inputs used in the<br> valuation of the Company’s power and infrastructure investments are primarily future distributable cash flows, terminal values and discount rates. Holding other factors constant, an increase to future distributable cash flows or terminal<br> values would tend to increase the fair value of a power and infrastructure investment, while an increase in the discount rate would have the opposite effect. Discount rates during the period ranged from 7.00% to 15.6% (for the year ended<br> December 31, 2019 – ranged from 7.00% to 16.5%). Disclosure of distributable cash flow and terminal value ranges are not meaningful given the disparity in estimates by project. The significant inputs used in the valuation of the Company’s<br> investments in timberland are timber prices and discount rates. Holding other factors constant, an increase to timber prices would tend to increase the fair value of a timberland investment, while an increase in the discount rates would<br> have the opposite effect. Discount rates during the period ranged from 5.0% to 7.0% (for the year ended December 31, 2019 – ranged from 5.0% to 7.0%). A range of prices for timber is not meaningful as the market price depends on factors<br> such as property location and proximity to markets and export yards. | |||||||
| --- | --- | |||||||
| ^(3)^ | Segregated funds net assets are measured at fair value. The Company’s Level 3 segregated funds assets are predominantly invested<br> in investment properties and timberland properties valued as described above. | |||||||
| --- | --- |
As a result of COVID-19 and the recent economic downturn, significant measurement uncertainty exists in determining the fair value of real estate and other invested assets. As at March 31, 2020, based on reasonable estimates and assumptions reflecting both the nature of the assets and currently available information, the Company has recognized a reduction in the carrying value oil and gas investments of $862, the measurement of which was subject to significant judgment. A summary of the measurement uncertainty and impacts to valuation inputs and techniques with respect to real estate and other invested assets is disclosed below. For the methodologies used in determining carrying values of the remaining invested assets, refer to note 1 of the 2019 Consolidated Financial Statements
Real Estate – For real estate investment properties valuation inputs include existing and assumed tenancies, market data from recent comparable transactions, future economic outlook and market risk assumptions, capitalization rates and internal rates of return. Measurement uncertainty is driven primarily by a reduction in available information, which could have a negative impact on future carrying value of these assets.
Timberland and Farmland – For investments in timberland and farmland, valuation inputs include asset-specific production, relevant commodity prices and discount rates. There has been an increase in uncertainty regarding these inputs used,
Manulife Financial Corporation – First Quarter 2020
43
including potential reduction in demand, which could have a negative impact on the future carrying value of these assets.
Infrastructure – For infrastructure investments, valuation is largely based on discounted cash flow techniques reflecting estimates regarding future cash flows, terminal values and discount rates. These assets are defensive in nature and are supported by existing contractual revenue streams. There has been an increase in uncertainty regarding critical valuation inputs listed, driven primarily by a reduction in available information, which could have a negative impact on future carrying value of these assets.
Oil and Gas – Investments in oil and gas comprise properties managed directly through a subsidiary, NAL Resources, as well as other oil and gas private equity interests. Significant declines in oil and gas commodity prices experienced in the current quarter coupled with economic uncertainty stemming from COVID-19 have resulted in reductions in the carrying value of these investments, by way of both impairment and fair value adjustments.
Methods for determining the fair value of directly held oil and gas properties use models and inputs reflecting forecasted price curves, planned production, capital expenditures, and operating costs. Investments in other private equity interests are valued primarily based on financial statements and inputs provided by third party general partners and sponsors for these funds. Significant measurement uncertainty relating to future prices for relevant commodities as well as the current absence of information from third parties could have an impact on the carrying value of these assets in future periods.
Private Equity – Included in the Company’s private equity investments are assets valued primarily based on net asset value as per financial statements provided by third party general partners or sponsors and reasonable techniques from a market participant perspective. Significant measurement uncertainty relating to volatility in underlying markets as well as the current absence of information from third parties could have an impact on the carrying value of these assets in future periods.
The following table presents fair value of invested assets not measured at fair value by the fair value hierarchy.
| As at March 31, 2020 | Carrying<br><br> <br>value | Total fair<br><br> <br>value | Level 1 | Level 2 | Level 3 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mortgages | $ | 51,781 | $ | 53,842 | $ | - | $ | - | $ | 53,842 |
| Private placements | 40,847 | 43,769 | - | 37,924 | 5,845 | |||||
| Policy loans | 7,255 | 7,255 | - | 7,255 | - | |||||
| Loans to Bank clients | 1,789 | 1,792 | - | 1,792 | - | |||||
| Real estate - own use property | 2,090 | 3,540 | - | - | 3,540 | |||||
| Other invested assets^(1)^ | 10,768 | 11,634 | 133 | - | 11,501 | |||||
| Total invested assets disclosed at fair value | $ | 114,530 | $ | 121,832 | $ | 133 | $ | 46,971 | $ | 74,728 |
| As at December 31, 2019 | Carrying<br><br> <br>value | Total fair<br><br> <br>value | Level 1 | Level 2 | Level 3 | |||||
| Mortgages | $ | 49,376 | $ | 51,450 | $ | - | $ | - | $ | 51,450 |
| Private placements | 37,979 | 41,743 | - | 36,234 | 5,509 | |||||
| Policy loans | 6,471 | 6,471 | - | 6,471 | - | |||||
| Loans to Bank clients | 1,740 | 1,742 | - | 1,742 | - | |||||
| Real estate - own use property | 1,926 | 3,275 | - | - | 3,275 | |||||
| Other invested assets^(1)^ | 10,566 | 11,346 | 165 | - | 11,181 | |||||
| Total invested assets disclosed at fair value | $ | 108,058 | $ | 116,027 | $ | 165 | $ | 44,447 | $ | 71,415 |
| ^(1)^ | Other invested assets disclosed at fair value include $3,716 (December 31, 2019 - $3,371) of leveraged leases which are<br> disclosed at their carrying values as fair value is not routinely calculated on these investments. | |||||||||
| --- | --- |
Transfers between Level 1 and Level 2
The Company records transfers of assets and liabilities between Level 1 and Level 2 at their fair values as at the end of each reporting period, consistent with the date of the determination of fair value. Assets are transferred out of Level 1 when they are no longer transacted with sufficient frequency and volume in an active market. Conversely, assets are transferred from Level 2 to Level 1 when transaction volume and frequency are indicative of an active market. During the three months ended March 31, 2020 and 2019, the Company had $nil transfers between Level 1 and Level 2.
For segregated funds net assets, the Company had $18 transfers from Level 1 and Level 2 for the three months ended March 31, 2020 (March 31, 2019 – $nil). The Company had $28 transfers from Level 2 to Level 1 for the three months ended March 31, 2020 (March 31, 2019 - $nil).
Invested assets and segregated funds net assets measured at fair value on the Consolidated Statements of Financial Position using significant unobservable inputs (Level 3)
The Company classifies the fair values of the invested assets and segregated funds net assets as Level 3 if there are no observable markets for these assets or, in the absence of an active markets, most of the inputs used to determine fair value
Manulife Financial Corporation – First Quarter 2020
44
are based on the Company’s own assumptions about market participant assumptions. The Company prioritizes the use of market-based inputs over entity-based assumptions in determining Level 3 fair values. The gains and losses in the tables below include the changes in fair value due to both observable and unobservable factors.
The following table presents a roll forward of invested assets and segregated funds net assets measured at fair value using significant unobservable inputs (Level 3) for the three months ended March 31, 2020 and 2019.
| For the three months ended March 31, 2020 | Balance,<br><br> <br>January 1,<br><br> <br>2020 | Net<br><br> <br>realized/<br><br> <br>unrealized<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in net<br><br> <br>income^(1)^ | Net<br><br> <br>realized/<br><br> <br>unrealized<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in AOCI^(2)^ | Purchases | Sales | Settlements | Transfer<br><br> <br>into<br><br> <br>Level 3^(3),(4)^ | Transfer<br><br> <br>out of<br><br> <br>Level 3^(3,(4)^ | Currency<br><br> <br>movement | Balance,<br><br> <br>March 31,<br><br> <br>2020 | Change in<br><br> <br>unrealized<br><br> <br>gain<br><br> <br>(losses)<br><br> <br>on assets<br><br> <br>still held | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt securities | ||||||||||||||||||||||||||||
| FVTPL | ||||||||||||||||||||||||||||
| Corporate | $ | 633 | $ | - | $ | - | $ | 36 | $ | - | $ | (1 | ) | $ | 29 | $ | - | $ | 53 | $ | 750 | $ | 1 | |||||
| AFS | ||||||||||||||||||||||||||||
| Corporate | 15 | - | - | - | - | - | - | (13 | ) | - | 2 | - | ||||||||||||||||
| Real estate - investment<br><br> <br>property | 11,002 | 118 | - | 318 | (253 | ) | - | - | - | 492 | 11,677 | 100 | ||||||||||||||||
| Other invested assets | 18,103 | (421 | ) | (42 | ) | 790 | (778 | ) | (177 | ) | 91 | - | 1,257 | 18,823 | (819 | ) | ||||||||||||
| 29,105 | (303 | ) | (42 | ) | 1,108 | (1,031 | ) | (177 | ) | 91 | - | 1,749 | 30,500 | (719 | ) | |||||||||||||
| Derivatives | 1,456 | 2,977 | (69 | ) | - | - | 645 | - | (185 | ) | 320 | 5,144 | 3,593 | |||||||||||||||
| Segregated funds net<br><br> <br>assets | 4,512 | (34 | ) | - | 15 | (32 | ) | (9 | ) | 4 | - | 208 | 4,664 | (43 | ) | |||||||||||||
| Total | $ | 35,721 | $ | 2,640 | $ | (111 | ) | $ | 1,159 | $ | (1,063 | ) | $ | 458 | $ | 124 | $ | (198 | ) | $ | 2,330 | $ | 41,060 | $ | 2,832 | |||
| For the three months<br><br> <br>ended March 31, 2019 | Balance,<br><br> <br>January 1,<br><br> <br>2019 | Net<br><br> <br>realized/<br><br> <br>unrealized<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in net<br><br> <br>income^(1)^ | Net<br><br> <br>realized/<br><br> <br>unrealized<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included in<br><br> <br>AOCI^(2)^ | Purchases | Sales | Settlements | Transfer<br><br> <br>into<br><br> <br>Level 3^(3),(4)^ | Transfer<br><br> <br>out of<br><br> <br>Level 3^(3,(4)^ | Currency<br><br> <br>movement | Balance,<br><br> <br>March 31,<br><br> <br>2019 | Change in<br><br> <br>unrealized<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>on assets<br><br> <br>still held | |||||||||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ||
| Debt securities | ||||||||||||||||||||||||||||
| FVTPL | ||||||||||||||||||||||||||||
| Other government & agency | $ | 180 | $ | 7 | $ | - | $ | 11 | $ | (5 | ) | $ | - | $ | - | $ | - | $ | (1 | ) | $ | 192 | $ | 7 | ||||
| Corporate | 784 | 19 | - | 34 | (45 | ) | (11 | ) | 161 | - | (15 | ) | 927 | 32 | ||||||||||||||
| Residential mortgage-<br><br> <br>backed securities | 7 | - | - | - | - | - | - | - | - | 7 | - | |||||||||||||||||
| 971 | 26 | - | 45 | (50 | ) | (11 | ) | 161 | - | (16 | ) | 1,126 | 39 | |||||||||||||||
| AFS | ||||||||||||||||||||||||||||
| Other government &<br><br> <br>agency | 37 | - | 1 | - | - | - | - | - | - | 38 | - | |||||||||||||||||
| Corporate | 120 | - | 1 | 8 | (3 | ) | (2 | ) | - | - | - | 124 | - | |||||||||||||||
| Residential mortgage-<br><br> <br>backed securities | 2 | - | - | - | - | - | - | - | (1 | ) | 1 | - | ||||||||||||||||
| Commercial mortgage-<br><br> <br>backed securities | - | - | - | 37 | - | - | - | - | - | 37 | - | |||||||||||||||||
| 159 | - | 2 | 45 | (3 | ) | (2 | ) | - | - | (1 | ) | 200 | - | |||||||||||||||
| Public equities | ||||||||||||||||||||||||||||
| FVTPL | 3 | - | - | - | - | - | - | - | - | 3 | - | |||||||||||||||||
| 3 | - | - | - | - | - | - | - | - | 3 | - | ||||||||||||||||||
| Real estate -<br><br> <br>investment property | 10,761 | 73 | - | 66 | - | - | 14 | - | (115 | ) | 10,799 | 73 | ||||||||||||||||
| Other invested assets | 17,562 | 282 | 30 | 936 | (82 | ) | (252 | ) | - | - | (307 | ) | 18,169 | 259 | ||||||||||||||
| 28,323 | 355 | 30 | 1,002 | (82 | ) | (252 | ) | 14 | - | (422 | ) | 28,968 | 332 | |||||||||||||||
| Derivatives | 106 | 695 | 21 | 2 | - | (43 | ) | 103 | (71 | ) | - | 813 | 669 | |||||||||||||||
| Segregated funds net<br><br> <br>assets | 4,447 | 40 | - | 4 | (39 | ) | (7 | ) | - | - | (49 | ) | 4,396 | 28 | ||||||||||||||
| Total | $ | 34,009 | $ | 1,116 | $ | 53 | $ | 1,098 | $ | (174 | ) | $ | (315 | ) | $ | 278 | $ | (71 | ) | $ | (488 | ) | $ | 35,506 | $ | 1,068 | ||
| ^(1)^ | These amounts are included in net investment income on the Consolidated Statements of Income except for the amount related to<br> segregated funds net assets, where the amount is recorded in changes in segregated funds net assets, refer to note 14. | |||||||||||||||||||||||||||
| --- | --- | |||||||||||||||||||||||||||
| ^(2)^ | These amounts are included in AOCI on the Consolidated Statements of Financial Position. | |||||||||||||||||||||||||||
| --- | --- | |||||||||||||||||||||||||||
| ^(3)^ | The Company uses fair values of the assets at the beginning of the year for assets transferred into and out of Level 3 except for derivatives, refer to<br> footnote 4 below. | |||||||||||||||||||||||||||
| --- | --- | |||||||||||||||||||||||||||
| ^(4)^ | For derivatives transfer into or out of Level 3, the Company uses fair value at the end of the year and at the beginning of the<br> year, respectively. | |||||||||||||||||||||||||||
| --- | --- |
Transfers into Level 3 primarily result from securities that were impaired during the periods or securities where a lack of observable market data (versus the previous period) resulted in reclassifying assets into Level 3. Transfers from Level 3 primarily result from observable market data now being available for the entire term structure of the debt security.
Manulife Financial Corporation – First Quarter 2020
45
| Note 4 | Derivative and Hedging Instruments |
|---|
Fair value of derivatives
The following table presents the gross notional amount and fair value of derivative instruments by the underlying risk exposure for derivatives in qualifying hedge accounting relationships and derivatives not designated in qualifying hedge accounting relationships.
| March 31, 2020 | December 31, 2019 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As at | Notional<br><br> <br>amount | Fair value | Notional<br><br> amount | Fair value | ||||||||||||
| Type of hedge | Instrument type | Assets | Liabilities | Assets | Liabilities | |||||||||||
| Qualifying hedge accounting relationships | ||||||||||||||||
| Fair value hedges | Interest rate swaps | $ | 100 | $ | 1 | $ | - | $ | 350 | $ | - | $ | 5 | |||
| Foreign currency swaps | 94 | 5 | - | 86 | 3 | 1 | ||||||||||
| Cash flow hedges | Foreign currency swaps | 1,825 | 58 | 686 | 1,790 | 39 | 407 | |||||||||
| Equity contracts | 189 | 11 | 30 | 132 | 16 | - | ||||||||||
| Net investment hedges | Foreign currency contracts | 1,111 | 21 | 20 | 2,822 | 7 | 22 | |||||||||
| Total derivatives in qualifying hedge accounting<br><br> <br>relationships | 3,319 | 96 | 736 | 5,180 | 65 | 435 | ||||||||||
| Derivatives not designated in qualifying hedge<br><br> <br>accounting relationships | ||||||||||||||||
| Interest rate swaps | 319,015 | 29,588 | 17,101 | 283,172 | 15,159 | 8,140 | ||||||||||
| Interest rate futures | 19,817 | - | - | 13,069 | - | - | ||||||||||
| Interest rate options | 13,725 | 1,135 | - | 12,248 | 423 | - | ||||||||||
| Foreign currency swaps | 28,904 | 1,196 | 2,919 | 26,329 | 606 | 1,399 | ||||||||||
| Currency rate futures | 4,778 | - | - | 3,387 | - | - | ||||||||||
| Forward contracts | 37,634 | 6,580 | 201 | 33,432 | 2,337 | 273 | ||||||||||
| Equity contracts | 15,779 | 1,071 | 233 | 14,582 | 853 | 37 | ||||||||||
| Credit default swaps | 493 | 4 | - | 502 | 6 | - | ||||||||||
| Equity futures | 9,992 | - | - | 10,576 | - | - | ||||||||||
| Total derivatives not designated in qualifying<br><br> <br>hedge accounting relationships | 450,137 | 39,574 | 20,454 | 397,297 | 19,384 | 9,849 | ||||||||||
| Total derivatives | $ | 453,456 | $ | 39,670 | $ | 21,190 | $ | 402,477 | $ | 19,449 | $ | 10,284 |
The total notional amount of $453 billion (December 31, 2019 – $402 billion) includes $156 billion (December 31, 2019 – $128 billion) related to derivatives utilized in the Company’s variable annuity guarantee dynamic hedging and macro equity risk hedging programs. Due to the Company’s variable annuity hedging practices, a large number of trades are in offsetting positions, resulting in materially lower net fair value exposure to the Company than what the gross notional amount would suggest.
The following table presents fair value of the derivative instruments by remaining term to maturity. Fair values disclosed below do not incorporate the impact of master netting agreements (refer to note 6).
| Remaining term to maturity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| As at March 31, 2020 | Less than<br><br> <br>1 year | 1 to 3<br><br> <br>years | 3 to 5<br><br> <br>years | Over 5<br><br> <br>years | Total | |||||
| Derivative assets | $ | 2,491 | $ | 4,710 | $ | 2,516 | $ | 29,953 | $ | 39,670 |
| Derivative liabilities | 484 | 357 | 479 | 19,870 | 21,190 | |||||
| Remaining term to maturity | ||||||||||
| As at December 31, 2019 | Less than<br><br> <br>1 year | 1 to 3<br><br> <br>years | 3 to 5<br><br> <br>years | Over 5<br><br> <br>years | Total | |||||
| Derivative assets | $ | 1,248 | $ | 1,659 | $ | 1,309 | $ | 15,233 | $ | 19,449 |
| Derivative liabilities | 332 | 145 | 218 | 9,589 | 10,284 |
Manulife Financial Corporation – First Quarter 2020
46
The following table presents fair value of the derivative contracts within the fair value hierarchy.
| As at March 31, 2020 | Fair value | Level 1 | Level 2 | Level 3 | ||||
|---|---|---|---|---|---|---|---|---|
| Derivative assets | ||||||||
| Interest rate contracts | $ | 37,185 | $ | - | $ | 30,868 | $ | 6,317 |
| Foreign exchange contracts | 1,399 | - | 1,399 | - | ||||
| Equity contracts | 1,082 | - | 960 | 122 | ||||
| Credit default swaps | 4 | - | 4 | - | ||||
| Total derivative assets | $ | 39,670 | $ | - | $ | 33,231 | $ | 6,439 |
| Derivative liabilities | ||||||||
| Interest rate contracts | $ | 17,192 | $ | - | $ | 16,041 | $ | 1,151 |
| Foreign exchange contracts | 3,735 | - | 3,725 | 10 | ||||
| Equity contracts | 263 | - | 129 | 134 | ||||
| Total derivative liabilities | $ | 21,190 | $ | - | $ | 19,895 | $ | 1,295 |
| As at December 31, 2019 | Fair value | Level 1 | Level 2 | Level 3 | ||||
| Derivative assets | ||||||||
| Interest rate contracts | $ | 17,894 | $ | - | $ | 15,801 | $ | 2,093 |
| Foreign exchange contracts | 680 | - | 680 | - | ||||
| Equity contracts | 869 | - | 821 | 48 | ||||
| Credit default swaps | 6 | - | 6 | - | ||||
| Total derivative assets | $ | 19,449 | $ | - | $ | 17,308 | $ | 2,141 |
| Derivative liabilities | ||||||||
| Interest rate contracts | $ | 8,397 | $ | - | $ | 7,730 | $ | 667 |
| Foreign exchange contracts | 1,850 | - | 1,849 | 1 | ||||
| Equity contracts | 37 | - | 20 | 17 | ||||
| Total derivative liabilities | $ | 10,284 | $ | - | $ | 9,599 | $ | 685 |
Level 3 roll forward information for net derivative contracts measured using significant unobservable inputs is disclosed in note 3(c).
Manulife Financial Corporation – First Quarter 2020
47
| Note 5 | Insurance and Investment Contract Liabilities |
|---|---|
| (a) | Insurance and investment contracts |
| --- | --- |
The Company monitors experience and reviews the assumptions used in the calculation of insurance and investment contract liabilities on an ongoing basis to ensure they appropriately reflect future expected experience and any changes in the risk profile of the business. Any changes to the methods and assumptions used in projecting future asset and liability cash flows will result in a change in insurance and investment contract liabilities.
For the three months ended March 31, 2020 and 2019, changes in assumptions and model enhancements did not impact insurance and investment contract liabilities or net income attributed to shareholders.
| (b) | Investment contracts – Fair value measurement |
|---|
As at March 31, 2020, the fair value of investment contract liabilities measured at fair value was $989 (December 31, 2019 – $789). The carrying value and fair value of investment contract liabilities measured at amortized cost were $2,396 and $2,713, respectively (December 31, 2019 – $2,315 and $2,640, respectively). The carrying value and fair value of investment contract liabilities net of reinsurance assets were $2,302 and $2,616, respectively (December 31, 2019 - $2,222 and $2,537, respectively).
| (c) | Gross claims and benefits |
|---|
The following table presents a breakdown of gross claims and benefits for the three months ended March 31, 2020 and 2019.
| For the three months ended March 31, | 2020 | 2019 | ||||
|---|---|---|---|---|---|---|
| Death, disability and other claims | $ | 4,607 | $ | 3,944 | ||
| Maturity and surrender benefits | 2,319 | 2,123 | ||||
| Annuity payments | 977 | 1,028 | ||||
| Policyholder dividends and experience rating refunds | 288 | 323 | ||||
| Net transfers from segregated funds | (536 | ) | (249 | ) | ||
| Total | $ | 7,655 | $ | 7,169 | ||
| (d) | Annuity coinsurance transactions | |||||
| --- | --- |
On September 26, 2018, the Company entered into coinsurance agreements with Reinsurance Group of America (“RGA”) to reinsure a block of legacy U.S. individual pay-out annuities business from John Hancock Life Insurance Company (U.S.A.) (“JHUSA”) with a 100% quota share and John Hancock Life Insurance Company of New York (“JHNY”) with a 90% quota share. Under the terms of the agreements, the Company will maintain responsibility for servicing the policies. The transaction was structured such that the Company ceded policyholder contract liabilities and transferred invested assets backing these liabilities. The JHUSA transaction closed in 2018.
The JHNY transaction closed with an effective date of January 1, 2019. The Company recorded an after-tax gain of $18, which includes an increase in reinsurance assets of $132, and ceded premiums of $131 on the Consolidated Statements of Income.
On October 31, 2018, the Company entered into coinsurance agreements with Jackson National Life Insurance Company (“Jackson”), a wholly-owned subsidiary of Prudential plc, to reinsure a block of legacy U.S. group pay-out annuities business from JHUSA with a 100% quota share and JHNY with a 90% quota share. Under the terms of the agreements, the Company will maintain responsibility for servicing the policies. The transaction was structured such that the Company ceded policyholder contract liabilities and transferred related invested assets backing these liabilities. The JHUSA transaction closed in 2018.
The JHNY transaction closed with an effective date of January 1, 2019. The Company recorded an after-tax gain of $31, which includes an increase in reinsurance assets of $621, a ceding commission paid of $35, and ceded premiums of $581 on the Consolidated Statements of Income.
Manulife Financial Corporation – First Quarter 2020
48
| Note 6 | Risk Management |
|---|
The Company’s policies and procedures for managing risk related to financial instruments and insurance contracts can be found in note 8 of the Company’s 2019 Annual Consolidated Financial Statements as well as the shaded tables and text in the “Risk Management” section of the Company’s Management Discussion and Analysis (“MD&A”) in the 2019 Annual Report.
| (a) | Risk disclosures included in the First Quarter’s MD&A |
|---|
Market risk sensitivities related to variable annuity and segregated fund guarantees, publicly traded equity performance risk, interest rate and spread risk and alternative long-duration asset performance risk are disclosed in shaded text and tables in the “Risk Management and Risk Factors” section of the First Quarter 2020 Management Discussion and Analysis. These disclosures are in accordance with IFRS 7 “Financial Instruments: Disclosures” and IAS 34 “Interim Financial Reporting” and are an integral part of these Interim Consolidated Financial Statements.
| (b) | Credit risk |
|---|---|
| (I) | Credit quality |
| --- | --- |
The credit quality of commercial mortgages and private placements is assessed at least annually by using an internal rating based on regular monitoring of credit related exposures, considering both qualitative and quantitative factors.
The following table presents the credit quality and carrying value of the commercial mortgages and private placements.
| As at March 31, 2020 | AAA | AA | A | BBB | BB | B and lower | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Commercial mortgages | ||||||||||||||
| Retail | $ | 150 | $ | 1,523 | $ | 5,428 | $ | 2,168 | $ | 11 | $ | - | $ | 9,280 |
| Office | 80 | 1,816 | 6,224 | 1,448 | 26 | 18 | 9,612 | |||||||
| Multi-family residential | 664 | 1,694 | 2,860 | 763 | 38 | - | 6,019 | |||||||
| Industrial | 40 | 370 | 2,013 | 268 | 3 | - | 2,694 | |||||||
| Other | 258 | 795 | 958 | 1,403 | - | 8 | 3,422 | |||||||
| Total commercial mortgages | 1,192 | 6,198 | 17,483 | 6,050 | 78 | 26 | 31,027 | |||||||
| Agricultural mortgages | - | 29 | 147 | 207 | 126 | - | 509 | |||||||
| Private placements | 1,156 | 5,840 | 15,409 | 14,807 | 953 | 2,682 | 40,847 | |||||||
| Total | $ | 2,348 | $ | 12,067 | $ | 33,039 | $ | 21,064 | $ | 1,157 | $ | 2,708 | $ | 72,383 |
| As at December 31, 2019 | AAA | AA | A | BBB | BB | B and lower | Total | |||||||
| Commercial mortgages | ||||||||||||||
| Retail | $ | 132 | $ | 1,374 | $ | 5,285 | $ | 2,039 | $ | 10 | $ | - | $ | 8,840 |
| Office | 77 | 1,540 | 5,808 | 1,402 | 26 | 18 | 8,871 | |||||||
| Multi-family residential | 640 | 1,585 | 2,397 | 714 | 35 | - | 5,371 | |||||||
| Industrial | 38 | 364 | 1,820 | 237 | 10 | - | 2,469 | |||||||
| Other | 260 | 739 | 976 | 1,290 | - | 8 | 3,273 | |||||||
| Total commercial mortgages | 1,147 | 5,602 | 16,286 | 5,682 | 81 | 26 | 28,824 | |||||||
| Agricultural mortgages | - | 27 | 137 | 312 | - | - | 476 | |||||||
| Private placements | 1,098 | 5,513 | 14,311 | 14,139 | 823 | 2,095 | 37,979 | |||||||
| Total | $ | 2,245 | $ | 11,142 | $ | 30,734 | $ | 20,133 | $ | 904 | $ | 2,121 | $ | 67,279 |
The company assess credit quality of residential mortgages and loans to Bank clients at least annually with the loan status as performing or non-performing being the key credit quality indicator.
Manulife Financial Corporation – First Quarter 2020
49
The following table presents the carrying value of residential mortgages and loans to Bank clients.
| As at | March 31, 2020 | December 31, 2019 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insured | Uninsured | Total | Insured | Uninsured | Total | |||||||
| Residential mortgages | ||||||||||||
| Performing | $ | 6,631 | $ | 13,554 | $ | 20,185 | $ | 6,613 | $ | 13,411 | $ | 20,024 |
| Non-performing^(1)^ | 32 | 28 | 60 | 25 | 27 | 52 | ||||||
| Loans to Bank clients | ||||||||||||
| Performing | n/a | 1,789 | 1,789 | n/a | 1,740 | 1,740 | ||||||
| Non-performing^(1)^ | n/a | - | - | n/a | - | - | ||||||
| Total | $ | 6,663 | $ | 15,371 | $ | 22,034 | $ | 6,638 | $ | 15,178 | $ | 21,816 |
| ^(1)^ | Non-performing refers to assets that are 90 days or more past due. | |||||||||||
| --- | --- | |||||||||||
| (II) | Past due or credit impaired financial assets | |||||||||||
| --- | --- |
The following table presents past due but not impaired and impaired financial assets and the allowance for credit losses.
| Past due but not impaired | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| As at March 31, 2020 | Less than 90<br><br> <br>days | 90 days and<br><br> <br>greater | Total | Total<br><br> <br>impaired | Allowance for<br><br> <br>credit losses | |||||
| Debt securities | ||||||||||
| FVTPL | $ | 422 | $ | - | $ | 422 | $ | 182 | $ | - |
| AFS | 12 | 6 | 18 | - | - | |||||
| Private placements | 137 | - | 137 | 7 | 4 | |||||
| Mortgages and loans to Bank clients | 74 | - | 74 | 59 | 23 | |||||
| Other financial assets | 328 | 61 | 389 | 2 | - | |||||
| Total | $ | 973 | $ | 67 | $ | 1,040 | $ | 250 | $ | 27 |
| Past due but not impaired | ||||||||||
| As at December 31, 2019 | Less than 90<br><br> <br>days | 90 days<br><br> <br>and greater | Total | Total<br><br> <br>impaired | Allowance for<br><br> <br>credit losses | |||||
| Debt securities | ||||||||||
| FVTPL | $ | 11 | $ | - | $ | 11 | $ | 167 | $ | - |
| AFS | 4 | 1 | 5 | - | - | |||||
| Private placements | 215 | - | 215 | 7 | 4 | |||||
| Mortgages and loans to Bank clients | 61 | - | 61 | 59 | 16 | |||||
| Other financial assets | 60 | 42 | 102 | 1 | - | |||||
| Total | $ | 351 | $ | 43 | $ | 394 | $ | 234 | $ | 20 |
| (c) | Securities lending, repurchase and reverse repurchase transactions | |||||||||
| --- | --- |
As at March 31, 2020, the Company had loaned securities (which are included in invested assets), with a market value of $869 (December 31, 2019 – $558). The Company holds collateral with a current market value that exceeds the value of securities lent in all cases.
As at March 31, 2020, the Company had engaged in reverse repurchase transactions of $1,614 (December 31, 2019 – $990) which are recorded as receivables. In addition, the Company had engaged in repurchase transactions of $170 as at March 31, 2020 (December 31, 2019 – $333) which are recorded as payables.
| (d) | Credit default swaps |
|---|
The Company replicates exposure to specific issuers by selling credit protection via credit default swaps (“CDS”) to complement its cash debt securities investing. The Company does not write CDS protection in excess of its government bond holdings.
Manulife Financial Corporation – First Quarter 2020
50
The following table presents details of the credit default swap protection sold by type of contract and external agency rating for the underlying reference security.
| As at March 31, 2020 | Notional<br><br> amount^(1)^ | Fair value | Weighted<br><br> <br>average maturity<br><br> <br>(in years)^(2)^ | |||
|---|---|---|---|---|---|---|
| Single name CDS^(3),(4)^– Corporate debt | ||||||
| A | $ | 375 | $ | 4 | 1 | |
| BBB | 118 | - | 2 | |||
| Total single name CDS | $ | 493 | $ | 4 | 1 | |
| Total CDS protection sold | $ | 493 | $ | 4 | 1 | |
| As at December 31, 2019 | Notional<br><br> <br>amount^(1)^ | Fair value | Weighted<br><br> <br>average maturity<br><br> <br>(in years)^(2)^ | |||
| Single name CDS^(3),(4)^– Corporate debt | ||||||
| AA | $ | 24 | $ | - | 1 | |
| A | 371 | 5 | 1 | |||
| BBB | 107 | 1 | 2 | |||
| Total single name CDS | $ | 502 | $ | 6 | 1 | |
| Total CDS protection sold | $ | 502 | $ | 6 | 1 | |
| ^(1)^ | Notional amounts represent the maximum future payments the Company would have to pay its counterparties assuming<br> a default of the underlying credit and zero recovery on the underlying issuer obligation. | |||||
| --- | --- | |||||
| ^(2)^ | The weighted average maturity of the CDS is weighted based on notional amounts. | |||||
| --- | --- | |||||
| ^(3)^ | Ratings are based on S&P where available followed by Moody’s, DBRS, and Fitch. If no rating is available from a rating agency,<br> an internally developed rating is used. | |||||
| --- | --- | |||||
| ^(4)^ | The Company held no purchased credit protection. | |||||
| --- | --- | |||||
| (e) | Derivatives | |||||
| --- | --- |
The Company’s point-in-time exposure to losses related to credit risk of a derivative counterparty is limited to the amount of any net gains that may have accrued with a particular counterparty. Gross derivative counterparty exposure is measured as the total fair value (including accrued interest) of all outstanding contracts in a gain position excluding any offsetting contracts in a loss position and the impact of collateral on hand. The Company limits the risk of credit losses from derivative counterparties by: using investment grade counterparties; entering into master netting arrangements which permit the offsetting of contracts in a loss position in the case of a counterparty default; and entering into Credit Support Annex agreements, whereby collateral must be provided when the exposure exceeds a certain threshold.
All contracts are held with counterparties rated BBB+ or higher. As at March 31, 2020, the percentage of the Company’s derivative exposure which was with counterparties rated AA- or higher amounted to 24 per cent (December 31, 2019 – 23 per cent). As at March 31, 2020, the largest single counterparty exposure, without taking into consideration the impact of master netting agreements or the benefit of collateral held, was $5,614 (December 31, 2019 – $3,047). The net exposure to this counterparty, after taking into consideration master netting agreements and the fair value of collateral held, was $nil (December 31, 2019 – $nil).
| (f) | Offsetting financial assets and financial liabilities |
|---|
Certain derivatives, securities lent and repurchase agreements have conditional offset rights. The Company does not offset these financial instruments in the Consolidated Statements of Financial Position, as the rights of offset are conditional. In the case of derivatives, collateral is collected from and pledged to counterparties and clearing houses to manage credit risk exposure in accordance with Credit Support Annexes to swap agreements and clearing agreements. Under master netting agreements, the Company has a right of offset in the event of default, insolvency, bankruptcy or other early termination.
In the case of reverse repurchase and repurchase transactions, additional collateral may be collected from or pledged to counterparties to manage credit exposure according to bilateral reverse repurchase or repurchase agreements. In the event of default by a counterparty, the Company is entitled to liquidate the collateral held to offset against the same counterparty’s obligation.
Manulife Financial Corporation – First Quarter 2020
51
The following table presents the effect of conditional master netting and similar arrangements. Similar arrangements may include global master repurchase agreements, global master securities lending agreements, and any related rights to financial collateral.
| Related amounts not set off in the<br><br> <br>Consolidated Statements of<br><br> <br>Financial Position | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As at March 31, 2020 | Gross amounts<br><br> <br>of financial<br><br> <br>instruments^(1)^ | Amounts<br><br> <br>subject to an<br><br> <br>enforceable<br><br> <br>master netting<br><br> <br>arrangement or<br><br> <br>similar<br><br> <br>agreements | Financial and<br><br> <br>cash collateral<br><br> <br>pledged<br><br> <br>(received)^(2)^ | Net amount<br><br> <br>including<br><br> <br>financing<br><br> <br>trusts^(3)^ | Net amounts<br><br> <br>excluding<br><br> <br>financing<br><br> <br>trusts | ||||||||||
| Financial assets | |||||||||||||||
| Derivative assets | $ | 40,365 | $ | (18,151 | ) | $ | (21,975 | ) | $ | 239 | $ | 239 | |||
| Securities lending | 869 | - | (869 | ) | - | - | |||||||||
| Reverse repurchase agreements | 1,614 | - | (1,613 | ) | 1 | 1 | |||||||||
| Total financial assets | $ | 42,848 | $ | (18,151 | ) | $ | (24,457 | ) | $ | 240 | $ | 240 | |||
| Financial liabilities | |||||||||||||||
| Derivative liabilities | $ | (22,355 | ) | $ | 18,151 | $ | 3,861 | $ | (343 | ) | $ | (29 | ) | ||
| Repurchase agreements | (170 | ) | - | 170 | - | - | |||||||||
| Total financial liabilities | $ | (22,525 | ) | $ | 18,151 | $ | 4,031 | $ | (343 | ) | $ | (29 | ) | ||
| Related amounts not set off in the<br><br> <br>Consolidated Statements of<br><br> <br>Financial Position | |||||||||||||||
| As at December 31, 2019 | Gross amounts<br><br> <br>of financial<br><br> <br>instruments^(1)^ | Amounts<br><br> <br>subject to an<br><br> <br>enforceable<br><br> <br>master netting<br><br> <br>arrangement or<br><br> <br>similar<br><br> <br>agreements | Financial and<br><br> <br>cash collateral<br><br> <br>pledged<br><br> <br>(received)^(2)^ | Net amount<br><br> <br>including<br><br> <br>financing<br><br> <br>trusts^(3)^ | Net amounts<br><br> <br>excluding<br><br> <br>financing trusts | ||||||||||
| Financial assets | |||||||||||||||
| Derivative assets | $ | 20,144 | $ | (9,188 | ) | $ | (10,889 | ) | $ | 67 | $ | 67 | |||
| Securities lending | 558 | - | (558 | ) | - | - | |||||||||
| Reverse repurchase agreements | 990 | - | (989 | ) | 1 | 1 | |||||||||
| Total financial assets | $ | 21,692 | $ | (9,188 | ) | $ | (12,436 | ) | $ | 68 | $ | 68 | |||
| Financial liabilities | |||||||||||||||
| Derivative liabilities | $ | (11,345 | ) | $ | 9,188 | $ | 1,903 | $ | (254 | ) | $ | (53 | ) | ||
| Repurchase agreements | (333 | ) | - | 330 | (3 | ) | (3 | ) | |||||||
| Total financial liabilities | $ | (11,678 | ) | $ | 9,188 | $ | 2,233 | $ | (257 | ) | $ | (56 | ) | ||
| ^(1)^ | Financial assets and liabilities in the above table include accrued interest of $700 and $1,165 respectively (December 31, 2019 – $696<br> and $1,061 respectively). | ||||||||||||||
| --- | --- | ||||||||||||||
| ^(2)^ | Financial and cash collateral excludes over-collateralization. As at March 31, 2020, the Company was over-collateralized on OTC derivative assets, OTC<br> derivative liabilities, securities lending and reverse purchase agreements and repurchase agreements in the amounts of $2,119, $1,597, $63 and $4, respectively (December 31, 2019<br> – $1,149, $526, $44 and $nil respectively). As at March 31, 2020, collateral pledged (received) does not include collateral in transit on OTC instruments or include initial margin on exchange traded contracts or cleared contracts. | ||||||||||||||
| --- | --- | ||||||||||||||
| ^(3)^ | Includes derivative contracts entered between the Company and its financing trusts which it does not consolidate. The Company does not exchange<br> collateral on derivative contracts entered with these trusts. | ||||||||||||||
| --- | --- |
The Company also has certain credit linked note assets and variable surplus note liabilities which have unconditional offset rights. Under the netting agreements, the Company has rights of offset including in the event of the Company’s default, insolvency, or bankruptcy. These financial instruments are offset in the Company’s Consolidated Statements of Financial Position.
A credit linked note is a security that allows the issuer to transfer a specific credit risk to the buyer. A surplus note is a subordinated debt obligation that often qualifies as surplus (the U.S. statutory equivalent of equity) by some U.S. state insurance regulators. Interest payments on surplus notes are made after all other contractual payments are made. The following table presents the effect of unconditional netting.
Manulife Financial Corporation – First Quarter 2020
52
| As at March 31, 2020 | Gross amounts<br><br> <br>of financial<br><br> <br>instruments | Amounts<br><br> <br>subject to an<br><br> <br>enforceable<br><br> <br>netting<br><br> <br>arrangement | Net amounts of<br><br> <br>financial<br><br> <br>instruments | |||||
|---|---|---|---|---|---|---|---|---|
| Credit linked note | $ | 900 | $ | (900 | ) | $ | - | |
| Variable surplus note | (900 | ) | 900 | - | ||||
| As at December 31, 2019 | Gross amounts<br><br> <br>of financial<br><br> <br>instruments | Amounts<br><br> <br>subject to an<br><br> <br>enforceable<br><br> <br>netting<br><br> <br>arrangement | Net amounts of<br><br> <br>financial<br><br> <br>instruments | |||||
| Credit linked note | $ | 782 | $ | (782 | ) | $ | - | |
| Variable surplus note | (782 | ) | 782 | - | ||||
| Note 7 | Long-Term Debt | |||||||
| --- | --- | |||||||
| (a) | Carrying value of long-term debt instruments | |||||||
| --- | --- | |||||||
| December 31, | ||||||||
| --- | --- | --- | --- | --- | --- | --- | ||
| As at | Issue date | Maturity date | Par value | 2019 | ||||
| 4.70% Senior notes^(1)^ | June 23, 2016 | June 23, 2046 | US1,000 | 1,410 | $ | 1,290 | ||
| 5.375% Senior notes^(1)^ | March 4, 2016 | March 4, 2046 | US750 | 1,051 | 962 | |||
| 3.527% Senior notes^(1)^ | December 2, 2016 | December 2, 2026 | US270 | 382 | 350 | |||
| 4.150% Senior notes^(1)^ | March 4, 2016 | March 4, 2026 | US1,000 | 1,411 | 1,292 | |||
| 4.90% Senior notes^(1)^ | September 17, 2010 | September 17, 2020 | US500 | 709 | 649 | |||
| Total | 4,963 | $ | 4,543 |
All values are in US Dollars.
| ^(1)^ | These U.S. dollar senior notes have been designated as hedges of the Company’s net investment in its<br> U.S. operations which reduces the earnings volatility that would otherwise arise from the re-measurement of these senior notes into Canadian dollars. |
|---|---|
| (b) | Fair value measurement |
| --- | --- |
Fair value of long-term debt instruments is determined using the following hierarchy:
Level 1 – Fair value is determined using quoted market prices where available.
Level 2 – When quoted market prices are not available, fair value is determined with reference to quoted prices of similar debt instruments or estimated using discounted cash flows based on observable market rates.
The Company measures long-term debt at amortized cost in the Consolidated Statements of Financial Position. As at March 31, 2020, the fair value of long-term debt was $5,274 (December 31, 2019 – $5,078). Fair value of long-term debt was determined using Level 2 valuation techniques (December 31, 2019 – Level 2).
| Note 8 | Capital Instruments | ||||||
|---|---|---|---|---|---|---|---|
| (a) | Carrying value of capital instruments | ||||||
| --- | --- | ||||||
| As at | Issue date | Earliest par<br><br> <br>redemption date | Maturity date | Par value | December 31,<br><br> 2019 | ||
| --- | --- | --- | --- | --- | --- | --- | --- |
| JHFC Subordinated notes | December 14, 2006 | n/a | December 15, 2036 | 650 | 647 | $ | 647 |
| 4.061% MFC Subordinated notes^(1)^ | February 24, 2017 | February 24, 2027 | February 24, 2032 | US750 | 1,059 | 969 | |
| 3.00% MFC Subordinated notes | November 21, 2017 | November 21, 2024 | November 21, 2029 | S500 | 496 | 481 | |
| 3.049% MFC Subordinated debentures | August 18, 2017 | August 20, 2024 | August 20, 2029 | 750 | 747 | 747 | |
| 3.317% MFC Subordinated debentures | May 9, 2018 | May 9, 2023 | May 9, 2028 | 600 | 598 | 598 | |
| 3.181% MLI Subordinated debentures | November 20, 2015 | November 22, 2022 | November 22, 2027 | 1,000 | 998 | 998 | |
| 3.85% MFC Subordinated notes | May 25, 2016 | May 25, 2021 | May 25, 2026 | S500 | 497 | 482 | |
| 2.389% MLI Subordinated debentures | June 1, 2015 | January 5, 2021 | January 5, 2026 | 350 | 350 | 350 | |
| 2.10% MLI Subordinated debentures | March 10, 2015 | June 1, 2020 | June 1, 2025 | 750 | 750 | 750 | |
| 2.64% MLI Subordinated debentures^(2)^ | December 1, 2014 | January 15, 2020 | January 15, 2025 | 500 | - | 500 | |
| 7.375% JHUSA Surplus notes | February 25, 1994 | n/a | February 15, 2024 | US450 | 654 | 598 | |
| Total | 6,796 | $ | 7,120 |
All values are in US Dollars.
| ^(1)^ | Designated as a hedge of the Company’s net investment in its U.S. operations which reduces the earnings volatility that would<br> otherwise arise from the re-measurement of the subordinated notes into Canadian dollars. |
|---|---|
| ^(2)^ | MLI redeemed in full the 2.64% subordinated debentures at par, on January 15, 2020, the earliest par redemption date. |
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
53
| (b) | Fair value measurement |
|---|
Fair value of capital instruments is determined using the following hierarchy:
Level 1 – Fair value is determined using quoted market prices where available.
Level 2 – When quoted market prices are not available, fair value is determined with reference to quoted prices of similar debt instruments or estimated using discounted cash flows based on observable market rates.
The Company measures capital instruments at amortized cost in the Consolidated Statements of Financial Position. As at March 31, 2020, the fair value of capital instruments was $6,710 (December 31, 2019 – $7,333). Fair value of capital instruments was determined using Level 2 valuation techniques (December 31, 2019 – Level 2).
| Note 9 | Share Capital and Earnings Per Share |
|---|---|
| (a) | Preferred shares |
| --- | --- |
The following table presents information about the outstanding preferred shares as at March 31, 2020 and December 31, 2019.
| Annual | Earliest | Number of | Net amount^(3)^ | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| dividend | redemption | shares | Face | March 31, | December 31, | |||||||||
| As at | Issue date | rate^(1)^ | date^(2)^ | (in millions) | amount | 2020 | 2019 | |||||||
| Class A preferred shares | ||||||||||||||
| Series 2 | February 18, 2005 | 4.65 | % | n/a | 14 | $ | 350 | $ | 344 | $ | 344 | |||
| Series 3 | January 3, 2006 | 4.50 | % | n/a | 12 | 300 | 294 | 294 | ||||||
| Class 1 preferred shares | ||||||||||||||
| Series 3^(4),(5)^ | March 11, 2011 | 2.178 | % | June 19, 2021 | 6 | 158 | 155 | 155 | ||||||
| Series 4^(6)^ | June 20, 2016 | floating | June 19, 2021 | 2 | 42 | 41 | 41 | |||||||
| Series 5^(4),(5)^ | December 6, 2011 | 3.891 | % | December 19, 2021 | 8 | 200 | 195 | 195 | ||||||
| Series 7^(4),(5)^ | February 22, 2012 | 4.312 | % | March 19, 2022 | 10 | 250 | 244 | 244 | ||||||
| Series 9^(4),(5)^ | May 24, 2012 | 4.351 | % | September 19, 2022 | 10 | 250 | 244 | 244 | ||||||
| Series 11^(4),(5)^ | December 4, 2012 | 4.731 | % | March 19, 2023 | 8 | 200 | 196 | 196 | ||||||
| Series 13^(4),(5)^ | June 21, 2013 | 4.414 | % | September 19, 2023 | 8 | 200 | 196 | 196 | ||||||
| Series 15^(4),(5)^ | February 25, 2014 | 3.786 | % | June 19, 2024 | 8 | 200 | 195 | 195 | ||||||
| Series 17^(4),(5)^ | August 15, 2014 | 3.80 | % | December 19, 2024 | 14 | 350 | 343 | 343 | ||||||
| Series 19^(4),(5),(7)^ | December 3, 2014 | 3.68 | % | March 19, 2025 | 10 | 250 | 246 | 246 | ||||||
| Series 21^(4),(5)^ | February 25, 2016 | 5.60 | % | June 19, 2021 | 17 | 425 | 417 | 417 | ||||||
| Series 23^(4),(5)^ | November 22, 2016 | 4.85 | % | March 19, 2022 | 19 | 475 | 467 | 467 | ||||||
| Series 25^(4),(5)^ | February 20, 2018 | 4.70 | % | June 19, 2023 | 10 | 250 | 245 | 245 | ||||||
| Total | 156 | $ | 3,900 | $ | 3,822 | $ | 3,822 | |||||||
| ^(1)^ | Holders of Class A and Class 1 preferred shares are entitled to receive non-cumulative preferential cash dividends on a quarterly<br> basis, as and when declared by the Board of Directors. | |||||||||||||
| --- | --- | |||||||||||||
| ^(2)^ | Redemption of all preferred shares is subject to regulatory approval. MFC may redeem each series, in whole or in part, at par, on the earliest<br> redemption date or every five years thereafter, except for Class A Series 2, Class A Series 3 and Class 1 Series 4 preferred shares. Class A Series 2 and Series 3 preferred shares are past their respective earliest redemption date and MFC<br> may redeem these shares, in whole or in part, at par at any time, subject to regulatory approval, as noted. MFC may redeem the Class 1 Series 4, in whole or in part, at any time, at $25.00 per share if redeemed on June 19, 2021 and on<br> June 19 every five years thereafter, or at $25.50 per share if redeemed on any other date after June 19, 2016, subject to regulatory approval, as noted. | |||||||||||||
| --- | --- | |||||||||||||
| ^(3)^ | Net of after-tax issuance costs. | |||||||||||||
| --- | --- | |||||||||||||
| ^(4)^ | On the earliest redemption date and every five years thereafter, the annual dividend rate will be reset to the five-year Government of Canada bond<br> yield plus a yield specified for each series. The specified yield for Class 1 shares is: Series 3 – 1.41%, Series 5 – 2.90%, Series 7 – 3.13%, Series 9 – 2.86%, Series 11 – 2.61%, Series 13 – 2.22%, Series 15 – 2.16%, Series 17 – 2.36%,<br> Series 19 – 2.30%, Series 21 – 4.97%, Series 23 – 3.83% and Series 25 – 2.55%. | |||||||||||||
| --- | --- | |||||||||||||
| ^(5)^ | On the earliest redemption date and every five years thereafter, Class 1 preferred shares are convertible at the option of the holder into a new series<br> that is one number higher than their existing series, and the holders are entitled to non-cumulative preferential cash dividends, payable quarterly if and when declared by the Board of Directors, at a rate equal to the three-month<br> Government of Canada Treasury bill yield plus the rate specified in footnote 4 above. | |||||||||||||
| --- | --- | |||||||||||||
| ^(6)^ | The floating dividend rate for the Class 1 Shares Series 4 equals the three-month Government of Canada Treasury bill yield plus 1.41%. | |||||||||||||
| --- | --- | |||||||||||||
| ^(7)^ | MFC did not exercise its right to redeem all or any of the outstanding Class 1 Shares Series 19 on March 19, 2020, the earliest redemption date. The<br> dividend rate was reset as specified in footnote 4 above to an annual fixed rate of 3.675%, for a five-year period commencing on March 20, 2020. | |||||||||||||
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
54
| (b) | Common shares |
|---|
As at March 31, 2020, there were 27 million outstanding stock options and deferred share units that entitle the holder to receive common shares or payment in cash or common shares, at the option of the holder (December 31, 2019 – 23 million).
| For the | three months<br><br> <br>ended | year ended | ||||
|---|---|---|---|---|---|---|
| Number of common shares (in millions) | March 31,<br><br> <br>2020 | December 31,<br><br> <br>2019 | ||||
| Balance, beginning of period | 1,949 | 1,971 | ||||
| Repurchased for cancellation | (10 | ) | (58 | ) | ||
| Issued under dividend reinvestment plan | - | 31 | ||||
| Issued on exercise of stock options and deferred share units | 1 | 5 | ||||
| Balance, end of period | 1,940 | 1,949 |
Normal Course Issuer Bid
The current NCIB commenced on November 14, 2019 and will continue until November 13, 2020, when the NCIB expires, or such earlier date as the Company completes its purchases. However, on March 13, 2020, the Office of the Superintendent of Financial Institutions (“OSFI”) announced measures to support the resilience of financial institutions. Consistent with these measures, OSFI set the expectation for all federally regulated financial institutions that dividend increases and share buybacks should be halted for the time being. Accordingly, the Company has not repurchased its shares since March 13, 2020.
From January 1, 2020 to March 12, 2020, the Company had purchased for cancellation 10 million shares for $253. Of this, $121 was recorded in common shares and $132 was recorded in retained earnings in the Consolidated Statements of Changes in Equity.
Dividend Reinvestment Plan
The Company offers a Dividend Reinvestment Program (“DRIP”) whereby shareholders may elect to automatically reinvest dividends in the form of MFC common shares instead of receiving cash. The offering of the program and its terms of execution are subject to the Board of Directors’ discretion. For the dividend paid on March 19, 2020, common shares in connection with the DRIP were purchased on the open market with no applicable discount.
| (c) | Earnings per share |
|---|
The following is a reconciliation of the denominator (number of shares) in the calculation of basic and diluted earnings per share.
| For the three months ended March 31, | 2020 | 2019 | ||
|---|---|---|---|---|
| Weighted average number of common shares (in millions) | 1,943 | 1,965 | ||
| Dilutive stock-based awards^(1)^ (in millions) | 4 | 4 | ||
| Weighted average number of diluted common shares (in millions) | 1,947 | 1,969 | ||
| ^(1)^ | The dilutive effect of stock-based awards was calculated using the treasury stock method. This method calculates the number of<br> incremental shares by assuming the outstanding stock-based awards are (i) exercised and (ii) then reduced by the number of shares assumed to be repurchased from the issuance proceeds, using the average market price of MFC common shares<br> for the period. | |||
| --- | --- | |||
| Note 10 | Revenue from Service Contracts | |||
| --- | --- |
The Company provides investment management services, administrative services and distribution and related services to proprietary and third-party investment funds, retirement plans, group benefit plans and other arrangements. The Company also provides real estate management services to tenants of the Company’s investment properties.
The Company’s service contracts generally impose single performance obligations, each consisting of a series of similar related services for each customer.
The Company’s performance obligations within service arrangements are generally satisfied over time as the customer simultaneously receives and consumes the benefits of the services rendered, measured using an output method. Fees typically include variable consideration and the related revenue is recognized to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty is subsequently resolved.
Asset based fees vary with asset values of accounts under management, subject to market conditions and investor behaviors beyond the Company’s control. Transaction processing and administrative fees vary with activity volume, also beyond the Company’s control. Some fees, including distribution fees, are based on account balances and transaction volumes. Fees
Manulife Financial Corporation – First Quarter 2020
55
related to account balances and transaction volumes are measured daily. Real estate management service fees include fixed portions plus recovery of variable costs of services rendered to tenants. Fees related to services provided are generally recognized as services are rendered, which is when it becomes highly probable that no significant reversal of cumulative revenue recognized will occur. The Company has determined that its service contracts have no significant financing components as fees are collected monthly. The Company has no significant contract assets or contract liabilities.
The following tables present revenue from service contracts by service lines and reporting segments as disclosed in note 13.
| For the three months ended March 31, 2020 | Asia | Canada | U.S. | Global<br><br> <br>WAM | Corporate<br><br> <br>and Other | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment management and other related fees | $ | 57 | $ | 55 | $ | 127 | $ | 691 | $ | (44 | ) | $ | 886 |
| Transaction processing, administration, and service fees | 57 | 201 | 4 | 535 | (1 | ) | 796 | ||||||
| Distribution fees and other | 52 | - | 17 | 185 | (15 | ) | 239 | ||||||
| Total included in other revenue | 166 | 256 | 148 | 1,411 | (60 | ) | 1,921 | ||||||
| Real estate management services included in net<br><br> <br>investment income | 9 | 37 | 34 | - | 2 | 82 | |||||||
| Total | $ | 175 | $ | 293 | $ | 182 | $ | 1,411 | $ | (58 | ) | $ | 2,003 |
| For the three months ended March 31, 2019 | Asia | Canada | U.S. | Global<br><br> <br>WAM | Corporate<br><br> <br>and Other | Total | |||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Investment management and other related fees | $ | 50 | $ | 39 | $ | 135 | $ | 675 | $ | (51 | ) | $ | 848 |
| Transaction processing, administration, and service fees | 52 | 200 | 4 | 489 | - | 745 | |||||||
| Distribution fees and other | 51 | 12 | 16 | 170 | (9 | ) | 240 | ||||||
| Total included in other revenue | 153 | 251 | 155 | 1,334 | (60 | ) | 1,833 | ||||||
| Real estate management services included in net<br><br> <br>investment income | 9 | 39 | 35 | - | 2 | 85 | |||||||
| Total | $ | 162 | $ | 290 | $ | 190 | $ | 1,334 | $ | (58 | ) | $ | 1,918 |
| Note 11 | Employee Future Benefits | ||||||||||||
| --- | --- |
The Company maintains a number of pension plans, both defined benefit and defined contribution, and retiree welfare plans for eligible employees and agents. Information about the cost of the Company’s material pension and retiree welfare plans in the U.S. and Canada is as follows.
| Pension plans | Retiree welfare plans | |||||||
|---|---|---|---|---|---|---|---|---|
| For the three months ended March 31, | 2020 | 2019 | 2020 | 2019 | ||||
| Defined benefit current service cost | $ | 10 | $ | 10 | $ | - | $ | - |
| Defined benefit administrative expenses | 2 | 5 | - | - | ||||
| Past service cost amendment | - | - | - | - | ||||
| Service cost | 12 | 15 | - | - | ||||
| Interest on net defined benefit (asset) liability | 2 | 4 | - | - | ||||
| Defined benefit cost | 14 | 19 | - | - | ||||
| Defined contribution cost | 24 | 23 | - | - | ||||
| Net benefit cost | $ | 38 | $ | 42 | $ | - | $ | - |
As disclosed in note 1, the COVID-19 pandemic and the recent economic downturn has introduced significant uncertainty regarding key inputs used in establishing the carrying amounts of the Company’s net defined pension obligation for material plans. The Company remeasures its net defined benefit obligation annually and evaluates quarterly for significant changes which could require a remeasurement on an interim basis. For the three months ended March 31, 2020, the net defined benefit obligation for material plans was estimated to have increased by $324 due to lower than expected investment returns and $12 due to foreign currency exchange impact, these increases were mostly offset by an estimated decrease of $305 due to slightly higher rates on the investment grade corporate bonds that are used to establish the discount rate for benefit obligations. The net impact of $31 was not significant, therefore, the Company did not adjust the net defined benefit obligation as at March 31, 2020. Any future changes in asset values or discount rates could have a material impact on the net defined pension obligation. Measurement uncertainty exists in the valuation of investments including potentially unobservable valuation inputs and the determination of discount rates. This uncertainty along with ongoing volatility in corporate bond markets could lead to remeasurement in the Company’s net defined benefit obligation in future interim periods.
Manulife Financial Corporation – First Quarter 2020
56
| Note 12 | Commitments and Contingencies |
|---|---|
| (a) | Legal proceedings |
| --- | --- |
The Company is regularly involved in legal actions, both as a defendant and as a plaintiff. The legal actions where the Company is a party ordinarily relate to its activities as a provider of insurance protection or wealth management products, reinsurance, or in its capacity as an investment adviser, employer, or taxpayer. Other life insurers and asset managers, operating in the jurisdictions in which the Company does business, have been subject to a wide variety of other types of actions, some of which resulted in substantial judgments or settlements against the defendants; it is possible that the Company may become involved in similar actions in the future. In addition, government and regulatory bodies in Canada, the United States, Asia and other jurisdictions where the Company conducts business regularly make inquiries and, from time to time, require the production of information or conduct examinations concerning the Company's compliance with, among other things, insurance laws, securities laws, and laws governing the activities of broker-dealers.
In June 2018, a class action was initiated against John Hancock Life Insurance Company (U.S.A.) (“JHUSA”) and John Hancock Life Insurance Company of New York (“JHNY”) in the U.S. District Court for the Southern District of New York on behalf of owners of approximately 1,500 Performance Universal Life policies issued between 2003 and 2009 whose policies were subject to a Cost of Insurance (“COI”) increase announced in 2018. In October 2018, a second and almost identical class action was initiated against JHUSA and JHNY in the U.S. District Court for the Southern District of New York. The two cases were determined to be related, and they were consolidated and assigned to the same judge. Discovery has commenced in these cases. No hearings on substantive matters have been scheduled. It is too early to assess the range of potential outcomes for these two related lawsuits. In addition to the consolidated class action, there are six non-class lawsuits opposing the Performance UL COI increases that also have been filed. Each of the lawsuits, except one, is brought by plaintiffs owning multiple policies and by entities managing them for investment purposes. Two of the non-class lawsuits are pending in New York state court; two of the lawsuits are pending in the U.S. District Court for the Southern District of New York; and the last two lawsuits are pending in the U.S. District Court for the Central District of California. Whether individually or on a combined basis, it remains premature, given the procedural status of these cases, as well as the relatively early development of parties’ respective legal theories, to suggest a reliable estimate of potential outcomes.
| (b) | Guarantees |
|---|---|
| (i) | Guarantees regarding Manulife Finance (Delaware), L.P. (“MFLP”) |
| --- | --- |
MFC has guaranteed the payment of amounts on the $650 subordinated debentures due on December 15, 2041 issued by MFLP, a wholly-owned unconsolidated partnership.
| (ii) | Guarantees regarding The Manufacturers Life Insurance Company |
|---|
MFC has provided a subordinated guarantee on the day of issuance for the following subordinated debentures issued by MLI: $750 issued on March 10, 2015; $350 issued on June 1, 2015; and $1,000 issued on November 20, 2015.
The following table sets forth certain condensed consolidated financial information for MFC and MFLP.
Condensed Consolidated Statements of Income Information
| For the three months ended March 31, 2020 | MFC<br><br> <br>(Guarantor) | MLI<br><br> <br>consolidated | Other<br><br> <br>subsidiaries<br><br> <br>of MFC on a<br><br> <br>combined basis | Consolidation<br><br> <br>adjustments | Total<br><br> <br>consolidated<br><br> <br>amounts | MFLP | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $ | (19 | ) | $ | 20,216 | $ | - | $ | (20 | ) | $ | 20,177 | $ | 27 | |
| Net income (loss) attributed to shareholders | 1,296 | 1,393 | - | (1,393 | ) | 1,296 | 14 | ||||||||
| For the three months ended March 31, 2019 | MFC<br><br> <br>(Guarantor) | MLI<br><br> <br>consolidated | Other<br><br> <br>subsidiaries<br><br> <br>of MFC on a<br><br> <br>combined basis | Consolidation<br><br> <br>adjustments | Total<br><br> <br>consolidated<br><br> <br>amounts | MFLP | |||||||||
| Total revenue | $ | (4 | ) | $ | 23,566 | $ | - | $ | (13 | ) | $ | 23,549 | $ | 5 | |
| Net income (loss) attributed to shareholders | 2,176 | 2,261 | - | (2,261 | ) | 2,176 | (3 | ) |
Manulife Financial Corporation – First Quarter 2020
57
Condensed Consolidated Statements of Financial Position Information
| As at March 31, 2020 | MFC<br><br> <br>(Guarantor) | MLI<br><br> <br>consolidated | Other<br><br> subsidiaries<br><br> <br>of MFC on a<br><br> <br>combined<br><br> <br>basis | Consolidation<br><br> <br>adjustments | Total<br><br> <br>consolidated<br><br> <br>amounts | MFLP | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invested assets | $ | 17 | $ | 405,216 | $ | 96 | $ | - | $ | 405,329 | $ | 7 | |
| Total other assets | 65,087 | 115,195 | 3 | (66,437 | ) | 113,848 | 1,227 | ||||||
| Segregated funds net assets | - | 312,253 | - | - | 312,253 | - | |||||||
| Insurance contract liabilities | - | 383,466 | - | - | 383,466 | - | |||||||
| Investment contract liabilities | - | 3,385 | - | - | 3,385 | - | |||||||
| Segregated funds net liabilities | - | 312,253 | - | - | 312,253 | - | |||||||
| Total other liabilities | 9,827 | 68,637 | 85 | (2,284 | ) | 76,265 | 984 | ||||||
| As at December 31, 2019 | MFC<br><br> <br>(Guarantor) | MLI<br><br> <br>consolidated | Other<br><br> <br>subsidiaries<br><br> <br>of MFC on a<br><br> <br>combined<br><br> <br>basis | Consolidation<br><br> adjustments | Total<br><br> <br>consolidated<br><br> <br>amounts | MFLP | |||||||
| Invested assets | $ | 21 | $ | 378,496 | $ | 10 | $ | - | $ | 378,527 | $ | 6 | |
| Total other assets | 57,474 | 87,774 | 3 | (57,756 | ) | 87,495 | 1,088 | ||||||
| Segregated funds net assets | - | 343,108 | - | - | 343,108 | - | |||||||
| Insurance contract liabilities | - | 351,161 | - | - | 351,161 | - | |||||||
| Investment contract liabilities | - | 3,104 | - | - | 3,104 | - | |||||||
| Segregated funds net liabilities | - | 343,108 | - | - | 343,108 | - | |||||||
| Total other liabilities | 8,357 | 53,998 | - | (704 | ) | 61,651 | 858 | ||||||
| (iii) | Guarantees regarding John Hancock Life Insurance Company (U.S.A.) (“JHUSA”) | ||||||||||||
| --- | --- |
Details of guarantees regarding certain securities issued or to be issued by JHUSA are outlined in note 15.
| Note 13 | Segment and Geographic Reporting |
|---|
The Company’s reporting segments are Asia, Canada, U.S., Global WAM and Corporate and Other. Each reporting segment is responsible for managing its operating results, developing products, defining strategies for services and distribution based on the profile and needs of its business and market. The Company’s significant product and service offerings by the reporting segments are mentioned below.
Wealth and asset management businesses (Global WAM) – include mutual funds and exchange traded funds, group retirement and savings products, and institutional asset management services across all major asset classes. These products and services are distributed through multiple distribution channels, including agents and brokers affiliated with the Company, independent securities brokerage firms and financial advisors pension plan consultants and banks.
Insurance and annuity products (Asia, Canada and U.S.) – includes a variety of individual life insurance, individual and group long-term care insurance and guaranteed and partially guaranteed annuity products. Products are distributed through multiple distribution channels, including insurance agents, brokers, banks, financial planners and direct marketing. Manulife Bank of Canada offers a variety of deposit and credit products to Canadian customers.
Corporate and Other Segment – comprised of investment performance on assets backing capital, net of amounts allocated to operating segments; costs incurred by the corporate office related to shareholder activities (not allocated to the operating segments); financing costs; Property and Casualty Reinsurance Business; and run-off reinsurance operations including variable annuities and accident and health.
Manulife Financial Corporation – First Quarter 2020
58
| (a) | By Segment | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| For the three months ended | Global | Corporate | ||||||||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 31, 2020 | Asia | Canada | U.S. | WAM | and Other | Total | ||||||||||||
| Revenue | ||||||||||||||||||
| Life and health insurance | $ | 4,675 | $ | 2,174 | $ | 1,574 | $ | - | $ | 31 | $ | 8,454 | ||||||
| Annuities and pensions | 714 | 102 | 85 | - | - | 901 | ||||||||||||
| Net premium income | 5,389 | 2,276 | 1,659 | - | 31 | 9,355 | ||||||||||||
| Net investment income | (1,704 | ) | 859 | 8,284 | 8 | 395 | 7,842 | |||||||||||
| Other revenue | 792 | 250 | 720 | 1,418 | (200 | ) | 2,980 | |||||||||||
| Total revenue | 4,477 | 3,385 | 10,663 | 1,426 | 226 | 20,177 | ||||||||||||
| Contract benefits and expenses | ||||||||||||||||||
| Life and health insurance | 2,773 | 1,614 | 2,900 | - | 60 | 7,347 | ||||||||||||
| Annuities and pensions | 593 | 1,488 | 4,613 | 48 | - | 6,742 | ||||||||||||
| Net benefits and claims | 3,366 | 3,102 | 7,513 | 48 | 60 | 14,089 | ||||||||||||
| Interest expense | 65 | 170 | 13 | 1 | 120 | 369 | ||||||||||||
| Other expenses | 1,248 | 810 | 770 | 1,089 | 98 | 4,015 | ||||||||||||
| Total contract benefits and expenses | 4,679 | 4,082 | 8,296 | 1,138 | 278 | 18,473 | ||||||||||||
| Income (loss) before income taxes | (202 | ) | (697 | ) | 2,367 | 288 | (52 | ) | 1,704 | |||||||||
| Income tax recovery (expense) | 73 | (134 | ) | (515 | ) | (38 | ) | 17 | (597 | ) | ||||||||
| Net income (loss) | (129 | ) | (831 | ) | 1,852 | 250 | (35 | ) | 1,107 | |||||||||
| Less net income (loss) attributed to: | ||||||||||||||||||
| Non-controlling interests | (43 | ) | - | - | - | - | (43 | ) | ||||||||||
| Participating policyholders | (181 | ) | 35 | - | - | - | (146 | ) | ||||||||||
| Net income (loss) attributed to shareholders | $ | 95 | $ | (866 | ) | $ | 1,852 | $ | 250 | $ | (35 | ) | $ | 1,296 | ||||
| Total assets | $ | 135,884 | $ | 154,544 | $ | 294,780 | $ | 198,284 | $ | 47,938 | $ | 831,430 | ||||||
| For the three months ended | Global | Corporate | ||||||||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 31, 2019 | Asia | Canada | U.S. | WAM | and Other | Total | ||||||||||||
| Revenue | ||||||||||||||||||
| Life and health insurance | $ | 4,461 | $ | 2,105 | $ | 1,487 | $ | - | $ | 24 | $ | 8,077 | ||||||
| Annuities and pensions^(1)^ | 708 | 115 | (586 | ) | - | - | 237 | |||||||||||
| Net premium income | 5,169 | 2,220 | 901 | - | 24 | 8,314 | ||||||||||||
| Net investment income | 3,254 | 4,582 | 4,588 | 23 | 226 | 12,673 | ||||||||||||
| Other revenue | 328 | 288 | 627 | 1,335 | (16 | ) | 2,562 | |||||||||||
| Total revenue | 8,751 | 7,090 | 6,116 | 1,358 | 234 | 23,549 | ||||||||||||
| Contract benefits and expenses | ||||||||||||||||||
| Life and health insurance | 5,458 | 3,220 | 5,596 | - | (8 | ) | 14,266 | |||||||||||
| Annuities and pensions | 1,029 | 2,219 | (704 | ) | 37 | - | 2,581 | |||||||||||
| Net benefits and claims | 6,487 | 5,439 | 4,892 | 37 | (8 | ) | 16,847 | |||||||||||
| Interest expense | 54 | 124 | 9 | 2 | 139 | 328 | ||||||||||||
| Other expenses | 1,281 | 755 | 670 | 1,052 | 92 | 3,850 | ||||||||||||
| Total contract benefits and expenses | 7,822 | 6,318 | 5,571 | 1,091 | 223 | 21,025 | ||||||||||||
| Income (loss) before income taxes | 929 | 772 | 545 | 267 | 11 | 2,524 | ||||||||||||
| Income tax recovery (expense) | (117 | ) | (78 | ) | (104 | ) | (34 | ) | 44 | (289 | ) | |||||||
| Net income (loss) | 812 | 694 | 441 | 233 | 55 | 2,235 | ||||||||||||
| Less net income (loss) attributed to: | ||||||||||||||||||
| Non-controlling interests | 74 | - | - | - | (1 | ) | 73 | |||||||||||
| Participating policyholders | 43 | (57 | ) | - | - | - | (14 | ) | ||||||||||
| Net income (loss) attributed to shareholders | $ | 695 | $ | 751 | $ | 441 | $ | 233 | $ | 56 | $ | 2,176 | ||||||
| Total assets | $ | 117,022 | $ | 153,906 | $ | 270,476 | $ | 209,574 | $ | 28,936 | $ | 779,914 | ||||||
| ^(1)^ | During the period, the Company ceded premiums to RGA and Jackson for the JHNY transactions, refer to note 5(d) for details. | |||||||||||||||||
| --- | --- |
Manulife Financial Corporation – First Quarter 2020
59
| (b) | By Geographic Location | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| For the three months ended | |||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 31, 2020 | Asia | Canada | U.S. | Other | Total | ||||||
| Revenue | |||||||||||
| Life and health insurance | $ | 4,696 | $ | 2,093 | $ | 1,574 | $ | 91 | $ | 8,454 | |
| Annuities and pensions | 714 | 102 | 85 | - | 901 | ||||||
| Net premium income | 5,410 | 2,195 | 1,659 | 91 | 9,355 | ||||||
| Net investment income | (1,576 | ) | 1,118 | 8,286 | 14 | 7,842 | |||||
| Other revenue | 1,037 | 609 | 1,334 | - | 2,980 | ||||||
| Total revenue | $ | 4,871 | $ | 3,922 | $ | 11,279 | $ | 105 | $ | 20,177 | |
| For the three months ended | |||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 31, 2019 | Asia | Canada | U.S. | Other | Total | ||||||
| Revenue | |||||||||||
| Life and health insurance | $ | 4,481 | $ | 2,003 | $ | 1,487 | $ | 106 | $ | 8,077 | |
| Annuities and pensions | 708 | 115 | (586 | ) | - | 237 | |||||
| Net premium income | 5,189 | 2,118 | 901 | 106 | 8,314 | ||||||
| Net investment income | 3,346 | 4,649 | 4,626 | 52 | 12,673 | ||||||
| Other revenue | 526 | 659 | 1,375 | 2 | 2,562 | ||||||
| Total revenue | $ | 9,061 | $ | 7,426 | $ | 6,902 | $ | 160 | $ | 23,549 | |
| Note 14 | Segregated Funds | ||||||||||
| --- | --- |
The Company manages a number of segregated funds on behalf of policyholders. Policyholders are provided with the opportunity to invest in different categories of segregated funds that respectively hold a range of underlying investments. The underlying investments of the segregated funds consist of both individual securities and mutual funds (collectively “net assets”). The carrying value and change in segregated funds net assets are as follows.
Segregated funds net assets
| As at | March 31,<br><br> <br>2020 | December 31,<br><br> <br>2019 | ||||
|---|---|---|---|---|---|---|
| Investments at market value | ||||||
| Cash and short-term securities | $ | 4,140 | $ | 3,364 | ||
| Debt securities | 16,335 | 16,883 | ||||
| Equities | 10,364 | 12,989 | ||||
| Mutual funds | 277,780 | 304,753 | ||||
| Other investments | 4,943 | 4,785 | ||||
| Accrued investment income | 282 | 1,678 | ||||
| Other assets and liabilities, net | (1,271 | ) | (975 | ) | ||
| Total segregated funds net assets | $ | 312,573 | $ | 343,477 | ||
| Composition of segregated funds net assets | ||||||
| Held by policyholders | $ | 312,253 | $ | 343,108 | ||
| Held by the Company | 320 | 369 | ||||
| Total segregated funds net assets | $ | 312,573 | $ | 343,477 |
Manulife Financial Corporation – First Quarter 2020
60
Changes in segregated funds net assets
| For the three months ended March 31, | 2020 | 2019 | ||||
|---|---|---|---|---|---|---|
| Net policyholder cash flow | ||||||
| Deposits from policyholders | $ | 11,215 | $ | 10,586 | ||
| Net transfers to general fund | (536 | ) | (249 | ) | ||
| Payments to policyholders | (13,033 | ) | (11,568 | ) | ||
| (2,354 | ) | (1,231 | ) | |||
| Investment related | ||||||
| Interest and dividends | 1,287 | 1,249 | ||||
| Net realized and unrealized investment gains (losses) | (47,566 | ) | 26,681 | |||
| (46,279 | ) | 27,930 | ||||
| Other | ||||||
| Management and administration fees | (1,051 | ) | (1,037 | ) | ||
| Impact of changes in foreign exchange rates | 18,780 | (4,416 | ) | |||
| 17,729 | (5,453 | ) | ||||
| Net additions (deductions) | (30,904 | ) | 21,246 | |||
| Segregated funds net assets, beginning of period | 343,477 | 313,596 | ||||
| Segregated funds net assets, end of period | $ | 312,573 | $ | 334,842 |
Segregated funds assets may be exposed to a variety of financial and other risks. These risks are primarily mitigated by investment guidelines that are actively monitored by professional and experienced portfolio advisors. The Company is not exposed to these risks beyond the liabilities related to the guarantees associated with certain variable life and annuity products. Accordingly, the Company’s exposure to loss from segregated fund products is limited to the value of these guarantees.
These guarantees are recorded within the Company’s insurance contract liabilities. Assets supporting these guarantees are recognized in invested assets according to their investment type. The “Risk Management and Risk Factors Update” section of the Company’s First Quarter 2020 Management Discussion and Analysis provides information regarding the risks associated with variable annuity and segregated fund guarantees.
| Note 15 | Information Provided in Connection with Investments in Deferred Annuity Contracts and SignatureNotes Issued or Assumed by John Hancock Life<br> Insurance Company (U.S.A.) |
|---|
The following condensed consolidating financial information, presented in accordance with IFRS, and the related disclosure have been included in these Interim Consolidated Financial Statements with respect to JHUSA in compliance with Regulation S-X and Rule 12h-5 of the United States Securities and Exchange Commission (the “Commission”). These financial statements are (i) incorporated by reference in the registration statements of MFC and JHUSA that relate to MFC’s guarantee of certain securities to be issued by JHUSA and (ii) are provided in reliance on an exemption from continuous disclosure obligations of JHUSA. For information about JHUSA, the MFC guarantees and restrictions on the ability of MFC to obtain funds from its subsidiaries by dividend or loan, refer to note 23 to the Company’s 2019 Annual Consolidated Financial Statements.
Manulife Financial Corporation – First Quarter 2020
61
Condensed Consolidated Statement of Financial Position
| As at March 31, 2020 | MFC<br><br> <br>(Guarantor) | JHUSA<br><br> <br>(Issuer) | Other<br><br> <br>subsidiaries | Consolidation<br><br> <br>adjustments | Consolidated<br><br> <br>MFC | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Invested assets | $ | 17 | $ | 119,752 | $ | 285,877 | $ | (317 | ) | $ | 405,329 | ||
| Investments in unconsolidated subsidiaries | 64,129 | 8,944 | 21,495 | (94,568 | ) | - | |||||||
| Reinsurance assets | - | 64,870 | 10,927 | (30,743 | ) | 45,054 | |||||||
| Other assets | 958 | 37,420 | 56,876 | (26,460 | ) | 68,794 | |||||||
| Segregated funds net assets | - | 165,182 | 149,664 | (2,593 | ) | 312,253 | |||||||
| Total assets | $ | 65,104 | $ | 396,168 | $ | 524,839 | $ | (154,681 | ) | $ | 831,430 | ||
| Liabilities and equity | |||||||||||||
| Insurance contract liabilities | $ | - | $ | 176,908 | $ | 238,018 | $ | (31,460 | ) | $ | 383,466 | ||
| Investment contract liabilities | - | 1,177 | 2,209 | (1 | ) | 3,385 | |||||||
| Other liabilities | 1,466 | 30,752 | 58,432 | (26,144 | ) | 64,506 | |||||||
| Long-term debt | 4,963 | - | - | - | 4,963 | ||||||||
| Capital instruments | 3,398 | 654 | 2,744 | - | 6,796 | ||||||||
| Segregated funds net liabilities | - | 165,182 | 149,664 | (2,593 | ) | 312,253 | |||||||
| Shareholders' equity | 55,277 | 21,495 | 72,988 | (94,483 | ) | 55,277 | |||||||
| Participating policyholders' equity | - | - | (388 | ) | - | (388 | ) | ||||||
| Non-controlling interests | - | - | 1,172 | - | 1,172 | ||||||||
| Total liabilities and equity | $ | 65,104 | $ | 396,168 | $ | 524,839 | $ | (154,681 | ) | $ | 831,430 |
Condensed Consolidated Statement of Financial Position
| As at December 31, 2019 | MFC<br><br> <br>(Guarantor) | JHUSA<br><br> <br>(Issuer) | Other<br><br> <br>subsidiaries | Consolidation<br><br> <br>adjustments | Consolidated<br><br> <br>MFC | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Invested assets | $ | 21 | $ | 107,746 | $ | 271,100 | $ | (340 | ) | $ | 378,527 | ||
| Investments in unconsolidated subsidiaries | 57,068 | 7,467 | 16,983 | (81,518 | ) | - | |||||||
| Reinsurance assets | - | 61,310 | 10,080 | (29,944 | ) | 41,446 | |||||||
| Other assets | 406 | 20,859 | 45,111 | (20,327 | ) | 46,049 | |||||||
| Segregated funds net assets | - | 181,982 | 162,845 | (1,719 | ) | 343,108 | |||||||
| Total assets | $ | 57,495 | $ | 379,364 | $ | 506,119 | $ | (133,848 | ) | $ | 809,130 | ||
| Liabilities and equity | |||||||||||||
| Insurance contract liabilities | $ | - | $ | 157,398 | $ | 224,378 | $ | (30,615 | ) | $ | 351,161 | ||
| Investment contract liabilities | - | 1,091 | 2,014 | (1 | ) | 3,104 | |||||||
| Other liabilities | 537 | 21,311 | 48,226 | (20,086 | ) | 49,988 | |||||||
| Long-term debt | 4,543 | - | - | - | 4,543 | ||||||||
| Capital instruments | 3,277 | 599 | 3,244 | - | 7,120 | ||||||||
| Segregated funds net liabilities | - | 181,982 | 162,845 | (1,719 | ) | 343,108 | |||||||
| Shareholders' equity | 49,138 | 16,983 | 64,444 | (81,427 | ) | 49,138 | |||||||
| Participating policyholders' equity | - | - | (243 | ) | - | (243 | ) | ||||||
| Non-controlling interests | - | - | 1,211 | - | 1,211 | ||||||||
| Total liabilities and equity | $ | 57,495 | $ | 379,364 | $ | 506,119 | $ | (133,848 | ) | $ | 809,130 |
Manulife Financial Corporation – First Quarter 2020
62
Condensed Consolidated Statement of Income
| For the three months ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2020 | MFC<br><br> <br>(Guarantor) | JHUSA<br><br> <br>(Issuer) | Other<br><br> <br>subsidiaries | Consolidation<br><br> <br>adjustments | Consolidated<br><br> <br>MFC | ||||||||||
| Revenue | |||||||||||||||
| Net premium income | $ | - | $ | 1,202 | $ | 8,153 | $ | - | $ | 9,355 | |||||
| Net investment income (loss) | (13 | ) | 8,226 | (363 | ) | (8 | ) | 7,842 | |||||||
| Net other revenue | (6 | ) | 479 | 6,812 | (4,305 | ) | 2,980 | ||||||||
| Total revenue | (19 | ) | 9,907 | 14,602 | (4,313 | ) | 20,177 | ||||||||
| Contract benefits and expenses | |||||||||||||||
| Net benefits and claims | - | 6,879 | 11,129 | (3,919 | ) | 14,089 | |||||||||
| Commissions, investment and general expenses | 7 | 884 | 3,380 | (361 | ) | 3,910 | |||||||||
| Other expenses | 104 | 61 | 342 | (33 | ) | 474 | |||||||||
| Total contract benefits and expenses | 111 | 7,824 | 14,851 | (4,313 | ) | 18,473 | |||||||||
| Income (loss) before income taxes | (130 | ) | 2,083 | (249 | ) | - | 1,704 | ||||||||
| Income tax (expense) recovery | 35 | (384 | ) | (248 | ) | - | (597 | ) | |||||||
| Income (loss) after income taxes | (95 | ) | 1,699 | (497 | ) | - | 1,107 | ||||||||
| Equity in net income (loss) of unconsolidated subsidiaries | 1,391 | (66 | ) | 1,633 | (2,958 | ) | - | ||||||||
| Net income (loss) | $ | 1,296 | $ | 1,633 | $ | 1,136 | $ | (2,958 | ) | $ | 1,107 | ||||
| Net income (loss) attributed to: | |||||||||||||||
| Non-controlling interests | $ | - | $ | - | $ | (43 | ) | $ | - | $ | (43 | ) | |||
| Participating policyholders | - | - | (146 | ) | - | (146 | ) | ||||||||
| Shareholders | 1,296 | 1,633 | 1,325 | (2,958 | ) | 1,296 | |||||||||
| $ | 1,296 | $ | 1,633 | $ | 1,136 | $ | (2,958 | ) | $ | 1,107 |
Condensed Consolidated Statement of Income
| For the three months ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2019 | MFC<br><br> <br>(Guarantor) | JHUSA<br><br> <br>(Issuer) | Other<br><br> <br>subsidiaries | Consolidation<br><br> <br>adjustments | Consolidated<br><br> <br>MFC | ||||||||||
| Revenue | |||||||||||||||
| Net premium income | $ | - | $ | 1,183 | $ | 7,131 | $ | - | $ | 8,314 | |||||
| Net investment income (loss) | (8 | ) | 3,406 | 9,301 | (26 | ) | 12,673 | ||||||||
| Net other revenue | 4 | 767 | 2,825 | (1,034 | ) | 2,562 | |||||||||
| Total revenue | (4 | ) | 5,356 | 19,257 | (1,060 | ) | 23,549 | ||||||||
| Contract benefits and expenses | |||||||||||||||
| Net benefits and claims | - | 4,413 | 13,097 | (663 | ) | 16,847 | |||||||||
| Commissions, investment and general expenses | 8 | 768 | 3,353 | (377 | ) | 3,752 | |||||||||
| Other expenses | 100 | 53 | 293 | (20 | ) | 426 | |||||||||
| Total contract benefits and expenses | 108 | 5,234 | 16,743 | (1,060 | ) | 21,025 | |||||||||
| Income (loss) before income taxes | (112 | ) | 122 | 2,514 | - | 2,524 | |||||||||
| Income tax (expense) recovery | 29 | (2 | ) | (316 | ) | - | (289 | ) | |||||||
| Income (loss) after income taxes | (83 | ) | 120 | 2,198 | - | 2,235 | |||||||||
| Equity in net income (loss) of unconsolidated subsidiaries | 2,259 | 238 | 358 | (2,855 | ) | - | |||||||||
| Net income (loss) | $ | 2,176 | $ | 358 | $ | 2,556 | $ | (2,855 | ) | $ | 2,235 | ||||
| Net income (loss) attributed to: | |||||||||||||||
| Non-controlling interests | $ | - | $ | - | $ | 73 | $ | - | $ | 73 | |||||
| Participating policyholders | - | - | (14 | ) | - | (14 | ) | ||||||||
| Shareholders | 2,176 | 358 | 2,497 | (2,855 | ) | 2,176 | |||||||||
| $ | 2,176 | $ | 358 | $ | 2,556 | $ | (2,855 | ) | $ | 2,235 |
Manulife Financial Corporation – First Quarter 2020
63
Consolidated Statement of Cash Flows
| For the three months ended March 31, 2020 | MFC<br><br> <br>(Guarantor) | JHUSA<br><br> <br>(Issuer) | Other<br><br> <br>subsidiaries | Consolidation<br><br> <br>adjustments | Consolidated<br><br> <br>MFC | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | |||||||||||||||
| Net income (loss) | $ | 1,296 | $ | 1,633 | $ | 1,136 | $ | (2,958 | ) | $ | 1,107 | ||||
| Adjustments: | |||||||||||||||
| Equity in net income of unconsolidated subsidiaries | (1,391 | ) | 66 | (1,633 | ) | 2,958 | - | ||||||||
| Increase (decrease) in insurance contract liabilities | - | (1,107 | ) | 9,207 | - | 8,100 | |||||||||
| Increase (decrease) in investment contract liabilities | - | 12 | 34 | - | 46 | ||||||||||
| (Increase) decrease in reinsurance assets excluding coinsurance transactions | - | 1,960 | (1,843 | ) | - | 117 | |||||||||
| Amortization of (premium) discount on invested assets | - | 11 | 17 | - | 28 | ||||||||||
| Other amortization | 1 | 39 | 134 | - | 174 | ||||||||||
| Net realized and unrealized (gains) losses and impairment on assets | (6 | ) | (7,189 | ) | 2,891 | - | (4,304 | ) | |||||||
| Deferred income tax expense (recovery) | (36 | ) | 144 | 343 | - | 451 | |||||||||
| Stock option expense | - | (1 | ) | 4 | - | 3 | |||||||||
| Cash provided by (used in) operating activities before undernoted items | (136 | ) | (4,432 | ) | 10,290 | - | 5,722 | ||||||||
| Dividends from unconsolidated subsidiary | - | 90 | 168 | (258 | ) | - | |||||||||
| Changes in policy related and operating receivables and payables | (31 | ) | 8,122 | (9,044 | ) | - | (953 | ) | |||||||
| Cash provided by (used in) operating activities | (167 | ) | 3,780 | 1,414 | (258 | ) | 4,769 | ||||||||
| Investing activities | |||||||||||||||
| Purchases and mortgage advances | - | (8,748 | ) | (18,236 | ) | - | (26,984 | ) | |||||||
| Disposals and repayments | - | 8,348 | 20,277 | - | 28,625 | ||||||||||
| Changes in investment broker net receivables and payables | - | (351 | ) | 662 | - | 311 | |||||||||
| Notes receivable from parent | - | - | (1,076 | ) | 1,076 | - | |||||||||
| Notes receivable from subsidiaries | (100 | ) | - | - | 100 | - | |||||||||
| Cash provided by (used in) investing activities | (100 | ) | (751 | ) | 1,627 | 1,176 | 1,952 | ||||||||
| Financing activities | |||||||||||||||
| Change in repurchase agreements and securities sold but not yet purchased | - | - | (163 | ) | - | (163 | ) | ||||||||
| Redemption of capital instruments | - | - | (500 | ) | - | (500 | ) | ||||||||
| Secured borrowings | - | 709 | 131 | - | 840 | ||||||||||
| Changes in deposits from Bank clients, net | - | - | (288 | ) | - | (288 | ) | ||||||||
| Lease payments | - | (2 | ) | (32 | ) | - | (34 | ) | |||||||
| Shareholders' dividends paid in cash | (583 | ) | - | - | - | (583 | ) | ||||||||
| Dividends paid to parent | - | (168 | ) | (90 | ) | 258 | - | ||||||||
| Contributions from (distributions to) non-controlling interests, net | - | - | 4 | - | 4 | ||||||||||
| Common shares repurchased | (253 | ) | - | - | - | (253 | ) | ||||||||
| Common shares issued, net | 19 | - | - | - | 19 | ||||||||||
| Notes payable to parent | - | - | 100 | (100 | ) | - | |||||||||
| Notes payable to subsidiaries | 1,076 | - | - | (1,076 | ) | - | |||||||||
| Cash provided by (used in) financing activities | 259 | 539 | (838 | ) | (918 | ) | (958 | ) | |||||||
| Cash and short-term securities | |||||||||||||||
| Increase (decrease) during the period | (8 | ) | 3,568 | 2,203 | - | 5,763 | |||||||||
| Effect of foreign exchange rate changes on cash and short-term securities | 3 | 281 | 808 | - | 1,092 | ||||||||||
| Balance, beginning of period | 22 | 2,564 | 16,962 | - | 19,548 | ||||||||||
| Balance, end of period | 17 | 6,413 | 19,973 | - | 26,403 | ||||||||||
| Cash and short-term securities | |||||||||||||||
| Beginning of period | |||||||||||||||
| Gross cash and short-term securities | 22 | 3,058 | 17,220 | - | 20,300 | ||||||||||
| Net payments in transit, included in other liabilities | - | (494 | ) | (258 | ) | - | (752 | ) | |||||||
| Net cash and short-term securities, beginning of period | 22 | 2,564 | 16,962 | - | 19,548 | ||||||||||
| End of period | |||||||||||||||
| Gross cash and short-term securities | 17 | 6,856 | 20,214 | - | 27,087 | ||||||||||
| Net payments in transit, included in other liabilities | - | (443 | ) | (241 | ) | - | (684 | ) | |||||||
| Net cash and short-term securities, end of period | $ | 17 | $ | 6,413 | $ | 19,973 | $ | - | $ | 26,403 | |||||
| Supplemental disclosures on cash flow information: | |||||||||||||||
| Interest received | $ | 25 | $ | 1,010 | $ | 1,741 | $ | (91 | ) | $ | 2,685 | ||||
| Interest paid | 142 | 11 | 232 | (91 | ) | 294 | |||||||||
| Income taxes paid (refund) | - | 1 | 215 | - | 216 |
Manulife Financial Corporation – First Quarter 2020
64
Consolidated Statement of Cash Flows
| For the three months ended March 31, 2019 | MFC<br><br> <br>(Guarantor) | JHUSA<br><br> <br>(Issuer) | Other<br><br> <br>subsidiaries | Consolidation<br><br> <br>adjustments | Consolidated<br><br> <br>MFC | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | |||||||||||||||
| Net income (loss) | $ | 2,176 | $ | 358 | $ | 2,556 | $ | (2,855 | ) | $ | 2,235 | ||||
| Adjustments: | |||||||||||||||
| Equity in net income of unconsolidated subsidiaries | (2,259 | ) | (238 | ) | (358 | ) | 2,855 | - | |||||||
| Increase (decrease) in insurance contract liabilities | - | 3,147 | 8,260 | - | 11,407 | ||||||||||
| Increase (decrease) in investment contract liabilities | - | 13 | 30 | - | 43 | ||||||||||
| (Increase) decrease in reinsurance assets excluding coinsurance transactions | - | (357 | ) | 771 | - | 414 | |||||||||
| Amortization of (premium) discount on invested assets | - | 7 | 23 | - | 30 | ||||||||||
| Other amortization | 1 | 29 | 125 | - | 155 | ||||||||||
| Net realized and unrealized (gains) losses and impairment on assets | (1 | ) | (2,226 | ) | (7,084 | ) | - | (9,311 | ) | ||||||
| Deferred income tax expense (recovery) | (30 | ) | (1 | ) | 163 | - | 132 | ||||||||
| Stock option expense | - | (1 | ) | 4 | - | 3 | |||||||||
| Cash provided by (used in) operating activities before undernoted items | (113 | ) | 731 | 4,490 | - | 5,108 | |||||||||
| Dividends from unconsolidated subsidiary | - | 1 | - | (1 | ) | - | |||||||||
| Changes in policy related and operating receivables and payables | (84 | ) | (1,568 | ) | 455 | - | (1,197 | ) | |||||||
| Cash provided by (used in) operating activities | (197 | ) | (836 | ) | 4,945 | (1 | ) | 3,911 | |||||||
| Investing activities | |||||||||||||||
| Purchases and mortgage advances | - | (5,416 | ) | (14,109 | ) | - | (19,525 | ) | |||||||
| Disposals and repayments | - | 5,860 | 10,065 | - | 15,925 | ||||||||||
| Changes in investment broker net receivables and payables | - | (2 | ) | 132 | - | 130 | |||||||||
| Net cash flows from acquisition and disposal of subsidiaries and businesses | - | - | 253 | - | 253 | ||||||||||
| Return of capital from unconsolidated subsidiaries | - | 67 | - | (67 | ) | - | |||||||||
| Notes receivable from parent | - | - | (815 | ) | 815 | - | |||||||||
| Notes receivable from subsidiaries | (81 | ) | - | - | 81 | - | |||||||||
| Cash provided by (used in) investing activities | (81 | ) | 509 | (4,474 | ) | 829 | (3,217 | ) | |||||||
| Financing activities | |||||||||||||||
| Change in repurchase agreements and securities sold but not yet purchased | - | - | 203 | - | 203 | ||||||||||
| Redemption of capital instruments | - | - | (500 | ) | - | (500 | ) | ||||||||
| Changes in deposits from Bank clients, net | - | - | 308 | - | 308 | ||||||||||
| Lease payments | - | (2 | ) | (25 | ) | - | (27 | ) | |||||||
| Shareholders' dividends paid in cash | (339 | ) | - | - | - | (339 | ) | ||||||||
| Dividends paid to parent | - | - | (1 | ) | 1 | - | |||||||||
| Common shares repurchased | (206 | ) | - | - | - | (206 | ) | ||||||||
| Common shares issued, net | 14 | - | - | - | 14 | ||||||||||
| Return of capital to parent | - | - | (67 | ) | 67 | - | |||||||||
| Notes payable to parent | - | - | 81 | (81 | ) | - | |||||||||
| Notes payable to subsidiaries | 815 | - | - | (815 | ) | - | |||||||||
| Cash provided by (used in) financing activities | 284 | (2 | ) | (1 | ) | (828 | ) | (547 | ) | ||||||
| Cash and short-term securities | |||||||||||||||
| Increase (decrease) during the period | 6 | (329 | ) | 470 | - | 147 | |||||||||
| Effect of foreign exchange rate changes on cash and short-term securities | - | (54 | ) | (152 | ) | - | (206 | ) | |||||||
| Balance, beginning of period | 21 | 2,317 | 13,044 | - | 15,382 | ||||||||||
| Balance, end of period | 27 | 1,934 | 13,362 | - | 15,323 | ||||||||||
| Cash and short-term securities | |||||||||||||||
| Beginning of period | |||||||||||||||
| Gross cash and short-term securities | 21 | 2,783 | 13,411 | - | 16,215 | ||||||||||
| Net payments in transit, included in other liabilities | - | (466 | ) | (367 | ) | - | (833 | ) | |||||||
| Net cash and short-term securities, beginning of period | 21 | 2,317 | 13,044 | - | 15,382 | ||||||||||
| End of period | |||||||||||||||
| Gross cash and short-term securities | 27 | 2,345 | 13,725 | - | 16,097 | ||||||||||
| Net payments in transit, included in other liabilities | - | (411 | ) | (363 | ) | - | (774 | ) | |||||||
| Net cash and short-term securities, end of period | $ | 27 | $ | 1,934 | $ | 13,362 | $ | - | $ | 15,323 | |||||
| Supplemental disclosures on cash flow information: | |||||||||||||||
| Interest received | $ | 28 | $ | 1,100 | $ | 1,724 | $ | (91 | ) | $ | 2,761 | ||||
| Interest paid | 143 | 17 | 190 | (91 | ) | 259 | |||||||||
| Income taxes paid (refund) | - | (1 | ) | 303 | - | 302 |
Manulife Financial Corporation – First Quarter 2020
65
| Note 16 | Comparatives |
|---|
Certain comparative amounts have been reclassified to conform to the current period’s presentation.
Manulife Financial Corporation – First Quarter 2020
66
SHAREHOLDER INFORMATION
| MANULIFE FINANCIAL CORPORATION<br><br> <br>HEAD OFFICE<br><br> <br>200 Bloor Street East<br><br> <br>Toronto, ON Canada M4W 1E5<br><br> <br>Telephone: 416 926-3000<br><br> <br>Online: www.manulife.com<br><br> <br><br><br> <br>INVESTOR RELATIONS<br><br> <br>Financial analysts, portfolio managers and<br><br> <br>other investors requiring financial information<br><br> <br>may contact our Investor Relations Department<br><br> <br>or access our Web site at www.manulife.com<br><br> <br>E-mail: InvestRel@manulife.com<br><br> <br><br><br> <br>SHAREHOLDER SERVICES<br><br> <br>For information or assistance regarding<br><br> <br>your share account, including dividends,<br><br> <br>changes of address or ownership, lost<br><br> <br>certificates, to eliminate duplicate mailings<br><br> <br>or to receive shareholder material<br><br> <br>electronically, please contact our Transfer<br><br> <br>Agents in Canada, the United States, Hong<br><br> <br>Kong or the Philippines. If you live outside one<br><br> <br>of these countries, please contact our Canadian<br><br> <br>Transfer Agent. | TRANSFER AGENTS<br><br> <br>Canada<br><br> <br>AST Trust Company (Canada)<br><br> <br>P.O. Box 700, Station B<br><br> <br>Montreal, QC Canada H3B 3K3<br><br> <br>Toll Free: 1 800 783-9495<br><br> <br>Collect: 416 682-3864<br><br> <br>E-mail: inquiries@astfinancial.com<br><br> <br>Online: www.astfinancial.com/ca-en<br><br> <br>AST Trust Company (Canada) offices are also<br><br> <br>located in Toronto, Vancouver and Calgary.<br><br> <br><br><br> <br>United States<br><br> <br>American Stock Transfer & Trust Company, LLC<br><br> <br>P.O. Box 199036<br><br> <br>Brooklyn, NY<br><br> <br>United States 11219<br><br> <br>Toll Free: 1 800 249-7702<br><br> <br>Collect: 416 682-3864<br><br> <br>E-mail: manulifeinquiries@astfinancial.com<br><br> <br>Online: www.astfinancial.com<br><br> <br><br><br> <br>Hong Kong<br><br> <br>Tricor Investor Services Limited<br><br> <br>Level 54, Hopewell Centre<br><br> <br>183 Queen's Road East<br><br> <br>Wan Chai, Hong Kong<br><br> <br>Telephone: 852 2980-1333<br><br> Email: is-enquiries@hk.tricorglobal.com<br><br> <br>Online: www.tricorglobal.com/services/investor-services | Philippines<br><br> <br>Rizal Commercial Banking Corporation<br><br> <br>Ground Floor, West Wing<br><br> <br>GPL (Grepalife) Building<br><br> <br>221 Senator Gil Puyat Avenue<br><br> <br>Makati City, Metro Manila, Philippines<br><br> <br>Telephone: 632 5318-8567<br><br> <br>E-mail: rcbcstocktransfer@rcbc.com<br><br> <br>Online: www.rcbc.com<br><br> <br><br><br> <br>AUDITORS<br><br> <br>Ernst & Young LLP<br><br> <br>Chartered Professional Accountants<br><br> <br>Licensed Public Accountants<br><br> <br>Toronto, Canada |
|---|---|---|
| The following Manulife documents are<br><br> <br>available online at www.manulife.com<br><br> <br><br><br> <br>· Annual Report<br> and Proxy Circular<br><br> <br>· Notice of<br> Annual Meeting<br><br> <br>· Shareholders<br> Reports<br><br> <br>· Public<br> Accountability Statement<br><br> <br>· Corporate<br> Governance material | ||
| RATING<br> Financial strength is a key factor in generating new business,<br> maintaining and expanding distribution relations and providing a base for expansion, acquisitions and growth. As at March 31, 2020, Manulife had total capital of C63.2 billion, including C55.2 billion of total shareholders’<br> equity. The Manufacturers Life Insurance Company’s financial strength and claims paying ability ratings are among the strongest in the insurance industry. | ||
| --- | --- | --- |
| Rating<br><br> <br>AA- | Rank<br><br> <br>(4th of 21 ratings) | |
| A1 | (5th of 21 ratings) | |
| AA- | (4th of 21 ratings) | |
| AA (low) | (4th of 22 ratings) | |
| A+ (Superior) | (2nd of 13 ratings) |
All values are in US Dollars.
| COMMON STOCK TRADING DATA<br><br> <br>The following values are the high, low and close prices, including the average daily trading volume<br> for Manulife Financial Corporation’s common stock on the Canadian exchanges, the U.S. exchanges, The Stock Exchange of Hong Kong and the Philippine Stock Exchange for the first quarter. The common stock symbol is MFC on all exchanges except Hong Kong where it is 945. | As at March 31, 2020, there were 1,940 million common<br> shares outstanding. | |||||
|---|---|---|---|---|---|---|
| January 1 –<br><br> <br>March 31,<br><br> 2020 | Canada<br><br> <br>Canadian $ | U.S.<br><br> <br>United States $ | Hong Kong<br><br> <br>Hong Kong $ | Philippines<br><br> <br>Philippine<br><br> <br>Pesos | ||
| High | $27.79 | $21.23 | $164.80 | P 880 | ||
| Low | $12.58 | $8.62 | $103.60 | P 600 | ||
| Close | $17.67 | $12.54 | $107.40 | P 718 | ||
| Average<br><br> <br>Daily Volume<br><br> <br>(000) | 13,856 | 3,050 | 43 | 0.10 |
Manulife Financial Corporation – First Quarter 2020
67
| Consent to receive documents electronically | |
|---|---|
| Electronic documents available from Manulife<br><br> <br> <br><br><br> <br> <br>Manulife is pleased to offer Electronic Documents. Access the<br><br> <br> <br>information when you want, no more waiting for the mail.<br><br> <br> <br><br><br> <br> <br>The Manulife documents available electronically are:<br><br> <br> <br>· Annual Report and<br> Proxy Circular<br><br> <br> <br>· Notice of Annual<br> Meeting<br><br> <br> <br>· Shareholder Reports<br><br> <br> <br>· Public<br> Accountability Statement<br><br> <br> <br>· Corporate Governance<br> material | These documents will be available to you on our Web site at www.manulife.com at the same time as they are mailed to other shareholders. Documents relating to the annual meeting, including annual reports will be available on the Web site at least until the<br> next version is available.<br><br> <br> <br><br><br> <br> <br>We will notify you when documents will be available on the Web site and confirm the<br> instructions for accessing the documents at the same time. In the event that the documents are not available on our Web site, paper copies will be mailed to you.<br><br> <br> <br><br><br> <br> <br>This information is also available for viewing or download under quarterly reports from the<br> Investor Relations section of our Web site at www.manulife.com |
| --- | --- |
.
…………………………………….………………….………Detach here ..…………………………..……………………………………………………
| To receive documents electronically when they are available through<br><br> <br>Manulife’s electronic delivery service, complete this form and<br><br> <br>return it as indicated.<br><br> <br><br><br> <br>I have read and understand the statement on the reverse and consent to<br><br> <br>receive electronically the Manulife documents listed in the<br><br> <br>manner described. I acknowledge that I have the computer requirements<br><br> <br>to access the documents that are made available on Manulife’s<br><br> <br>Web site. I understand that I am not required to consent to electronic<br><br> <br>delivery and that I may revoke my consent at any time.<br><br> <br><br><br> <br>Please note: We will contact you by phone only if there is a problem with<br><br> <br>your email address.<br><br> <br><br><br> <br>The information provided is confidential and will not be used for any<br><br> <br>purpose other than that described. | Please Print:<br><br> <br><br><br> <br>_________________________________________________________<br><br> <br>Shareholder Name<br><br> <br><br><br> <br>_________________________________________________________<br><br> <br>Contact Phone Number<br><br> <br><br><br> <br>_________________________________________________________<br><br> <br>Shareholder email Address<br><br> <br><br><br> <br><br><br> <br><br><br> <br>_________________________________________________________<br><br> <br>Shareholder Signature<br><br> <br><br><br> <br>_________________________________________________________<br><br> <br>Date |
|---|
Manulife Financial Corporation – First Quarter 2020
68
Form 52-109F2
Certification of Interim Filings
Full Certificate
I, Roy Gori, President and Chief Executive Officer of Manulife Financial Corporation, certify the following:
| 1. | Review: I have reviewed the interim financial report and interim<br> MD&A (together, the “interim filings”) of Manulife Financial Corporation (the “issuer”) for the interim period ended March 31, 2020. |
|---|---|
| 2. | No misrepresentations: Based on my knowledge, having exercised<br> reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances<br> under which it was made, with respect to the period covered by the interim filings. |
| --- | --- |
| 3. | Fair presentation: Based on my knowledge, having exercised reasonable<br> diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as<br> of the date of and for the periods presented in the interim filings. |
| --- | --- |
| 4. | Responsibility: The issuer’s other certifying officer(s) and I are<br> responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuer’s Annual and Interim Filings, for the issuer. |
| --- | --- |
| 5. | Design: Subject to the limitations, if any, described in paragraphs<br> 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings |
| --- | --- |
| (a) | designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that |
| --- | --- |
| (i) | material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and |
| --- | --- |
| (ii) | information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is<br> recorded, processed, summarized and reported within the time periods specified in securities legislation; and |
| --- | --- |
| (b) | designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of<br> financial statements for external purposes in accordance with the issuer’s GAAP. |
| --- | --- |
| 5.1 | Control framework: The control framework the issuer’s other<br> certifying officer(s) and I used to design the issuer’s ICFR is Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. |
| --- | --- |
| 5.2 | N/A |
| --- | --- |
| 5.3 | N/A |
| --- | --- |
| 6. | Reporting changes in ICFR: The issuer has disclosed in its interim<br> MD&A any change in the issuer’s ICFR that occurred during the period beginning on January 1, 2020 and ended on March 31, 2020 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR. |
| --- | --- |
Date: May 6, 2020
/s/ Roy Gori
Roy Gori
President and Chief Executive Officer
Form 52-109F2
Certification of Interim Filings
Full Certificate
I, Philip J. Witherington, Chief Financial Officer of Manulife Financial Corporation, certify the following:
| 1. | Review: I have reviewed the interim financial report and interim<br> MD&A (together, the “interim filings”) of Manulife Financial Corporation (the “issuer”) for the interim period ended March 31, 2020. |
|---|---|
| 2. | No misrepresentations: Based on my knowledge, having exercised<br> reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances<br> under which it was made, with respect to the period covered by the interim filings. |
| --- | --- |
| 3. | Fair presentation: Based on my knowledge, having exercised reasonable<br> diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as<br> of the date of and for the periods presented in the interim filings. |
| --- | --- |
| 4. | Responsibility: The issuer’s other certifying officer(s) and I are<br> responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuer’s Annual and Interim Filings, for the issuer. |
| --- | --- |
| 5. | Design: Subject to the limitations, if any, described in paragraphs<br> 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings |
| --- | --- |
| (a) | designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that |
| --- | --- |
| (i) | material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and |
| --- | --- |
| (ii) | information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is<br> recorded, processed, summarized and reported within the time periods specified in securities legislation; and |
| --- | --- |
| (b) | designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of<br> financial statements for external purposes in accordance with the issuer’s GAAP. |
| --- | --- |
| 5.1 | Control framework: The control framework the issuer’s other<br> certifying officer(s) and I used to design the issuer’s ICFR is Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. |
| --- | --- |
| 5.2 | N/A |
| --- | --- |
| 5.3 | N/A |
| --- | --- |
| 6. | Reporting changes in ICFR: The issuer has disclosed in its interim<br> MD&A any change in the issuer’s ICFR that occurred during the period beginning on January 1, 2020 and ended on March 31, 2020 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR. |
| --- | --- |
Date: May 6, 2020
/s/ Philip J. Witherington
Philip J. Witherington
Chief Financial Officer